Roles for NFkappaB, PHD3 and neural activity in the development of the peripheral nervous system by Gallagher, Denis J.
Roles for NFkB, PHD3 and Neural Activity in the 
Development of the Peripheral Nervous System
A thesis submitted to Cardiff University for the degree of PhD
2008
Denis J. Gallagher
Cardiff School of Biosciences 
Cardiff University
UMI Number: U585100
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U585100
Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
DECLARATION
This work has not previously been accepted in substance for any degree and is not 
concurrently submitted in candidature for any degree.
Date “2$ / 2J°°8
STATEMENT 1
This thesis is being submitted in partial fulfillment of the requirements for the degree 
o f  f.hD ......................(insert MCh, MD, MPhil, PhD etc, as appropriate)
Signed   (candidate) Dat
STATEMENT 2
This thesis is the result of my own independent work/investigation, except where 
otherwise stated.
Other sources are acknowledged by explicit references.
Signed   (candidate) Date
STATEMENT 3
I hereby give consent for my thesis, if accepted, to be available for photocopying and 
for inter-library loan, and for the title and summary to be made available to outside 
organisations.
Signed (candidate)
STATEMENT 4
I hereby give consent for my thesis, if accepted, to be available for photocopying and 
for inter-library loans after expiry of a bar on access previously approved by the 
Graduate Development Committee.
2
Abstract
In the developing peripheral nervous system, neuronal survival and axonal growth are 
regulated to a large extent by neurotrophic factors acting via intracellular signalling 
cascades that are not fully understood. Here, I describe crucial roles for the nuclear 
factor-kappa B (NFkB) transcription cascade and the cellular oxygen sensor proline 
hydroxylase domain 3 (PHD3) in the regulation of axonal growth and neuronal 
survival during the phase of target field innervation, and I describe a novel role for 
purinergic signalling in promoting neuronal survival at a later stage of development. 
Using sensory neurons of the nodose ganglion, I show that distinct NFkB activation 
mechanisms are responsible for neurite growth promoted by ciliary neurotrophic 
factor (CNTF) and brain-derived neurotrophic factor (BDNF). Whereas a non- 
canonical NFkB signalling pathway that requires tyrosine phosphorylation of IicBa is 
crucial for CNTF -promoted growth, canonical signalling that requires serine 
phosphorylation of IicBa contributes to BDNF -promoted growth. Using sympathetic 
neurons of the superior cervical ganglion of wild type and PHD3-deficient mice, I 
show that PHD3 exerts a negative regulatory effect on neuronal survival and neurite 
growth, implicating oxygen sensitive pathways in the regulation of sympathetic 
neuron development. Despite increased numbers of sympathetic neurons in PHD3- 
deficient mice there was decreased target innervation density and defective 
sympathetic function. Finally, in nodose neurons I describe roles for depolarization 
and purinergic signalling in promoting neuronal survival during a window of 
development as the neurons begin to lose their dependence on BDNF for survival.
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Chapter 1 — General Introduction
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1.1 Brief overview of neuronal development
1.1.1 Introduction
A series of tightly regulated mechanisms have been conserved throughout 
evolutionary time to construct the vertebrate nervous system. Neurons are bom, 
migrate, extend processes towards their targets and finally make an appropriate 
number of functional synaptic contacts with a target tissue. I will first provide a brief 
overview of these stages of neuronal development followed by a description of the 
structure and development of the peripheral nervous system (PNS). I will then 
describe in detail the regulation of neuronal survival and neurite outgrowth. Finally, I 
will introduce two families of proteins, the NFkB transcription factor family and PHD 
family, whose roles in peripheral neuronal survival and / or neurite outgrowth are the 
main focus of this research.
1.1.2 Neural induction
The fertilised ovum undergoes multiple divisions eventually forming a bilaminar disc. 
The bilaminar disc contains two cell types, ectodermal and endodermal cells. 
Ectodermal cells migrate to form an intermediate layer called the mesoderm. The 
formation of the trilaminar embryo, consisting of ectoderm, endoderm and mesoderm 
is known as gastrulation. These three layers give rise to the adult body. The ectoderm 
will eventually give rise to the entire nervous system as well as the epidermis. Neural 
induction is the process by which ectodermal cells “decide” to become neuronal.
Once ectodermal cells have been induced, they elongate and are referred to as 
neuroectodermal cells or neural plate cells.
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A series of pioneering experiments using amphibian embryos, established that the 
signal which specifies induction of ectoderm is contained within an “organiser” tissue 
in the dorsal blastopore lip. Transplantation of “Spemann’s organiser” from the dorsal 
side of one embryo to the ventral side of another embryo induced the formation of a 
secondary neural axis ventrally. Interestingly, transplantation of “organiser” tissue 
(Hensen’s node in mammals) from one species can induce the formation of a neural 
axis in another species which indicates that the mechanisms of neural induction are 
highly conserved [1-3]
Hilde Mangold, who carried out the classical experiments which identified the 
“organiser”, died in 1924 at the age of 26 in a kitchen fire. Had she survived, she 
would have witnessed decades of research dedicated to identifying the molecular 
mechanisms of neural induction. It was not until the early 1990s that three proteins 
were identified within the organiser that were capable of neuralising the ectoderm ; 
Noggin [4-7], Follistatin [8] and Chordin [9,10].All three proteins are inhibitors of 
bone morphogenetic proteins (BMPs) [11-13] The finding that BMP4 inhibits neural 
fate but promotes epidermal fate led to the proposal of a default model of neural 
induction [14-16]. The default model of neural induction proposes that ectodermal 
cells tend to differentiate into neuronal cells but when BMP4 is present ectodermal 
cells differentiate into epidermal cells. Molecules like noggin, follistatin and chordin 
therefore induce neural differentiation by inhibiting the promoter of epidermal 
differentiation. Other BMP-inhibiting molecules have been identified such as 
Cerberus [17,18], Gremlin, Dan and Drm [19-23] and Ogon/Sizzled [24,25]. Recent 
findings have suggested that the simple default model described above may be too
20
simple to account for the complexity of neural induction. In addition to BMP 
signalling, Fibroblast growth factor (FGF),Wingless (Wnt), Protein kinase C (PKC)
i
and Ca have all been implicated in the regulation of neural induction [26]. It has 
become clear that the activation or repression of many genes at various times during 
induction regulate the formation of the neural plate.
1.13 The neural tube
A critical event during neuronal development is the formation of the neural tube. The 
neural tube gives rise to the entire adult central nervous system (CNS). The formation 
of the neural tube begins when the flat layer of cells making up the neural plate begins 
to fold and eventually fuses in the midline to form a hollow tube (Fig. 1). The fusion 
of the neural tube proceeds rostrally and caudally from the initial site(s) of fusion, 
forming a hollow cylinder with openings at both ends called the cranial and caudal 
neuropores. Although the cellular events leading to neural tube formation are well 
known [27], the molecular mechanisms are only beginning to be elucidated.
The initial neural plate re-shaping involves a process called convergent extension, 
during which laterally placed cells move towards the midline [28-30]. Convergent 
extension appears to be regulated by members of a non-canonical Wnt signalling 
pathway, the planar cell polarity pathway. The subsequent bending and folding of the 
neural plate is at least partially regulated by Sonic Hedgehog [31, 32]. The neural 
folds fuse in the midline and processes are extended between the neural folds whilst 
glycoproteins are deposited at the point of fusion [27]. Failure of the neural folds to 
elevate and fuse can result in a myriad of birth defects collectively referred to as
21
neural tube defects (NTDs). In humans the most common NTDs are anencephaly (a 
fatal failure of rostral neural tube closure) and myelomeningocele (failure of the 
vertebral neural tube fusion). To date, there have been over 80 mouse mutants 
generated which display NTDs, examples of which are shown in figure 2. The co­
ordinated action of many genes and environmental signals regulate neural tube 
formation and expansion of this simple tube leads to the formation of the brain and 
spinal cord [33].
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Figure 1 | Neural tube formation. The neural tube is formed as the flat neural plate (A) folds towards 
the midline (B and C). The apices of the neural folds join in the midline to form the neural tube (D).
Figure 2 | Neural tube defects. Mouse foetuses at embryonic day (E) 15.5 illustrate the appearance of 
(a) craniorachischisis and (b) exencephaly and open spina bifida. In craniorachischisis, the neural tube is 
open from the midbrain to the lower spine (between the two thin arrows in a). In the foetus shown in b, 
exencephaly is restricted to the midbrain (thin arrow in b), whereas spina bifida affects the lumbosacral 
region (arrowhead in b).
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1.1.4 Neurogenesis
The neural tube consists of bi-polar neuroepithelial cells that stretch the width of the 
tube from the pial surface to the ventricular surface. The nuclei o f neuroepithelial 
cells move between the pial and ventricular surfaces in a process termed interkinetic 
nuclear migration [34] which is illustrated in figure 3. The position of the nuclei 
varies depending on the stage of the cell cycle. Nuclei move towards the pial surface 
during Gi where they begin DNA synthesis (S). Once DNA synthesis is complete 
cells enter G2 and the nuclei return to the ventricular surface [35-37]. At the 
ventricular surface the neural epithelial cell divides by mitosis (M). Daughter cells 
then “decide” whether to re-join the pial surface and re-enter the cell cycle or exit the 
cell cycle and accumulate in a region called the intermediate zone. Proliferation of 
cells in the early embryonic neural tube leads to the formation of swellings called the 
telencephalon, diencephalon, metencephalon, mylencephalon mesencephalon and 
rhombencephalon, the precursors o f the adult forebrain, midbrain and hindbrain (Fig.
4).
Markers like [3H]-thymidine and BrdU have been used to identify the birth dates of 
neurons by binding to cells in S-phase [38-41]. Birth dating studies have revealed that 
withdrawal from the mitotic cell cycle occurs at defined times and varies between 
different regions of the neural tube. Neurons in the hindbrain are first to withdraw, 
followed by neurons in the spinal cord and ventral mesencephalon. Neocortical and 
cerebellar neurons withdraw from the cell cycle later in development. In general, 
firstborn neurons contribute to ventral brain structures and neurons bom later in 
development form dorsal structures involved in sensory and integrative functions. The
25
decision to exit the cell cycle may be regulated by retinoblastoma protein (pRb) 
through its inhibitory effect on the EF2 family of transcription factors which are 
essesntial for Gi to S transition. Inactivation of cyclin-dependent kinases by cyclin 
kinase inhibitors may also be required for cell cycle withdrawal[42]. Post-mitotic (Go) 
progenitor cells in the intermediate zone then begin migration and differentiation. The 
multitude of neuronal and glial cell types found in the adult CNS originate from a 
population of neuroepithelial precursors in the embryonic neural tube.
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Cell Fate 
Specification
Decision ' to Exit 
or Re-enter Cell Cycle
Figure 3 | Neurogenesis. Drawing illustrating interkinetic nuclear migration. The ventricular surface is 
at the bottom and the pial surface at the top o f the illustration. Nuclei move towards the pial surface 
during GI , where DNA synthesis (S) begins. Nuclei return to the ventricular surface at G2 where 
mitosis begins (M). Taken from (Hollyday 2001) based on (Sauer 1935)
Telencephalon
Diencephalon
Metencephalon
Mylencephalon
Spinal cord
Prosencephalon
Mesencephalon
Rhombencephalon
Figure 4| Early embryonic CNS. Illustration showing the neural tube and vesicles. Proliferation and 
migration of progenitor cells in the walls of the neural tube will give rise to the forebrain, midbrain, 
hindbrain and spinal cord.
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1.1.5 Neuronal migration
Neurons are bom when proliferating neuroepithelial cells withdraw from the cell 
cycle and accumulate in the ventricular zone. Newborn neurons must then migrate to 
their final destination. One type of neural progenitor in the early neural tube, the 
radial glial cell, retains its contacts with both the pial and ventricular surfaces. The 
processes of radial glial cells stretch, like the spokes of a bicycle wheel, between the 
pial and ventricular surfaces [43]. These long radial processes provide a scaffold for 
neurons migrating from the site of proliferation to their final destination (Fig. 5A-C) 
[44, 45]. Radial migration is the route by which the vast majority of neuronal 
precursors in the mammalian cortex reach there final destination [46]. In addition to 
the cerebral cortex, other laminated structures such as the cerebellar cortex, spinal 
cord, striatum and thalamus use either radial migration, or a mixture of radial and 
tangential migration. Tangential migratory routes have also been identified from the 
medial ganglionic eminence (MGE) to the neocortex and hippocampus, and from the 
lateral ganglionic eminence (LGE) to the olfactory bulb [47, 48].
Molecular regulation of neuronal migration requires complex co-ordination of 
external guidance cues and intracellular signalling mechanisms involved in cell 
motility [49]. Mutations effecting these pathways of neuronal migration can result in 
severe developmental abnormalities such as lissencephaly (Fig. 5D).
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Figure 5 |NeuronaI migration. (A) Illustration of a cortical neuron migrating on a glial cell process. (B) 
Electron micrograph of the region where the neuronal cell body adheres to the glial process. (C) 
Sequential photographs of a neuron migrating on a cerebellar glial process. Images taken from Gilbert 
Developmental Biology 6th edition. (D) MRI images comparing normal brain (left) with Lissencephaly 
(right). 30
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1.1.6 Axon growth and PCD
Before, during or after migration is complete, neurons begin to extend axons which 
are guided towards their targets. A combination of locally acting and diffusible 
guidance cues and target-derived neurotrophic factors regulate the final innervation 
pattern in the target tissue. During the period of target innervation approximately 50% 
of neurons die by programmed cell death (PCD). The regulation of PCD and axon 
growth / guidance is discussed in detail in sections 1.3 and 1.4.
1.1.7 Synaptogenesis
Neural signalling is based on complex patterns of activity between networks of 
neuronal and non-neuronal cells. Waves of activity are communicated between 
neurons via specialised regions of apposition called synapses. Neurotransmitters are 
released from the presynaptic active zone, traverse the synaptic cleft and bind to 
receptors that are clustered in a region called the postsynaptic density. The binding of 
neurotransmitters to postsynaptic receptors then stimulates or inhibits electrical 
activity in the postsynaptic cell. The structure of a typical synapse is shown in figure 
6. The formation of synapses occurs over a protracted period of embryonic and 
postnatal development. Synapse formation and elimination are also crucial for 
complex adult brain functions such as learning and memory so the cellular and 
molecular events involved are of broad interest to neurobiologists.
Much of our understanding of synapse formation comes from studies of the 
neuromuscular junction (NMJ). The clustering of nicotinic acetylcholine receptors 
(AChR) at the site of innervation is a crucial step in the development of the NMJ [50]. 
Agrin, a protein expressed at the NMJ, can induce clustering [51] and mice lacking
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agrin die perinatally due to defective NMJ development [52]. The physiological role 
of agrin appears to be to prevent the dispersion of AChR clusters on developing 
muscle cells rather than inducing the initial clustered pattern [50]. Receptor associated 
protein of the synapse (Rapsyn) forms complexes with AChRs which are required for 
the formation of clusters [53]. Another postsynaptic protein, muscle specific tyrosine 
kinase (MuSK) has also been implicated in receptor clustering in vivo [54]. MuSK 
regulates synaptic formation by stabilising the postsynaptic density [55, 56]. The 
formation and maintenance of synapses in the CNS also requires the co-ordinated 
action of many cell surface adhesion molecules, secreted proteins like Wnt and FGF 
and neural activity [57].
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Figure 6 jSynaptic structure. Micrograph showing a synapse between two neurons. Neurotransmitters 
contained within synpatic vesicles are released from the presynaptic cell, traverse the synpatic cleft and 
bind to receptors on the postsynaptic membrane.
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1.2 Organisation and development of the peripheral nervous system
1.2.1 Introduction
The CNS, which develops from proliferating cells in the neural tube (as described 
above), consists of the brain and spinal cord. The PNS provides a link between the 
CNS and the periphery. The PNS can be separated into somatic and autonomic 
subdivisions. The somatic sensory PNS consists of sensory neurons of the dorsal root 
and cranial sensory ganglia. The autonomic PNS consists of the sympathetic, 
parasympathetic and enteric systems. The work described in this thesis is centred on 
the roles of the NFkB family of transcription factors and PHD3, in the regulation of 
neuronal survival and/or neurite growth from discrete populations of sensory and 
sympathetic peripheral neurons during development. A pilot study will also be 
presented examining the role of neural activity in the regulation of neuronal survival 
during the development of the same populations of peripheral neurons. In this section 
I will therefore describe the organisation of the PNS and then provide a brief 
overview of the embryonic development of the PNS.
1.2.2 Organisation of the somatic PNS
Sensory information from the skin, muscles and joints of the limbs and trunk is 
relayed to the spinal cord by neurons contained in the dorsal root ganglia (DRG). The 
DRG lie adjacent to the spinal cord and contain pseudounipolar neurons. The 
peripheral branch of DRG neurons forms the dorsal root of the appropriate spinal 
nerve for that level and the central branch synapses in the dorsal column of the spinal 
cord. The ventral root of each spinal nerve consists of motor axons originating in the 
ventral spinal cord. The organisation of a typical spinal nerve is illustrated in figure 7.
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The twelve pairs of cranial nerves (Fig. 8) provide peripheral innervation to various 
tissues in the head and thorax. There are seven cranial sensory ganglia whose axons 
form part of five of the twelve cranial nerves. The trigeminal ganglion is located on 
cranial nerve V and its neurons innervate mechanoreceptors, thermoreceptors and 
nociceptors in the face. The geniculate ganglion, found on cranial nerve VII, 
innervates taste buds on the anterior tongue. The vestibulo-cochlear ganglion, which 
joins cranial nerve VIII, innervates hair cells in the inner ear. The petrosal ganglion is 
located on cranial nerve IX and innervates taste buds in the posterior tongue. The 
jugular and nodose ganglia join cranial nerve X and innervate various targets in the 
pharynx, thorax and abdomen. Finally, the superior glossopharyngeal ganglion, is also 
located on cranial nerve IX. In summary, spinal and cranial nerves link muscles, 
glands and other peripheral end organs with the CNS.
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Figure 7 Spinal nerves. Illustration showing the typical composition of a spinal nerve. Sensory neurons 
are contained in the DRG and synapse centrally in the dorsal horn of the spinal cord. Motor neurons 
from the ventral spinal cord form the ventral root of the spinal nerve and sympathetic ganglia in thoraco­
lumbar spinal levels join the spinal nerve to innervate smooth muscles and glands.
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1.23 Organisation of the autonomic nervous system
The autonomic nervous system provides visceral motor innervation to smooth muscle, 
heart muscle and exocrine glands. The autonomic nervous system can be separated 
into three subdivisions ; the sympathetic nervous system, the parasympathetic nervous 
system and the enteric nervous system.
Preganglionic sympathetic neurons are found in the intermediolateral column of the 
spinal cord between segments T1-L2. Preganglionic sympathetic axons leave the 
spinal cord via the ventral root and synapse with neurons contained within 
sympathetic paravertebral ganglia. The paired sympathetic paravertebral ganglia are 
found adjacent to the spine from cervical to sacral segments. There are three cervical 
paravertebral ganglia: the superior cervical ganglion, the middle cervical ganglion, 
and the stellate ganglion. There are eleven thoracic ganglia, four lumbar ganglia, and 
four or five sacral ganglia. At the level of the coccyx, the two sympathetic ganglia 
chains join in the single ganglion impar [58]. Postganglionic axons leave the 
paravertebral ganglia via the gray rami communicantes to join segmental spinal 
nerves. Postganglionic sympathetic fibres from the superior cervical ganglion 
innervate the eyes, salivary glands, lacrimal glands and major blood vessels of the 
head and neck. Prevertebral ganglia, found in groups related to major abdominal 
blood vessels, including the coeliac, aorticorenal and mesenteric ganglia innervate 
organs of the digestive and urogenital tracts. Preganglionic neurons innervating the 
prevertebral ganglia are situated in the intermediolateral column but also receive 
afferent input from neurons located in the walls of the target organs.
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Sweat glands, piloerector muscles, and blood vessels throughout the body receive 
sympathetic innervation from postganglionic sympathetic fibres. Sympathetic 
stimulation results in pupillary dilatation, increased heart rate and contractility, 
bronchodilation, vasoconstriction of the mesenteric circulation, and vasodilation of 
skeletal muscle arterioles in what is commonly referred to as the “fight or flight” 
response.
Preganglionic parasympathetic neurons are found in the brainstem and sacral spinal 
segments (S2, S3 and S4) and are often referred to as craniosacral outflow. Cranial 
parasympathetic neurons are found in four brainstem nuclei; Edinger-Westphal 
nucleus, superior salivatory nucleus, inferior salivatory nucleus, and the dorsal vagal 
complex of the medulla. Axons emerging from these nuclei travel in cranial nerves III 
(oculomotor); VII (facial nerve); EX (glossopharyngeal nerve); and X (vagus nerve) 
respectively. Cranial postganglionic parasympathetic ganglia are embedded in or 
found close to their peripheral targets and innervate the ciliary body, lacrimal glands, 
salivary glands and mucous glands and provide the parasympathetic innervation to 
thoracic and abdominal viscera as far as the transverse colon. Sacral preganglionic 
parasympathetic fibres exit via the sacral ventral roots S2-S4 and corresponding sacral 
spinal nerves and then continue to the pelvic viscera as the pelvic nerve. The sacral 
preganglionic parasympathetic efferent axons of the pelvic nerve synapse with 
postganglionic parasympathetic neurons in the ganglia of the pelvic plexus. 
Postganglionic axons innervate the descending colon, rectum, urinary bladder and 
sexual organs.
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The enteric nervous system controls the coordinated muscular contractions involved 
in digestion and also innervates blood vessels and glands of the gastric mucosa. The 
enteric nervous system has two divisions that are connected by nerve processes: the 
submucosal plexus (Meissner's plexus), which innervates the mucosa and regulates 
secretion; and the myenteric plexus (Auerbach's plexus), which innervates the circular 
and longitudinal smooth muscle layers and regulates motility.
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Figure 9 [Sympathetic and parasym pathetic nervous systems Illustration showing the organisation of 
the sympathetic (left) and parasympathetic (right) nervous systems and some peripheral target tissues of 
each system.
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1.2.4 Development of the sensory and autonomic PNS
Peripheral sensory neurons are derived from two sources: the neural crest and the 
neurogenic placodes. The neural crest is an incredibly diverse structure which 
originates from the neural folds after interactions between the neural plate and the 
presumptive epidermis [59,60]. Migration and differentiation of neural crest cells 
from the dorsal neural tube gives rise to many cell types including; neurons and glia 
of the sensory, sympathetic, and parasympathetic nervous systems, melanocytes, 
facial cartilage, bone and connective tissue [61]. The fate of neural crest cells is 
largely dependent on the migratory route taken and the final position of the cells.
The trunk neural crest is a transitory structure whose cells begin to migrate as the 
neural tube closes [61]. There are two principal modes of migration utilised by trunk 
neural crest cells, the dorsolateral pathway and the ventral pathway. Cells that migrate 
along the dorsolateral pathway travel into the epidermis and become melanocytes. 
Cells migrating in the ventral pathway give rise to the dorsal root ganglia (DRG), 
sympathetic ganglia and cells of the adrenal medulla. The dorsomedial part of the 
trigeminal ganglion, the trigeminal mesencephalic nucleus, and the jugular ganglion 
are all derived from the cranial neural crest Neurons of the parasympathetic nervous 
system are derived from the mesencephalic neural crest and the enteric nervous 
system is derived from the vagal and lumbrosacral neural crest [62]. All Schwann 
and satellite cells in sensory and autonomic ganglia have been shown to be neural 
crest derived [63]. The molecular regulation of neural crest formation and migration is 
incompletely understood [64]. Both BMP and FGF signalling have been implicated in 
neural crest induction [59,65]. Mouse embryos in which p-catenin has been 
inactivated have malformed neural crest derivatives, including the DRG and various
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craniofacial regions, implicating Wnt signalling in neural crest formation and 
differentiation [66].
Although the majority of sensory neurons are formed after migration and 
differentiation of neural crest cells, cranial sensory ganglia are derived from both 
neural crest cells and neurogenic placodes [67]. Neurogenic placodes are focal 
thickenings of embryonic ectoderm which are induced by signals originating in the 
surrounding cranial tissue. The neurogenic placodes can be divided into two groups, 
dorsolateral and epibranchial, based on their position in the developing cranium. The 
dorsolateral placodes give rise to the vestibular and ventrolateral trigeminal ganglia. 
The epibranchial placodes give rise to the nodose, petrosal and geniculate ganglia.
1.3 Regulation of neuronal survival in the PNS
13.1 Introduction
Apoptosis or programmed cell death (PCD) is crucial both during normal 
development and in the adult. A family of intracellular proteases known as caspases 
are largely responsible for the well-described biochemical and morphological changes 
associated with apoptosis. The intrinsic apoptotic pathway is activated by 
developmental cues, DNA damage and growth factor deprivation and is tightly 
controlled by members of the B-cell lymphoma-2 (Bcl-2) family. The extrinsic 
apoptotic pathway is triggered by activation of death receptors leading to caspase 
activation independently of Bcl-2 family members. Members of the Bcl-2 family are
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typically divided into three groups ; anti-apoptotic (Bcl-2, B c1-Xl, Bcl-W), pro- 
apoptotic (BAX, BAK, BOK) and BH3-only proteins (BAD, BIK, BIM, NOXA, 
PUMA) which regulate anti-apoptotic members of the Bcl-2 family to promote 
apoptosis [68]. Pro-apoptotic members like BAX can permeabilise the mitochondrial 
membrane leading to the release of apoptogenic molecules such as cytochrome c and 
DIABLO. Cytochrome c binds to apoptotic protease-activating factor-1 (APAF1) to 
form a protein ring known as the apoptosome that binds to and activates caspase 9 to 
promote apoptosis [69, 70]. Signal transduction pathways link the extracellular 
environment to cell death/survival machinery during development and in the adult. 
Neuronal apoptosis is regulated by a tightly controlled balance of survival-promoting, 
target-derived neurotrophic factors and death signals. For example, nerve growth 
factor (NGF) binding to TrkA activates numerous pro-survival pathways like PI-3 
kinase, Akt and MEK/MAPK which support survival by inhibiting pro-apoptotic 
proteins like Bad and Forkhead and by activating other pro-survival pathways like 
CREB (Yuan and Yankner 2000). The following sections introduce the origins of the 
neurotrophic theory, describe the neurotrophic requirements of relevant PNS neurons 
and introduce the biology of the neurotrophic factors.
1.3.2 The neurotrophic theory
During the development of the nervous system excess neurons are generated. The 
surplus neurons are removed during a phase of naturally occurring cell death shortly 
after axons reach their targets [71-73]. This phase of apoptotic cell death is thought to 
remove neurons with inappropriate synaptic connections and ensures that a suitable 
number of neurons survive relative to the size of the target field. Neurons compete 
for a limited supply of neurotrophic factors. According to the neurotrophic theory,
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neurons that acquire neurotrophic support survive and those that do not die by 
apoptosis. The neurotrophic theory was formulated following the discovery of the first 
neurotrophic factor, nerve growth factor (NGF). The pioneering studies of Hamburger 
and Levi-Montalcini in the 1940s and 1950s led to the discovery of NGF. Since the 
discovery of NGF evidence has mounted in support of the neurotrophic theory.
Whereas populations of sympathetic and sensory neurons that are dependent on NGF 
in vitro are eliminated by administration of anti-NGF antibodies in vivo during the 
period of target innervation, administration of NGF during this period prevents 
naturally occurring neuronal death in these populations [74-79]. Genetic deletion of 
genes encoding NGF or its receptor tyrosine kinase (TrkA) also results in decreased 
numbers of peripheral sensory and sympathetic neurons [80-82]. The production of 
NGF begins in target tissues with the arrival of the earliest axons [83], and removal of 
the target tissue increases programmed cell death (PCD) in the relevant peripheral 
ganglia [84]. The neurotrophic theory, as described above, is an over-simplification 
because neurons require trophic support before and after synaptogenesis from sources 
other than the target field [85]. Furthermore, many populations of neurons switch their 
dependence from one trophic factor to another depending on their stage of 
development [86, 87]. In vitro studies have shown that populations of PNS neurons 
survive independently of neurotrophic factors at the stage when axons begin to sprout 
(Davies, 1994). The duration of neurotrophic factor independence is proportional to 
the distance axons need to travel in order to reach their targets [88, 89].
Since the discovery of the original neurotrophic factor, NGF, much effort has been 
made to identify novel neurotrophins. Brain-derived neurotrophic factor (BDNF) was
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the second neurotrophic factor to be purified [90]. Since then several other 
neurotrophic factors have been identified. The neurotrophin family of proteins has 6 
members; nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) 
neurotrophin-3 (NT-3), neurotrophin 4/5 (NT-4/5), neurotrophin 6 (NT-6) and 
neurotrophin-7 (NT-7). These proteins are both structurally and functionally secreted 
proteins that signal through two classes of receptor; the high-affinity tyrosine kinase 
receptors of the Trk family (TrkA, TrkB, and TrkC) and a common lower-affinity 
receptor, p75. Several other families of proteins have been shown to promote the 
survival of various populations of neurons during particular stages of their 
development. These include the glial cell-derived neurotrophic factor (GDNF) family 
, the neurotrophic cytokines [ciliary neurotrophic factor (CNTF), leukaemia inhibitory 
factor (LIF), oncostatin-M (OSM), cardiotrophin-1 (CT-1) and interleukin-6 (IL-6)] 
and some other related factors including hepatocyte growth factor (HGF) and 
macrophage-stimulating protein (MSP) [86,91-93]. The search for novel neurotrophic 
factors is ongoing, and as recently as July 2007, a novel neurotrophic factor for 
midbrain dopaminergic neurons, conserved dopamine neurotrophic factor (CDNF) 
was identified [94].
In addition to regulating neuronal survival during development, neurotrophins also 
have a role in diverse processes from cellular proliferation, differentiation and process 
outgrowth to synaptic plasticity [95-99]. The original research described in this thesis 
is focused on the role of neurotrophins in the regulation of neuronal survival and 
process outgrowth during the development of specific populations of peripheral 
sensory and sympathetic neurons. Although the individual neurotrophic requirements 
of PNS neurons during development have been described, the downstream signalling
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events mediating neuronal survival and neurite outgrowth are only beginning to be 
elucidated. I will therefore briefly describe the neurotrophic requirements of the 
relevant peripheral ganglia, followed by an introduction to the biology of the 
neurotrophic factors and their receptors.
1.3.3 Neurotrophic requirements of selected peripheral ganglia
The studies described in this thesis were performed on sensory neurons of the mouse 
nodose ganglion (NG), trigeminal ganglion (TG) and DRG and on the sympathetic 
neurons of the superior cervical ganglion (SCG).
Numerous in vitro studies have implicated BDNF and to a lesser extent, NT-3 and 
NT-4 in promoting the survival of nodose neurons [89,100-103]. Genetic inactivation 
of BDNF, NT-3 and NT-4 results in increased cell death in nodose neurons [104-107]. 
Early in the development of the NG, the survival of a small subpopulation of nodose 
neurons is supported in vitro by NGF [108]. This in vitro observation was 
substantiated by the slight decrease in the number of nodose neurons in NGF -/- mice 
[108]. Subpopulations of nodose neurons respond to a variety of other neurotrophic 
factors, notably the neurotrophic cytokines, CNTF, LIF, OsM and CT-1 [109]. The 
in vitro survival of neonatal nodose neurons is supported equally well by both BDNF 
and neurotrophic cytokines [109].
Trigeminal neurons switch their dependence between different neurotrophic factors 
during development Early trigeminal neurons are dependent on both NT-3 and BDNF 
for survival but by E12 the vast majority of trigeminal neurons are NGF-dependent 
[110]. The switch in responsiveness from NT-3 and BDNF to NGF is correlated with 
a switch in the expression of appropriate Trk receptor and the switch to expression of
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NGF in the target tissue [83,110-112]. The DRG contains a mixture of functionally 
distinct sensory neurons. Thermoceptive and nociceptive, small diameter neurons, 
express TrkA and are dependent on NGF for survival in vitro. Neonatal TrkA-/- mice 
display a substantial reduction in the number of small diameter neurons, but not large 
diameter DRG neurons [80]. This observation combined with the decrease in small 
diameter DRG neurons in NGF-/- mice suggest that thermoceptive and nociceptive 
DRG neurons are dependent on NGF signalling through TrkA for survival during 
development [80]. Large diameter, proprioceptive DRG neurons are dependent on 
both BDNF and NT-3 during development [86].
The sympathetic neurons of the SCG originate from proliferating precursors in the 
neural crest. Throughout their development, SCG neurons respond to a variety of 
neurotrophic factors and in vitro survival of SCG neurons can be supported by a wide 
range of neurotrophic factors between early embryonic and early adult life. Artemin 
promotes sympathetic precursor proliferation and hepatocyte growth factor (HGF) 
promotes the differentiation of sympathetic neuroblasts into postmitotic sympatheitc 
neurons [97,113,114]. SCG neurons respond to NGF at E14 and remain dependent 
on NGF for survival throughout the remainder of embryonic life [115]. By birth, and 
into early adulthood the survival of SCG neurons in vitro can be supported by both 
NGF and NT-3. The dependence of SCG neurons on NGF and / or NT-3 correlates 
with expression of TrkA and not TrkC during and after the period of naturally 
occuring cell death [116]. Late postnatal SCG neurons also respond to CNTF, LIF and 
HGF in vitro [117,118].
Cell culture systems, described herein, were used to analyse neuronal survival and / or 
process outgrowth in embryonic or postnatal DRG (supported by NGF), TG
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(supported by NGF), NG (supported by BDNF or CNTF), and SCG (supported by 
NGF or NT-3). The biology of these neurotrophic factors and their associated receptor 
systems is introduced in the upcoming sections.
1.3.4 NGF
NGF, the founding member of the neurotrophin family, is a highly conserved protein 
first isolated from mouse salivary glands [119-123]. The amino acid sequence [124] 
and subsequently the 3-dimensional structure of NGF [125] have been determined. 
The NGF gene encodes a precursor protein which is cleaved to form mature NGF 
which is a homodimer consisting of two 118 amino acid subunits, each containing a 
cysteine knot motif and two anti-parallel p strands [125-128].
NGF is expressed in many regions of the CNS including the basal forebrain and 
hippocampus [129]. The targets of NGF-dependent peripheral neurons also secrete 
NGF, including the heart, submandibular glands and whisker pads [83,129-132]. 
Many other non-neuronal cells of the cardiovascular, endocrine, reproductive and 
immune systems express NGF but the developmental function of NGF in these 
systems is poorly understood [133]. The crucial role of NGF signalling in the 
development of certain populations of sympathetic and sensory neurons is highlighted 
by the severe defects in cell survival and target innervation observed in NGF -/- mice 
[80]. In addition to well documented roles in neuronal survival, NGF also regulates 
terminal innervation patterns in target tissues. The significant loss of sensory neurons 
brought about by deletion of NGF can be prevented when NGF-/- mice are crossed 
with Bax-deficient mice [134]. However, peripheral target innervation remains 
decreased in these mice, suggesting that NGF signalling regulates the extent of
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terminal branching in target tissues [134]. NGF also regulates neurite growth in 
sympathetic neurons [135]. NGF released by the target tissue is taken up by distal 
processes and transported retrogradely in signalling endosomes along with TrkA, to 
support neuronal survival [136,137].
13.5 BDNF
The identification and purification of BDNF in 1982 expanded the field of 
neurotrophic factor biology and generalised the role of target-derived neurotrophic 
factors in neuronal survival and process outgrowth during development [90]. Like 
NGF, BDNF is synthesized as a precursor protein that is cleaved to produce a 119aa 
mature protein. BDNF shares approximately 50% of its sequence with NGF, 
including the 6 cysteine residues involved in forming the cysteine knot structure, and 
also forms a homodimer to produce its biologically active species [90, 138].
BDNF is relatively highly expressed in the central nervous system with strong 
expression in the cortex, hippocampus and cerebellum, as well as lower expression in 
the striatum, olfactory bulb, midbrain, hindbrain and spinal cord [139, 140]. BDNF 
signalling has been implicated in almost all aspects of CNS development from 
proliferation to synaptic plasticity, learning and memory [141]. In the CNS, BDNF 
expression is upregulated during periods of neuronal activity [142]. As early as 1949, 
Hebb proposed that strengthening of synaptic contacts may underlie synaptic 
plasticity [143]. BDNF, and many other molecules, have been shown to translate 
neural activity into synaptic plasticity and BDNF-/- mice display defects in long-term 
potentiation (LTP) [144,145].
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BDNF is also expressed in certain populations of peripheral sensory ganglia and in 
the target tissues of BDNF-dependent neurons, including the heart, skin, muscle, and 
lung [110,146,147]. BDNF promotes the survival of placode-derived trigeminal, 
nodose, geniculate, petrosal and vestibular neurons during development and also 
increases the survival of some early neural crest-derived sensory neurons such as 
those in the DRG [100,148-150]. Like NGF-/-, BDNF-/- mice die perinatally and 
display significant defects in populations of sensory neurons dependent on BDNF for 
survival [151,152]. BDNF is also involved in neurite outgrowth in vestibular, DRG, 
sympathetic and nodose neurons [153-160] of the PNS and in neurite outgrowth and 
maintenance of cortical and hippocampal processes [145,161-168].
13.6 NT-3
NT-3 was discovered after identification of highly conserved regions of NGF and 
BDNF using a homology cloning approach [146,169,170]. Like BDNF , NT-3 
shares approximately 50% identity in amino acid sequence with NGF including 
conservation of critical cysteine residues [171]. NT-3 is also formed from from 
cleavage of a precursor protein into a 119 amino acid mature protein [169].
NT-3 is expressed in the CNS and in the targets of many populations of sensory 
neurons during development and in the adult [146,169,170]. In vitro, subpopulations 
of neurons from the nodose, cochlear and dorsal root ganglia as well as the 
proprioceptive neurons of the trigeminal mesencephalic nucleus respond to NT-3 and 
a transient survival response of neural crest-derived sensory neurons can also be 
detected [103,110,146,169,170,172-176]. NT-3 also promotes the survival, 
differentiation and proliferation of sensory neuronal precursors [107,177,178]. NT-
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3-/- mice have significantly reduced numbers of neurons in SCG, DRG, trigeminal 
and nodose ganglia [116,152,173,175,176,179,180]. Recent evidence suggests 
that, unlike NGF, NT-3 is not retrogradely transported from peripheral targets of 
sympathetic neurons but promotes the growth of some sympathetic axons along 
intermediate targets like blood vessels [136, 137]. Interestingly, terminal target 
derived NGF may reduce the sensitivity of developing neurons to NT-3 in a proposed 
hierarchical mechanism of neurotrophin-dependent development [137]. NT-3 also 
regulates terminal innervation patterns in vestibular, DRG, trigeminal and 
sympathetic neurons [135,137,154, 155, 158,159, 181,182].
13.7 CNTF
CNTF was first identified and purified from the embryonic chick eye and supports the 
survival of parasympathetic ciliary ganglion neurons [183-185]. CNTF is a 20-24kDa 
protein bearing no similarity with known members of the neurotrophin or fibroblast 
growth factor gene families [186-188]. However, there are significant structural 
similarities, including a four helix bundle, between CNTF and other neuropoietic 
cytokines such as LIF, IL-6, OSM and G-CSF [189,190].
Highest levels of CNTF mRNA are found in postnatal peripheral nerves [191]. In the 
adult rat central nervous system, highest levels of CNTF mRNA are found in the optic 
nerve, olfactory bulb [192] and spinal cord [193]. Low but still significant levels are 
detectable in the brain stem, cerebellum, septum, hippocampus, striatum, midbrain, 
and thalamus / hypothalamus [192, 194,195]. CNTF supports the survival of a wide 
variety of peripheral and central neurons in vitro, including neurons of the nodose, 
trigeminal, dorsal root and sympathetic ganglia, spinal motoneurons, hippocampal
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neurons and Purkinje cells [109,184,196-199]. Recent evidence suggests that CNTF 
is only secreted from injured or damaged cells, hence there is no observable neuronal 
phenotype in neonatal CNTF-/- mice [200]. However, a slow degeneration of adult 
motomeurons is observed in these mice [200]. The potential role of CNTF in 
regeneration has sparked a lot of interest in CNTF signalling in the regulation of 
neuronal survival and growth in the CNS and PNS. Some of the intracellular 
mediators of CNTF-promoted growth from developing sensory neurons are 
investigated in detail in chapter 3
13.8 Trk receptors
The effects of neurotrophic factors on neuronal survival and process outgrowth are 
mediated by intracellular signalling pathways downstream of the Trk or p75 receptors. 
The original Trk receptor was discovered as an oncogene product of the trk gene 
(tropomyosin-related kinase), an oncoprotein present in a human colon carcinoma 
[201]. The Trk proto-oncogene encodes a 140 kDa transmembrane glycoprotein with 
the typical structure of tyrosine protein kinase cell surface receptors including an 
extracellular domain which recognises NGF, a single transmembrane domain and a 
cytoplasmic domain with tyrosine kinase activity which activates intracellular 
signalling pathways [202,203]. After the discovery of TrkA, two other related Trk 
genes were identified; TrkB [204,205] and TrkC [206]. TrkB mediates the biological 
activity of both BDNF [207-209] and NT-4 [210-212], and TrkC is the primary 
receptor for NT-3 [206]. There is also some physiologically relevant, lower affinity 
binding between NT-3 and trkA and trkB and between NT-4/5 and trkA [207-210]. 
This small group of three kinases [213] is one of twenty subfamilies of tyrosine kinase 
receptors, with unique common structural features and high levels of expression in
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both the CNS and PNS [214,215]. The importance of neurotrophin signalling through 
Trk receptors in the developing PNS is highlighted by the observation that all 
peripheral neurons express Trk receptors, with the exception of parasympathetic 
ciliary neurons [112,179, 204, 216-218].
Trk receptors are activated through ligand-mediated dimerisation followed by 
phosphorylation of several conserved cytoplasmic tyrosine residues, providing 
docking sites for adaptor molecules and enzymes mediating intracellular signalling 
pathways [98, 219-221].Neurotrophin signalling through Trk receptors leads to the 
activation of many intracellular signalling molecules such as Ras, PI3-K and PLCy 
[222] as illustrated in Figure 10. Neurotrophin signalling in the cell soma and nucleus 
is crucial for neuronal differentiation and survival [75, 223]. However, especially in 
the PNS, the source of neurotrophic factor may be quite a distance from the soma. 
These observations have prompted investigations into the mechanisms of retrograde 
signal transduction after ligand engagement Ligand engagement stimulates 
internalization of Trk receptors through clathrin-coated pits and by macropinocytosis 
in cell surface ruffles [224,225]. After internalization, neurotrophins are localized 
with Trk receptors in endosomes that also contain activated signaling intermediates, 
such as She and PLC-yl [226]. NGF-TrkA internalisation and retrograde transport to 
the soma is required for transmission of the neurotrophin signal [137, 227]. Recent 
data describing NGF-promoted neuronal survival without NGF internalisation [228] 
and the lack of retrograde signalling of NT-3/TrkA in sympathetic neurons have 
added layers of complexity to neurotrophin signalling cascades.
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In general, populations of neurons depleted in Trk-/- mice overlap with those lost in 
the knockout mouse of the primary neurotrophin for that receptor. TrkA-/- mice have 
decreased neuronal numbers in trigeminal, dorsal root and sympathetic ganglia [81]. 
TrkB-/- mice lose a substantial proportion of trigeminal, nodose and DRG neurons 
[229], while trkC-/- mice have decreased numbers of myelinated axons emerging 
from the dorsal root and posterior columns of the spinal cord, as well as loss of a 
subpopulation of DRG neurons [230].
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Figure 10 |Trk signalling. Illustration detailing some o f the intracellular signalling pathways activated 
after ligand-mediated Trk activation which result in gene expression, increased neuronal survival and 
neurite outgrowth (Illustration from Huang and Reichardt (2003).
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1.3.9 P75ntr
The p75 common neurotrophin receptor is a 75kDa transmembrane glycoprotein 
capable of binding all the neurotrophins with lower affinity than the Trk receptors 
[231]. p75 is expressed in both the PNS and CNS but also in non-neuronal cells and 
after trauma [222]. The physiological role of p75 during neuronal development is only 
beginning to be elucidated and some interesting and surprising observations have 
been made. p75 modifies the function of Trk receptors [222],can bind pro- 
neurotrophins in complex with a co-receptor to elicit apoptosis [232-234] and can 
either promote [235-237] or inhibit [238] cell death.
13.10 CNTF receptor complex
Investigation into the mechanism of action of CNTF has lead to the discovery of a 
three component receptor complex whose expression explains the specificity of CNTF 
activity in the nervous system. Epitope tagged CNTF was used to identify the unique 
component of the CNTF receptor complex, CNTF receptor a  (CNTFRa) [239]. 
CNTFRa expression was limited to neuronal cells and was expressed by all CNTF- 
responsive cells including sympathetic, sensory, motor and parasympathetic neurons 
[194, 240]. Sequence analysis revealed that CNTFRa, unlike other neurotrophic 
factor receptors, does not have a transmembrane domain but is attached to the cell 
surface via glycosyl phosphatidylinositol (GPI) linkage [240]. CNTFRa is a member 
of the cytokine receptor superfamily, closely related to interleukin-6 (IL-6). 
Subsequent analysis revealed that CNTF and CNTFRa could form a complex with 
two transmembrane proteins that become tyrosine phosphorylated upon ligand 
binding, gpl30 and LIFRp [193,241,242]. Numerous studies have found that 
coexpression of all three subunits of the CNTFR complex were required to generate a
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functional receptor [243-245]. Reconstitution experiments have revealed that the 
CNTFR complex is initially unassociated and only assembles after ligand binding 
[246]. CNTFRa-/- mice die perinatally, and like CNTF-/- mice exhibit a significant 
loss of motomeurons [247]. The phenotype of CNTFRa-/- mice is more severe than 
the CNTF-/- mice, correlating with relatively early expression of the receptor 
comapared to the ligand [193,195]. The more severe phenotype observed in 
CNTFRa-/- mice may also be partially explained by studies describing a role for a 
soluble form of the receptor as a co-factor for CNTF [243]. Experiments using a 
soluble form of CNTFRa revealed that it can bind to CNTF and activate cells which 
are not normally responsive to CNTF [243]. LIFR{3-/- mice also die within hours of 
birth, with significant reductions in the number of facial, trigeminal hypoglossal and 
spinal motor neurons and a loss of astrocytes in the brainstem and spinal cord [248, 
249]. In gpl30-/- mice there is loss of DRG neurons and specific populations of 
motor neurons, that occurs between E14.5 and El 8.5, suggesting that cytokines are 
principally involved in regulating neuronal survival during the period of naturally 
occurring cell death [250].
1.3.11 Neural activity regulates survival
During development, approximately half of all neurons generated die by PCD which 
is largely regulated by the availability of target-derived neurotrophic factors as 
described above [71]. However, in vitro survival of neurotrophin-deprived cells from 
both the CNS and PNS is supported by increased neural activity [251-258]. The 
crucial role of activity has also been shown in vivo, where removal or inhibition of 
afferent input increases neuronal PCD [259] [260]. Patterned neural activity is crucial 
for normal development of thalamocortical, local intracortical, and long-range
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horizontal connections in the cortex [261]. The survival-promoting effects of neural 
activity on various neuronal populations have been studied extensively in vitro using 
increased K+ in the culture media [262]. Elevation of K+ leads to depolarisation of the 
membrane and activation of voltage gated calcium channels. K+-dependent neuronal 
survival is largely mediated by increases in intracellular calcium concentration [Ca2+]j 
[262]. The calcium set-point hypothesis has been proposed to explain the relationship 
between neurotrophin-dependent survival and activity dependent survival [262, 263]. 
Low [Ca ], is associated with neurotrophic factor dependence, moderate [Ca ]i is 
associated with neurotrophin independence and high [Ca2+]j is associated with 
toxicity. It has been suggested that trophic factor dependence is inversely related to 
[Ca2+]i which correlates with the observation that [Ca2+]i increases with age [264]. 
Most studies using depolarising concentrations of K+to promote the survival of 
peripheral neurons have relied on neonatal neurons artificially aged in culture. The 
cell culture studies described in this thesis (chapter 5) have used peripheral sensory 
and sympathetic neurons dissected from mice over a range of embryonic and postnatal 
ages and tracked the onset of neurotrophin independence and examined the 
mechanisms involved in the survival promoting effects of elevated K+.
1.4 Regulation of neurite outgrowth
1.4.1 Axon extension and guidance
To form a functional nervous system, every neuron must make appropriate synaptic 
connections. The first step towards a properly wired nervous system is the extension
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of an axon towards a target cells. The growing axon extends at its leading edge by 
means of a specialised structure called the growth cone. Important fibrillar structures 
including microfilamentous actin and microtubules give the growth cone its 
characteristic structure. The growth cone appears as a hand-like enlargement at the 
leading edge of the developing axon which reaches into the external environment with 
numerous finger-like extensions called filopodia. Microtubules extend as far as the 
filopodia and are polarised such that the end at which tubulin polymerises most 
rapidly faces the leading edge of the growth cone. Axon extension is achieved through 
polymerisation of actin and tubulin filaments in the growth cone which pushes the 
membrane forwards [265,266]. The ability of developing axons to twist and turn 
their way through diverse environments and successfully reach the appropriate target, 
has amazed neurobiologists since Ramon Y Cajal in the 1890s. The direction of 
growth cone extension is determined by gradients of both locally acting and diffusable 
attractive or repellent cues in the external environment. Many of these attractive 
and/or repellent cues have been identified and include semaphorins, netrins, slits, 
ephrins, morphogens and associated receptor systems [267, 268].
1.4.2 The role of neurotrophic factors in neurite outgrowth from PNS neurons
The role of neurotrophic factors in the regulation of neurite growth in vitro, is well 
established [135,137, 155, 269-272]. The role of neurotrophic factors in neurite 
growth in vivo is less straight forward and it has been demonstrated that the initial 
extension of axons from peripheral ganglia occurs normally in the absence of 
neurotrophin/ Trie signalling [72,273]. The major effects of neurotrophic factors on 
neuronal survival have impeded efforts to investigate the requirement of neurotrophic 
factors for axon extension and peripheral target innervation. The separation of
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survival effects from effects on neurite outgrowth was achieved by crossing NGF-/- 
and TrkA-/- mice with Bax-/- mice [134]. Bax deletion prevents PCD in developing 
peripheral neurons [274] so crossing these mice with NGF-/- or TrkA-/- mice 
provided an ideal framework for analysing the growth-promoting effects of 
NGF/TrkA signalling in vitro and in vivo [134]. In the absence of NGF/TrkA 
signalling, DRG neurons extend processes through the dorsal roots and into the dorsal 
horn but cutaneous peripheral axons fail to develop, establishing that neurotrophin 
signalling is required for peripheral target field innervation [134]. Further work has 
shown that peripheral axons can be induced to grow towards ectopic sources of 
neurotrophic factors, a process which can be reversed by application of function- 
blocking antibodies directed towards NGF, BDNF or NT-3 [154]. Further in vivo 
analyses have revealed that increased levels of NGF or NT-3 in the brain, pancreas, 
heart or skin leads to increased axonal growth in sensory and sympathetic neurons 
[180, 275-277]. CNTF can also promote neurite outgrowth from a variety of neuronal 
populations in vitro but its role in vivo is poorly understood [278].
1.43 Intracellular signalling pathways downstream of neurotrophic factors 
regulating neuronal survival and neurite outgrowth
Binding of neurotrophic factors to Trk receptors results in the phosphorylation of 10 
conserved cytoplasmic tyrosine residues. Phosphorylation of these residues either 
further activates the receptor or promotes intracellular signalling by creating docking 
sites for adaptor proteins containing phosphotyrosine-binding (PTB) or src-homology- 
2 (SH-2) motifs [220,279]. Phosphorylation of tyrosine residues and binding of 
adaptor proteins couple Trk receptors to intracellular signalling pathways including
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the Ras/Erk protein kinase pathway, the PI-3 kinase / AKT pathway, phospholipase C 
(PLCy) and She. All of these pathways have been implicated in neuronal survival and 
/ or neurite outgrowth in various populations of neurons [220,280]. JAK/Tyk 
tyrosine kinases have been shown to associate with both gpl30 and LIFRp 
components of the CNTFR complex and become active upon dimerisation of the 
receptor components [280]. After activation of JAK/Tyk kinases a host of intracellular 
pathways are activated, many of which overlap with those activated by other 
cytokines and growth factors, such as PLCy, PI3-kinase, STAT proteins, ERK1/2 and 
nuclear-factor k B (NFkB) [281,282] to regulate survival and growth.
The signalling events downstream of neural activity that regulate neuronal survival 
and process outgrowth are poorly understood, but recent studies in cerebellar granular 
cells have demonstrated that Ca2+ signalling mediated by calcium calmodulin 
dependent protein kinase 2 (CaMKII) induces dissociation of kinesin superfamily 
protein 4 (KIF4) from poly (ADP-ribose) polymerase-1 (PARP-1) which supports 
neuronal survival [283,284]. Studies in primary sympathetic neurons have shown that 
depolarisation and neurotrophic factors converge on the PI-3 kinase / AKT pathway to 
synergistically regulate neuronal survival [285]. Further studies on sympathetic 
neurons have revealed that neural activity can promote local axonal outgrowth via 
activation of L-type calcium channels and subsequent activation of CaMKII-MEK 
pathway [286].
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1.5 NFkB Signalling
1.5.1 The NFkB family of transcription factors
In order to trigger specific long-term structural, morphological or functional changes, 
short-term events such as synpatic activity or receptor engagement must elicit 
differential gene expression [287-290]. This may be achieved by activation of 
transcription factors. NFkB was first described as a nuclear factor that, when activated 
by bacterial lipopolysaccharides binds to the enhancer region of the gene encoding the 
k  light chain of antibodies in B cells [291]. Since this original description NFkB has 
been shown to be expressed in a variety of tissues from drosophila to man and 
regulates expression of genes involved mainly in the immune response [292]. Five 
NFkB family members have been cloned and characterised, c-Rel, NFkBI 
(p50/pl05), NFkB2 (p52/pl00), RelA (p65), and RelB. All members of the NFkB 
family contain a characteristic Rel homology domain (RHD) involved in DNA 
binding, dimerization and interaction with inhibitory proteins called IkB [293]. The 
NFkB family can be divided into two groups. One group (p i05 and p i00) have long 
C-terminal containing ankyrin repeats. P105 and pi 00 give rise to shorter proteins 
containing the RHD (p50 from pi 05 and p52 from pi 00) by limited proteolysis or 
arrested translation [294-297]. These proteins cannot act as activators of transcription 
unless they form dimers with members of the second group, which include c-Rel, p65 
and RelB. In addition to the RHD these proteins contain C-terminal transcriptional 
activation domains. All NFkB proteins form either homo or heterodimers, NFkB 
being the original name for the p50-p65 heterodimer, which is the most abundant 
form in the nervous system. In unstimulated cells NFkB dimers are held inactive in 
the cytoplasm by members of a family of inhibitory proteins called IkB. IkB proteins, 
IkBci, IkBP, IkBy, IkBb and Bcl-3 contain C-terminal ankyrin repeats essential for
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their interaction with NFkB dimers. IkB proteins inhibit NFkB by masking several 
important regions of the NFkB subunits such as the nuclear localisation sequence of 
p65, regions important for DNA binding of NFkB and phosphorylation sites 
necessary for transcriptional activation [298]. Free NFkB then migrates to the nucleus 
and binds to kB sites with consensus sequence GGGRNNYYCC (N = any base,
R = purine, and Y = pyrimidine) in the promoter or enhancer regions of target genes, 
and activates their transcription.
Cells of the immune system must respond rapidly to diverse stimuli from bacterial 
infection to UV light and the ability of NFkB to rapidly transduce extracellular stimuli 
into defensive genetic responses is crucial. NFKB-dependent gene transcription 
regulates the function of T cells, B cells, macrophages and monocytes [292,299-301]. 
The mechanisms of NFkB signalling are also of major interest in cancer research due 
to the role of this family of transcription factors in apoptosis, the cell cycle, 
differentiation and cell migration [302]. Constitutive NFkB activation has been 
associated with almost all forms of human cancer and many other human diseases 
[303]. NFkB signalling has more recently been implicated in diverse functions within 
the developing and adult nervous system.
1.5.2 Emerging roles for NFkB in the nervous system
NFkB is widely expressed throughout the nervous system [304-309] and has been 
implicated in plasticity, learning and memory, development and neurodegenerative 
disease. p65 is located distally on dendrites and basal synaptic input has been shown 
to stimulate retrograde transport of p65, in association with dynein/dynactin to the
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nucleus [310-312] .The relationship between synaptic activity and nuclear 
translocation of p65 implies that NFkB may be involved in synaptic plasticity. Indeed, 
inhibition of NFkB or deletion of p65 has been shown to impair spatial memory 
formation in the mouse [311,313, 314]. NFkB signalling is also regulated during 
development and plays a role in proliferation and migration of early neurons [308,
315, 316]. NFkB promotes survival and process outgrowth during development [317- 
321]. NFkB promotes the survival of cortical neurons, cerebellar granule cells and 
sympathetic and sensory neurons [238, 308, 318, 319, 322, 323]. Conversely, NFkB 
activation may lead to increased apoptosis under certain conditions, such as ischaemia 
and p50-/- mice display increased infarct volumes [324, 325]. Inhibiting NFkB 
decreases neurite growth and arborisation in the neonatal somatosensory cortex and 
NG [321]. Since many of the same signal transduction pathways regulating neuronal 
survival and process outgrowth during normal development are also implicated in 
neurodegeneration, numerous studies have investigated the role of NFkB in 
neurodegenerative pathology. Increased NFkB activity has been demonstrated in brain 
tissue from Alzheimer’s and Parkinson’s disease patients [326-328]. NFkB activation 
promotes cell death programs in central neurons exposed to excitotoxic insults or 
DNA damage, as well as during exposure to dopamine, mutant huntingtin and P* 
amyloid peptide [327, 329-335].Whether increased NFkB activation has a causative 
role in promoting neurodegeneration or simply becomes upregulated as part of a 
general neuroprotective response is still in question [336].
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1.5.3 NFkB activation mechanisms
NFkB is induced in various cell types by a range of stimuli including cytokines, 
bacterial cell wall components, viruses, physical or chemical stress and UV light [337, 
338]. In neurons, NFkB can also be induced by a variety signals, including tumour 
necrosis factor-a (TNF-a), glutamate, NGF, CNTF, activity-dependent neurotrophic 
factor (ADNF) and cell adhesion molecules have been identified [291, 318, 319, 339- 
343].
Activation of NFkB begins with the release of NFkB dimers from IkB proteins (Fig.
11). In the canonical NFkB activation pathway, this is achieved by phosphorylation of 
Serines 32 and 36 of hcBa. Phosphorylated IkBoi is then recognised by the pTrCP 
subunit of the SCF ubiquitin ligase complex and degraded [296]. Free NFkB 
translocates to the nucleus and activates the transcription of a wide range of genes. 
Both pl05 and pi 00 function as iKB-like inhibitors of NFkB [344, 345]. 
Phosphorylation of pi 00 on at least 5 serine residues results in degradation of the C- 
terminus and the formation of p52/RelB active dimers [346, 347]. Processing of pi 05 
is constitutive but processing of pi 00 is tightly regulated and highly inducible [348]. 
The NFkB activation mediated by p i00 processing, resulting in nuclear translocation 
of p52-containing dimers, thus is termed non-canonical NFkB pathway [349]. 
Recently, an alternative mechanism of NFkB activation has been described involving 
phosphorylation of IkBcl on tyrosine 42 [350]. This mechanism has been observed as 
a cellular response to oxidative stress and interestingly does not involve proteasomal 
degradation of IkB<x [350-352].
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In short, NFkB activation is brought about by phosphorylation of specific residues on 
IkB which results in the dissociation or degradation of IkB and translocation of NFkB 
to the nucleus. The IkB kinase (IKK) complex, consisting of three members IKKa, 
IKKp and IKKy (also called NEMO ; NFkB Essential Modifier) is a key activator of 
NFkB due to it’s ability to phosphorylate IkB [353]. IKKP is essential for NFkB 
activation via the canonical pathway and cannot be replaced by IKKa [298]. IKKa 
phosphorylates p i00 on C-terminal serine residues resulting in NFkB activation via a 
non-canonical pathway [348, 354]. Less is known about phosphorylation of hcBa on 
tyrosine 42, although some evidence links spleen tyrosine kinase (Syk), to tyrosine 42 
phosphorylation and NFkB activation in cells exposed to hydrogen peroxide [350]. 
Several MAP kinases, including NFkB -inducing kinase (NIK), mitogen-activated 
protein/extracellular signal-regulated kinase (ERK) kinase kinase 1 (MEKK1), 
MEKK3, TGF £ -activating kinase 1 (TAK1) and NFkB activating kinase (NAK) all 
phosphorylate IKKs and can induce NFkB activation under in vitro or overexpression 
conditions. Other proposed upstream kinases include Cot/Tpl-2, the novel protein 
kinase C (PKCs) isoforms PKC*, £ or A and others [291, 298, 353, 355].
Studies presented in chapter 3 describe how different neurotrophic factors can 
promote neurite growth using either canonical (BDNF) or non-canonical (CNTF) 
NFkB activation pathways. Given the diversity on NFkB function, the elucidation of 
NFkB activation mechanisms in response to diverse stimuli and identification of 
NFKB-regulated genes is of broad interest to biologists and clinicians.
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Figure 11 |NFkB activation. NFKB-inducing signals lead to the phosphorylation and subsequent 
degradation o f IkB proteins. Free, or active NFkB then translocates to the nucleus where it directs the 
transcription of numerous genes.
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1.5.4 Downstream of NFkB
Active NFkB dimers bind to a set of related lObp DNA sites called kB sites and 
regulate the expression of over 150 genes, many of which are involved in immune 
responses [356]. Cell type and signal specific NFkB gene transcription is achieved 
through the combinatorial response of promoter and enhancer regions, the selective 
activation of signalling molecules and the selective activation and binding of 
individual NFkB proteins [291, 356, 357]. Furthermore, differential phosphorylation 
of various residues of activated NFkB proteins like p65, add another layer of 
selectivity to KB-dependent gene transcription [358].
NF-kB target genes identified in the nervous system, which may be relevant for 
specific functions, include TNFa, IL-6, chemokines, N-CAM, inducible nitric oxide 
synthase (NOS-II), amyloid p precursor protein (APP), P-secretase, p-opioid 
receptors, BDNF, inducible cyclooxygenase-2 (COX-2), calcium/calmodulin- 
dependent protein kinase II and both pro and anti-apoptotic proteins [359, 360]. It will 
be of interest in the future to identify stimulus specific arrays of NFKB-dependent 
genes activated in response to specific stimuli during development and in disease.
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1.6 Hypoxia-inducible factor (HIF) signalling
1.6.1 Oxygen sensing
A significant event in the evolution of life occurred approximately 2 billion years ago 
when atmospheric oxygen concentration began to increase dramatically [361-364]. 
The rise in oxygen concentration allowed a switch from anaerobic metabolism to the 
more efficient aerobic metabolism, and facilitated the later evolution of complex 
multicellular, eukaryotic organisms [365, 366]. Large multicellular animals 
developed systems of oxygen uptake (lungs) and distribution to all tissues 
(cardiovascular). Since oxygen deficit causes irreversible damage to cells and excess 
oxygen produces reactive oxygen species that can also damage cells, an oxygen 
sensing system that maintains oxygen tension within a narrow physiological range is 
crucial for survival.
The primary site of oxygen sensing is the carotid body, which lies at the bifurcation of 
the common carotid artery and senses the partial pressure of oxygen in the 
mammalian bloodstream. Small decreases in oxygen tension activate neurons in the 
carotid body which send signals to the brain resulting in increased ventilatory and 
cardiac rates and thus increased tissue oxygenation [367]. Erythropoietin-producing 
cells of the liver and kidney also respond to low oxygen by stimulating increased 
production of red blood cells which also increases tissue oxygenation.
Recently, oxygen sensing has been shown to be a general, adaptive property of all 
nucleated cells by the identification of families of transcription factors that respond to 
hypoxia [367-369]. One such family of highly conserved transcription factors, the 
hypoxia-inducible factors (HIFs), regulate the expression of many genes involved in 
adaptive physiological responses to hypoxia, such as, angiogenesis, erythropoiesis,
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vasodilation, glycolysis and cell survival [369-371]. HIF proteins and their regulation 
are discussed in more detail in sections 1.6.2 and 1.6.3.
Mean tissue oxygen levels in vivo are as low as 3% and the hypoxia-specific marker 
EF5 has recently been used to identify hypoxic (considerably less than 1% oxygen) 
regions within the normally developing rat embryo at El 1 [372, 373]. These areas 
include the otic vesicle, optic cup, first branchial arch, somites, and interestingly the 
neural tube in both the midbrain and hindbrain [373]. When neural crest stem cells are 
cultured at low oxygen levels, there is a marked increase in survival, proliferation and 
multilineage differentiation [374]. Increased survival, proliferation and dopaminergic 
differentiation of CNS stem cells is also observed when cultured at low oxygen levels 
[375]. It is likely that there are critical periods during which an embryo must be 
exposed to a hypoxic environment in order for normal development to proceed [373]. 
Some of the mechanisms by which hypoxic environments may influence gene 
transcription during development are introduced in the following sections.
1.6.2 Regulation of HIF
HIF comprises heterodimers of two subunits, HIFa and HIFp, of the Per-Amt-Sim 
(PAS) family of basic helix-loop-helix proteins [376, 377]. Under hypoxic 
conditions, HIFs are active and bind to consensus binding motifs in hypoxia- 
responsive genes [376]. Three HIFa subunits have been identified so fa r; HIF la, 
HIF2a and HIF3a, all of which bind to the ubiquitously expressed HIF-lp subunit 
[378, 379]. Under normoxic conditions, HIFa subunits are rapidly degraded, whereas
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the HIFp subunit is unaffected by oxygen tension [380]. HIF la  is ubiquitously 
expressed and is the major regulator of hypoxia-induced gene transcription, HIF2a 
shows more tissue restricted expression patterns and HIF3a expression is not well 
characterised and encodes at least one splice variant that inhibits HIF [381-383]. HIF1 
and HIF2 contain dedicated DNA dimerisation domains as well as two transactivation 
domains [384]. HIF1 and HIF2 activate the transcription of many overlapping genes 
but also activate unique, specific downstream genes in response to hypoxia [385-387]. 
Previous studies of HIF proteins have revealed an essential role during development 
of the neural tube and the vasculature [368, 388-391]. Interestingly, the phenotype of 
HIF1-/- mice is very similar to that observed in embryos which are denied a low 
oxygen environment; defective neural tube closure, reduction in the number of 
somites and malformation of the neural folds [373]. Genetic inactivation of either 
HIF1 or HIF2 is lethal, but results in different phenotypes, indicating specific, non- 
redundant roles for HIF proteins during development [389, 390, 392-394]. However, 
the mechanisms regulating HIF activation during hypoxia or normoxia remained 
unknown. The first vital clue came from studies of a rare inherited form of cancer 
called von-Hippel-Lindau (VHL) disease. Individuals with VHL disease are 
susceptible to highly vascularised tumours in the CNS, renal carcinoma and 
pheochromocytoma [395]. Individuals with VHL disease are VHL heterozygotes 
carrying one wild-type allele and one defective allele [396]. Highly vascularised 
tumours begin to develop when the remaining wild-type allele is inactivated in 
susceptible cells [395]. Tumour cells removed from VHL patients were highly 
vascularised, with overproduction of vascular endothelial growth factor (VEGF) and 
erythropoetin (EPO) [395, 397]. The observed over production of VEGF and EPO, 
normally observed during hypoxia lead to the hypothesis that the VHL gene product,
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pVHL might be involved in oxygen sensing [398]. Subsequent studies revealed that 
hypoxia inducible genes were negatively regulated by pVHL and that HIFa was not 
degraded in VHL-/- tumor cells due to binding of pVHL to an oxygen-dependent 
degradation domain (ODD) on HIFa which targets it for proteasomal degradation 
[399-402]. Mutational and peptide mass spectrophotometric analysis revealed that the 
interaction between the ODD of HIFa with pVHL required hydroxylation of proline 
564 of HIFa [403]. Mutation of EGL-9 in C. elegans leads to an increase in HIFa 
levels under normoxic conditions and EGL-9 was also shown to hydroxylate proline 
564 of HIF in vitro [404]. Sequence homology identified three human orthologues of 
EGL-9, the HIF proline hydroxylase domain containing proteins (PHDs), which can 
act as cellular oxygen sensors by hydroxylating HIFa [404].
1.6.3 PHD enzymes
Three specific residues in the ODD of HIF are subject to hydroxylation by PHD 
enzymes. In humans, hydroxylation of prolines 564 and 402 promotes proteasomal 
degradation, whereas hydroxylation of asparagine804 inactivates the HIF complex by 
preventing the binding of the transcriptional co-activator p300 [405]. These residues 
are conserved in HIF la  and HIF2a and are crucial for cellular oxygen sensing [405]. 
PHD-dependent regulation of HIF during normoxia and hypoxia is illustrated in 
figure 12. To date, members of the 2-oxoglutarate (2-OG)-dependent dioxygenase 
superfamily have been shown to perform this crucial post-translational modification 
of HIF. There are three PHD enzymes, PHD 1-3, which are dependent on iron and 
dioxygen [405]. PHD enzymes use one oxygen atom to hydroxylate a proline residue 
on HIF a and the other in the decarboxylation of 2-OG to yield succinate and carbon 
dioxide [406]. PHD homologues have been indentified in C. elegans, Drosophila
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Melanogaster, mouse, rat and human [368, 404,407-409]. Although widely 
expressed, PHD enzymes have distinct patterns of tissue expression [408, 410].
PHD2 is the most widely expressed, PHD1 expression is highest in the testis and 
PHD3 expression is highest in the heart and placenta [368,411,412]. In addition to 
distinct patterns of subcellular location and tissue expression, there are differential 
functions of the PHD enzymes in regulation of HIFs. PHD2 preferentially regulates 
HIF la  over HIF2a, whereas PHD3 had a greater influence on HIF2a [413].
Numerous recent studies have linked oxygen sensing pathways to neuronal PCD [368, 
373,414-418]. Interestingly, numerous reports have shown that HIF signalling can be 
influenced by stimuli other than hypoxia, including, growth factors like EGF and 
HGF, oncogenes and cytokines like TNFa [405]. The expression of PHD3 is induced 
following withdrawal of NGF from sympathetic neurons and promotes apoptosis 
[417, 418]. These observations taken together with studies showing a requirement for 
hypoxic microenvironments during development [373] suggest that oxygen sensitive 
PHD enzymes may play a role in the developing PNS. I have investigated this 
possibility by analysing the survival and growth of sympathetic and sensory neurons 
dissected from mice deficient for the PHD enzymes (Chapter 4).
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Figure 12 |H1F regulation. Cartoon illustrating the regulation o f HIF signalling by PHD enzymes. 
During normoxia (left), PHD enzymes hydroxlate the ODD of HIFa which targets HIF for proteasomal 
degradation. PHD enzymes are oxygen dependent, so during hypoxia (right) there is no hydroxylation of 
HIFa and it is free to direct the transcription o f hypoxia responsive genes.
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Chapter 2 
Materials and Methods
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2.1 Introduction
The research described in this thesis uses a variety of in vitro and in vivo protocols to 
analyse neuronal survival and process outgrowth in wild-type and various transgenic 
animals. The in vitro protocols developed in this lab are well established, widely used 
and serve as a powerful tool for investigating the mechanisms of neuronal survival 
and neurite outgrowth (overview of experimental design shown in Fig. 13). In certain 
cases, in vitro observations were substantiated by using in vivo quantification of 
neuronal number and target field innervation density.
2.2 Maintenance of wild-type mice
Embryonic and postnatal wild-type mice were obtained from timed matings of CD1 
mice. Adult CD1 mice were fed with rodent global diet pellets (Harlan) and given 
water ad libidum.
2.3 Maintenance of transgenic mice
Wild-type, PHD3-/-, PHD1-/-, PHD2+/-, PHD3-/-; HIF-la+/-, PHD3-/-; HIF-2a+/- 
and HIF-2a+/~ mice on a mixed Swiss/ 129SvEv genetic background were kindly 
provided by Dr. Peter Ratcliffe (University of Oxford) and Dr. Peter Carmeliet 
(Centre for Transgene Technology and Gene Therapy (CTG), K. U. Leuven) and fed 
with rodent global diet pills and given water ad libidum. Wild-type, heterozygous and 
homozygous animals were obtained from overnight matings of heterozygous mice and 
offspring were genotyped as described in section 2.3. Breeding was confirmed by the 
presence of a vaginal plug and the period of gestation was considered to be embryonic 
day (E) 0.5.
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2.4 Genotyping of transgenic mice
2.4.1 Isolation o f genomic DNA
For routine colony maintenance and rapid genotyping of neonatal tissue required for 
in vitro or in vivo analysis, a Maxwell™ 16 Blood Purification Kit (Promega) was 
used in combination with a Maxwell™ 16 Instrument and carried out according to the 
manufacturer’s instructions.
2.4.2 Genotyping protocol
To determine the genotype at the PHD1 locus, two PCR reactions were required for 
each animal. The wild type PHD1 allele was amplified using forward (5’- AGT CCC 
TCT GGT TCT AGA GTG GGG -3 ’) and reverse (5’- TCT CAG CAT CTC ATC 
ACT CCC CTG -3 ’) PHD1-WT primers. The recombinant PHD1 null allele was 
detected using forward (5’- TTG CAT CGC ATT GTC TGA GTA GGT GT -3 ’) and 
reverse (5’- TCT CAG CAT CTC ATC ACT CCC CTG -3 ’) PHDl-null primers.
To determine the genotype at the PHD2 locus, the wild type PHD2 allele was 
amplified using forward (5’- ACC TAT GAT CTC AGC ATT TGG GAG -3 ’) and 
reverse (5’- AAA TTC TAA TCG TAG CTG ATG TGA GC-3’) PHD2-WT primers. 
The recombinant PHD2 allele was detected using forward (5’- TCA GGA CAG TGA 
AGC CTA GAA ACT CT -3 ’) and reverse (5’- ACC TAT GAT CTC AGC ATT 
TGG GAG -3 ’) PHD2-recombinant primers. Similarly, the genotype at the PHD3 
locus was detected using forward (5’- CGA GAT GCC TCT GGG ACA CAT CAT -  
3’) and reverse (5’- GGA CCG CTC CTT GAC ATA GTA TTT -3 ’ ) PHD3-WT 
primers and the recombinant PHD3-null allele was detected using forward (5’- CGA 
CGG GCG TTC CTT GCG CAG -3 ’) and reverse (5’- CGG ATC GAT CCC CTC 
AGA AGA AC -3 ’) PHD3-null primers.
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All reactions were assembled in 0.2 ml PCR tubes containing lpl each of forward and 
reverse primers, 12.5 pi of 2 x BioTaq buffer (BioLine), lpl Taq DNA polymerase 
and 8.5pl of PCR-grade (IH2O to give a final volume of 23.5pl. 2 x BioTaq buffer 
contained 200pl of 10 x Taq buffer (BioLine), 80pl of 50mM magnesium chloride, 
16|il of lOOmM dNTP mixture and 704pi of dfLO. Samples were amplified using a 
PTC-100 programmable thermal controller (details of PCR cycle conditions are 
shown in the appendix). PCR products were then run on a 1.5% agarose gel with 
ethidium bromide (0.5mg/ml) against a 1Kb DNA ladder with the following expected 
band sizes PHD1 wild-type allele 900bp, PHD 1-null allele 590bp, PHD2 wild-type 
allele 350bp, PHD2-null allele 400bp, PHD3 wild-type allele 357bp and PHD3-null 
allele 590bp.
2.5 Isolation of mouse embryos
Pregnant CD1 females were killed at the required stage of gestation by exposure to a 
rising concentration of CO2, followed by cervical dislocation in line with the 
regulations of the Home Office Animals (Scientific Procedures) Act, ASP A, 1986. 
Death was confirmed by pedal reflex. Embryos were isolated by laparotomy as 
follows; scissors that had been sterilised in 70% ethanol were used to make a small 
incision across the front of the abdomen. The skin lying above and below the incision 
was then pulled manually in opposing directions, exposing the underlying abdominal 
muscles. A pair of toothed forceps was used to hold the anterior abdominal muscle 
whilst making an incision using scissors, allowing air to enter the peritoneal cavity. 
The incision was then extended across the abdominal muscles without the hazard of 
cutting the intestines and contaminating the dissection with gut bacteria [419]. Each
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gravid uterine horn was removed from the abdomen using toothed forceps cutting 
tissue free with a pair of scissors, and transferring to a 50ml Falcon tube (Greiner) 
containing sterile L-15 medium (Gibco, Invitrogen). Embryos were then transferred 
to a 90mm Petri dish (Greiner) containing L-15 medium where one continuous 
incision was made along the anti-mesometrial border of each uterine horn, exposing 
the embryos enclosed within their membranes [419]. Embryos were detached from 
their uterine horns using a pair of scissors and finally removed from the chorion and 
amnios using watchmaker’s forceps and transferred to a fresh 90mm Petri dish 
containing L-15 medium [419].
2.6 Dissection of peripheral ganglia
The nodose ganglion, superior cervical ganglion, trigeminal ganglion and dorsal root 
ganglion were removed from embryonic or postnatal pups as follows, using standard 
sterile technique, in a laminar flow hood. Embryos (E l6) and pups (P0-P5) were 
killed by decapitation with a pair of sharp scissors. Mouse pups older than P5 were 
killed using a rising concentration of CO2 in line with ASPA (1986). The top of the 
skull and underlying forebrain was removed and the head was cut in half along the 
sagittal plane. The jugular foramen was opened up by deflection of the occipital bone 
using watchmaker’s forceps, revealing the nodose and superior cervical ganglia at the 
mouth of the foramen. The nodose ganglion was identifiable due to its spherical 
appearance and prominent vagus nerve attached to its distal aspect [419] . The SCG 
is a more elongated structure lying above the carotid artery, attached caudally to the 
sympathetic chain [419]. The trigeminal ganglion was dissected from neonatal mice 
by removing the top of the skull and forebrain in a plane above the eyes and whisker 
pads. Trigeminal ganglia were found bilaterally on the base of the skull and identified
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by their elongated appearance. In order to isolate the dorsal root ganglion, thoraco­
lumbar vertebral columns of embryonic and neonatal mice were removed and cut in 
the midline. The dorsal root ganglia were identified by their characteristic appearance 
and by following the posterior root of the spinal nerve. All ganglia were then cleaned 
of adherent tissue using tungsten needles as described in section 2.6.
2.7 Preparation of tungsten needles
The tips of two 3cm lengths of 0.5mm tungsten wire were bent into a 90° angle, 
placed in 1M KOH and a 3-12 V AC current passed through the solution. A second 
electrode was placed in the solution which resulted in the gradual etching away of the 
tungsten tip forming a sharp, tapered end. The tip may be placed vertically in the 
KOH solution to form an extra sharp point. The sharpened tungsten needles are then 
held in chuck-grip platinum wire holders during the dissection. Tungsten needles were 
sterilised using ethanol and a Bunsen burner flame before and after each use.
2.8 Dissociated neuronal cultures
2.8.1 Preparation o f  dishes
Neurons were cultured on a laminin/poly-omithine substratum. Dishes were prepared 
by adding 2ml poly-DL-omithine (Sigma) / borate solution to 35mm tissue culture 
dishes (Greiner) and left overnight at room temperature. The poly-ornithine solution 
was aspirated after 24 hours and the dishes were washed three times with sterile 
distilled water before being allowed to air dry in a laminar flow hood. 50-100pl of a 
20mg.mT1 solution of laminin (Sigma) in Hank’s Balance Salt Solution (HBSS) 
(Gibco, Invitrogen) was added to the centre of each dish. The dishes with laminin
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solution were then placed in an incubator at 37°C for 2 hours. After dissection and 
dissociation, neurons were plated onto the prepared dishes having washed and 
removed the laminin.
2.8.2 Culture media
A lOx concentrated Ham’s Modified F-14 (JRH Biosciences) stock solution was 
prepared and stored at -30°C. lx FI4 media was prepared as follows; 500mg of 
sodium hydrogen carbonate was added to 250mls of distilled water. 25 mis of this 
solution was removed and replaced with 25mls of lOx stock F-14 solution containing 
streptomycin (Sigma) and penicillin (Sigma). The IX F-14 solution was then 
supplemented with 2.5ml 200mM glutamine (Gibco, Invitrogen) (2mM final) and 
5.5ml of an Albumax I solution containing Albumax I (Gibco, Invitrogen), 
progesterone, putrescine, L-thyroxine, sodium selenite and tri-iodothyronine (all 
Sigma). The supplemented F-14 medium was then filter sterilised using a 0.2pm 
Acrocap filter unit (Pall Corporation) and stored at 4°C for up to a month (Davies 
book chapter).
2.8.3 Dissociation o f ganglia
After dissection and removal of adherent tissue using tungsten needles, ganglia were 
added to 950pl HBSS (Gibco, Invitrogen) containing 50pl of 1% trypsin 
(Worthington). The trypsin-HBSS mixture was then incubated at 37°C for a period of 
time suitable for that developmental stage. Embryonic neurons were incubated with 
trypsin for 15-18 minutes and postnatal neurons were incubated with trypsin for 20-25 
minutes. The trypsin-HBSS mixture was then aspirated and the ganglia were washed 
twice with 10ml of F-12 (Gibco, Invitrogen) with 10% heat inactivated horse serum
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(HIHS), to inactivate any residual trypsin [419]. Ganglia were then gently triturated 
using a fire-polished siliconised glass pipette to provide a dissociated cell suspension 
[419].
2.8.4 Seeding o f neurons
Neurons were seeded in laminin-coated 35mm dishes. A cell suspension was made 
by visualising 10pl of dissociated neurons using an Nikon Diaphot inverted phase- 
contrast microscope to estimate the volume of suspension needed to seed 100-200 
neurons per 12mm grid in order to study neurite growth or neuronal survival. The 
volume of cell suspension required to seed the total number of dishes in the 
experiment was transferred to a 50ml Falcon tube containing the total volume of F-14 
required. The cell suspension was kept uniform by mixing end over end, while 1ml 
was added to each 35mm dish. At the time of plating, or shortly afterwards in the case 
of transfected neurons, neurotrophic factors (NGF, BDNF, CNTF, NT-3) or 
pharmacological inhibitors (SN50, Piceatannol, ALLN, MG 132, nifedipine, verapmil, 
KN-62) were added to the culture media at the concentrations indicated in figure 
legends.
2.9 Estimation of neuronal survival
To quantify the percentage neuronal survival, a standard graticule for examining each 
culture dish was constructed from the base of a 900mm plastic Petri dish, where a 
scalpel blade was used to inscribe a 12 x 12mm2 grid consisting of 2mm squares 
[419]. Cells were counted 3-4hrs after plating by mounting the graticule on an 
inverted phase-contrast Nikon Diaphot microscope. Each dish was then placed over 
the graticule and the number of neurons present in the 12mm grid was then counted.
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Neurons which had not attached to the substratum were ignored. The number of 
phase-bright neurons in all dishes was counted at 24hr intervals until necessary. The 
number of phase-bright neurons at 24hrs ,48hrs or 72hrs was then expressed as a 
percentage of the initial cell count.
For estimating the survival of transfected neurons, cultures were transfected with a 
YFP-plasmid along with a plasmid of interest, using the gene gun (Helios, described 
in section...) and the number of YFP-labelled neurons was counted 12 hours after 
plating and again at 24 hours. The number of labelled neurons surviving at 24 hours 
was expressed as a percentage of the initial number of labelled neurons. The area 
counted was defined by the area in which gold particles could be seen to be embedded 
in the bottom of the culture dish.
2.10 Quantification of neurite outgrowth
Transfected, YFP-labelled neurons were visualized and digitally acquired using an 
Axioplan Zeiss laser scanning confocal microscope. For experiments in which the 
neurons were not transfected, viable neurons were stained with Calcein-AM dye 
(Invitrogen) and digitally acquired as described above. Neurons were incubated at 
37°C for 15-20 minutes with Calcein-AM prior to digital acquisition. For every 
condition studied, between 40 and 70 neurons were captured, and neuritic arbors were 
traced using LSM510 software. These traces were used to ascertain total neurite 
length and number of branch points. Sholl analysis was also carried out on these 
traces. For this, concentric, digitally generated rings, 30 pm apart were centered on 
the cell soma, and the number of neurites intersecting each ring was counted [420].
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2.11 Ballistic Transfection
2.11.1 Plasmid preparation
Competent, E. coli H I07 cells was transferred from -70°C and thawed on ice. To 
lOOpl of these, 5-20ng of plasmid DNA was added in a volume of 1-5 pi and 
incubated on ice for 30mins. Competent E. coli were heat shocked at 42°C for 30secs 
and returned to ice for 2min before adding 800pl LB and shaking at 37°C for 45mins. 
lOOpl of transformation reaction was subsequently spread onto selective LB/agar 
plates and incubated overnight. A single colony was selected and added to 100ml LB 
media and incubated overnight at 37 °C in a shaking incubator. The LB containing 
plasmid DNA was then centrifuged for 10 minutes at 6000rpm. Plasmid DNA was 
isolated from the resulting bacterial pellet using a plasmid midi kit (Qiagen) according 
to the manufacturer’s protocol. The concentration of plasmid DNA was then 
measured using the nanodrop spectrophotmeter system.
2.11.2 Preparation o f gold microcarriers for ballistic transfection 
Ballistic transfection was carried out by shooting gold microcarriers coated with 
plasmid DNA and YFP into dissociated neurons. To prepare the microcarriers, 20 mg 
of 1.6 pm gold particles (Biorad) were suspended in lOOpl of 50 mM spermidine 
(Sigma) and 2pg of pYFP (Clontech) together with lOpg pIicBa super-repressor or 
Y42F mutants, constructs expressing NFkB subunits p50, p65 or both p50 plus p65, 
Syk-DN or pCDNA control plasmid. The gold particles were precipitated with 100 pi 
of 2M CaCl2, washed three times with 100% ethanol, resuspended in 1.2 ml of 100%
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ethanol plus 0.01 mg/ml polivinylpirrolidone and loaded into Teflon tubing. The gold 
particles were then thoroughly dried and stored at 4°C for up to 30 days.
2.11.3 Ballistic transfection
Gold microcarriers coated with plasmid DNA and YFP were shot into dissociated 
neurons using a hand-held gene gun (Helios Gene-gun, BioRad Hercules, CA USA). 
Between 1,000 and 3,000 neurons were plated in a 50 pi droplet of defined medium in 
the centre of a 35 mm diameter tissue culture dish that had been pre-coated with poly- 
omithine (Sigma) and laminin (Sigma). Neurons were incubated at 37.5°C in a 
humidified 3.5% C 02 incubator for 2 hours to allow the cells to attach, and the
medium was removed from the dish just prior to transfection. The coated gold 
particles were shot into the cultured neurons with the gun pressurized at 200 psi. A 70 
pm nylon mesh screen was placed between the gun and the culture to protect the cells 
from the shock wave. After transfection, 2mls of F-14 containing the appropriate 
neurotrophic factor were added and cells returned to the incubator at 37°C overnight.
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Figure 13 {Experimental outline. Flowchart describing the basic experimental design. Ganglia from 
wild-type and transgenic mice are dissected (A) and plated in defined media (B). Neurons may be 
transfected with a plasmid using the gene gun (C) or pharmacological agents added along with 
neurotrophic factors (D). Quantification o f neuronal survival requires an initial count 3 hours after 
plating (E). Cells are then incubated overnight and may be digitally acquired and analysed for neurite 
growth (F) or a second count is performed and percentage neuronal survival estimated (G). 87
2.12 Preparation of kB decoy DNA
Double-stranded «B Decoy DNA was prepared by annealing complementary single 
stranded oligonucleotides of the following sequences: 5'-GAGGGGACTTTCCCT-3' 
and 5'-AGGGAAAGTCCCCTC-3'. Control DNA with a scrambled sequence was 
prepared by annealing the following sequences: 5-GATGCGTCTGTCGCA-3' and 5'- 
TGCGACAGACGCACT-3'. Double-stranded DNA solutions were prepared at a 
concentration of 50 mmol/1 and ethanol precipitated onto the gold microcarriers along 
with pYFP and used to transfect neonatal nodose neurons.
2.13 NFkB activation assay
To estimate the relative level of NFkB activation in cultured neurons under different 
experimental conditions, the neurons were transfected with a plasmid expressing GFP 
under the control of an NFkB promoter. Neurons were imaged with a Zeiss Axioplan 
laser scanning confocal microscope. The mean fluorescence intensity for each soma 
was obtained after 24 hours in culture using LSM510 software, based on the standard 
255 intensity level scale after subtraction of background intensity. 40-60 neurons were 
imaged for each experimental condition. Levels of NFkB activation were measured in 
this way after treatment of nodose neurons with 50ng CNTF, after treatment of 
CNTF-supported neurons with piceatannol (lOpM), or after transfection of CNTF- 
supported neurons with Syk dominant negative or IkBol tyrosine mutant Y42F.
2.14 qPCR analysis of PHD3 induction after NGF withdrawal
Dissociated SCG, DRG and TG neurons from wild-type P0 mouse pups were cultured 
overnight in 10 ng/ ml NGF as described above. Neurons were then washed with 
defined culture medium and grown either in the presence or absence of NGF for 10 h
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(timepoint at which PHD3 mRNA induction is maximal in the SCG; (Lipscomb 1999) 
before harvesting the cells for RNA. Total RNA was isolated with the RNeasy Mini 
extraction kit (Qiagen, Hilden, Germany). The RNA was reverse transcribed for 1 hr 
at 37°C with StrataScript reverse transcriptase (Stratagene) in a 40 pi reaction 
containing the manufacturer’s buffer supplemented with 5 mM dNTPs (Stratagene) 
and 10 pM random hexamers (Amersham). 3 pi aliquots of the reverse transcription 
reactions were amplified in a 25 pi reaction volume using the Brilliant QPCR core 
reagent kit (Stratagene). Each reaction mixture consisted of lxPCR buffer, 3 mM 
MgCl2, 300 pmol primers, 0.4 mM dNTPs, 1 unit of Taq, lx  reference dye and 1 unit 
of SYBR green (Molecular Probes). The forward and reverse primers for PHD3 
cDNA were 5 ’ -CT AT GGGAAGAGC A A AGC -3’ and 5’- 
AGAGCAGATGATGTGGAA - 3’, respectively. The PCR was performed with the 
Mx3000P (Stratagene) for 45 cycles of 95 °C for 30 s, 52 °C (for PHD3) or 51 °C (for 
GAPDH) for 1 min, 72 °C for 30 s. A melting curve was obtained to confirm that the 
SYBR green signal corresponded to a unique and specific amplicon. Standard curves 
were generated for every real-time PCR run by using serial three-fold dilutions of a 
reverse transcribed RNA extract from an El 3 whole mouse embryo. All values 
obtained were normalized to GAPDH mRNA. The forward and reverse primers for 
GAPDH cDNA were 5’-TCCCACTCTTCCACCTTC-3’ and 5’- 
CTGTAGCCGTATTCATTGTC- 3’, respectively. qPCR was performed three times, 
as described above, on ganglia obtained from three separate litters.
2.15 Western blots
Neurons were plated at high density in poly-omithine/laminin coated 96-well plates 
(5,000 neurons per well) in defined medium. Four hours after plating, 50 ng/ml
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CNTF or lOng/ml BDNF was added to the wells for the indicated times. The medium 
was removed and the cells were lysed in RIPA buffer (50mM Tris pH7.4, 150mM 
NaCl, 10% Glycerol, 1% Triton X-100, ImM EDTA and lOOjig/ml PMSF) and the 
cell extract was incubated on ice for lh. Insoluble debris was removed by 
centrifugation at 10,000 x g for 10 min at 4°C. Equal amounts of each sample were 
transferred to PVDF membranes using the Bio-Rad trans-blot system. Membranes 
were blocked for 1 h in 5% dried milk in PBS with 0.1% Tween-20. Following this, 
membranes were incubated with antibodies for phospho Syk (Cell signalling 
technology ; 1:1000), serine phosphorylated IicBa (Cell signalling technology ; 
1:1000), tyrosine phosphorylated IkBcx (Cell signalling technology ; 1:1000) or p-III 
tubulin (Promega ; 1:1000) diluted in 1% dried milk in lxPBS with 0.1% Tween-20. 
The appropriate peroxidase-linked secondary antibody (Amersham) was used to 
detect each primary antibody on the blots and staining was visualised using ECL-plus 
(Amersham). Densitometry was carried out using Adobe photoshop to determine the 
levels of phosphorylated forms of IkBo, or Syk after treatment with either BDNF or 
CNTF.
2.16 Dissociated cell counts
Superior cervical ganglia were carefully dissected from neonatal wild-type, PHD1-/-, 
PHD2+/-, PHD3-/-, PHD3-/-;HIF1+/- and PHD3-/- ;HIF2+/- mice. Ganglia were then 
dissociated in trypsin as described above and a 1ml single cell suspension was 
obtained. Triplicate counts were made of the total number of phase bright, viable 
neurons per SCG using a Neubauer haemocytometer for each genotype. This process
90
was repeated at least three times using SCG obtained from at least three separate 
litters.
2.17 Adult stereology
As part of a collaborative project investigating the neuronal phenotype of PHD3-/-
mice, the total number of tyrosine hydroxylase (TH)-positive cells in SCG, carotid
body and adrenal medulla were counted in wild-type and PHD3-/- mice using
standard stereological analysis. Adult stereology was carried out by Alberto Pascual
(University of Sevilla, Spain). Briefly, the SCG, adrenal medulla and carotid body
from adult mice were fixed in formalin overnight then transferred into PBS containing
30 % sucrose. 20 pm sections were blocked for 1 h at room temperature with 10 %
FCS and 1 mg/ ml BSA containing 0.1 % tritonX-100 in PBS, then incubated for 16 h
at 4 °C with a rabbit anti-TH polyclonal antibody (Pel-Freez; diluted 1:1000 in
blocking solution). The sections were washed four times in PBS-triton before being
incubated with goat anti-rabbit secondary antibody (Envision+, Dako). Stereological
estimation of the number of TH-positive cells was performed on sections spaced 80
pm (SCG and adrenal medulla) or 40 pm (carotid body) throughout the organ. The
•  •  1number of cells was estimated by systematic random sampling using a 106954 pm 
optical dissector [421], excluding cells in the superficial planes of sections. The 
volume of each organ was estimated according to Cavalieri’s principle [422]. 
Stereological measurements were performed using the C.A.S.T. Grid System 
(Olympus) with a coefficient of error < 0.09.
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2.18 Measuring sympathetic innervation density
To assess the density of sympathetic innervation, the eyes, submandibular and pineal 
glands from adult (or P5 for the pineal glands) wild-type and PHD3-/- mice were 
fixed in 4% paraformaldehyde for 24 h and were cryoprotected in 30% sucrose before 
being frozen. 15 pm serial sections were cut through the tissue which were then 
mounted onto poly-lysine-coated slides (BDH), blocked with 10% normal goat serum 
containing 0.1% tritonX-100 in 10 mM PBS for 1 h at room temperature, and then 
incubated for 18 hr at 4°C with a rabbit anti-TH polyclonal antibody (Chemicon) 
diluted 1:200 in PBS with 1% normal goat serum (Sigma). The sections were washed 
three times in PBS before being incubated with goat anti-rabbit secondary antibody 
(Alexa-Fluor, Invitrogen, 1:500) for 2 hours. In the case of the iris and submandibular 
glands, four random images were taken from each section using an Axioplan Zeiss 
laser scanning confocal microscope. One image from the smaller pineal gland was 
taken per section. The images were than traced using Adobe Photoshop 7 and the total 
area and the area containing TH-positive fibres were estimated by automated pixel 
counts. The ratio of TH-positive area to total area was then calculated as a percentage.
2.19 Pupillometry
As part of a collaborative project examining the physiological effects of PHD3 
inactivation on the sympathetic nervous system, Dr. Joseph de Bono (University of 
Oxford) measured pupillary reflexes in PHD3-/- mice. Briefly, adult wild-type and 
PHD3-/- mice were dark-adapted for 1 h. Subsequently, animals were removed from 
their home cage, immobilised by scruffing and pupil reactions were monitored (at 0 
lux followed by 150 lux of bright white light) using a commercial CCD camcorder 
(DCR-HC17E, Sony, Tokyo, Japan) attached to a dissecting microscope (Olympus,
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Tokyo, Japan) under infrared LED illumination (A^ ax of 850nm). Pupil areas were 
estimated by manually fitting an ellipse to digitalised video still images using 
Windows Movie Maker (Microsoft, Redmond, WA) and Adobe Photoshop (San Jose, 
CA) software.
2.20 Statistical analyses
Data are presented as means ± SEM, and statistical significance was determined by 
student’s T-test or, if there were more than two sets of data to compare, the one-way 
analysis of variance (ANOVA) with Fisher’s post hoc test was used. The level of 
significance accepted was P<0.05. For neurite growth analysis, between 40 and 70 
neurons were sampled per condition and each experiment was repeated at least three 
times. All other studies presented were performed on litter mate-controls and were 
repeated using at least three* separate litters and the error calculated using the average 
values obtained from each repeat.
* In cases where more than three repeats were performed, the number of repeats is 
indicated in the parentheses (see figures).
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Chapter 3
NFkB Activation via Tyrosine Phosphorylation of IkB-ce is Crucial 
for CNTF-promoted neurite growth from developing neurons
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3.1 Introduction
Nuclear factor-kappa B (NF-kB) is a ubiquitously expressed transcription factor 
system that consists of homodimers or heterodimers of five structurally related 
proteins: p65, RelB, c-Rel, p50 and p52, of which the p50/p65 heterodimer is the 
most abundant and widely expressed [298]. NF-kB is held in an inactive form in the 
cytosol by interaction with a member of the IkB family of inhibitory proteins: IicBa, 
IicBp, IkBb, IkBy, Bcl-3, pi 00 and pi 05, of which IkB a  is the predominantly 
expressed inhibitor. In the canonical NF-kB signalling pathway, NF-kB is activated 
by phosphorylation of IkBo, on serine residues 32 and 36 by an IkB kinase complex. 
This leads to ubiquitination and proteasome-mediated degradation of IkBo, and 
translocation of liberated NF-kB to the nucleus where it binds to consensus kB 
sequences in the promoter and enhancer regions of responsive genes [298]. NF-kB 
can also be activated by several alternative mechanisms including one in which IkBcx 
is phosphorylated on tyrosine 42, which results in its dissociation from NF-kB 
without proteasome-mediated degradation [350, 423-425].
Classically, NF-kB has been shown to regulate the expression of genes involved in 
innate and adaptive immune responses, stress responses, cell survival and cell 
proliferation [426]. In the nervous system, NF-kB is activated by a variety of 
neurotrophic factors, cytokines and neurotransmitters, and can promote neuronal 
survival or bring about neuronal death [427]. NF-kB signalling also regulates synaptic 
function, plays a role learning and memory and participates in peripheral nerve 
myelination [313, 428-430]. Most recently, the ability of the neurotrophins nerve 
growth factor (NGF) and brain-derived neurotrophic factor (BDNF) to promote
neurite growth has been shown to be partially dependent on NF-kB signalling [291, 
321,431].
Because neurotrophins and other families of neurotrophic factors exert qualitatively 
and quantitatively different effects on neurite growth from various kinds of neurons, 
we asked to what extent NF-kB signalling is involved in regulating neurite growth in 
response to different kinds of neurotrophic factors. For these studies I chose the 
sensory neurons of the nodose ganglion of newborn mice because the survival of the 
great majority of these neurons is supported equally well by two different 
neurotrophic factors, the neurotrophin BDNF and the cytokine ciliary neurotrophic 
factor (CNTF), both of which promote neurite growth [102,109]. Moreover, these 
neurotrophic factors utilize different receptor systems that engage downstream 
signalling networks in different ways. BDNF binds to the TrkB receptor tyrosine 
kinase and the common neurotrophin receptor p75NTR, and CNTF binds to a receptor 
complex consisting of gpl30, LIFRp and CNTFRa [220, 280]. I find that NF-kB 
signalling contributes to the neurite growth-promoting effects of BDNF and is 
essential for CNTF-promoted neurite growth, but plays no role in mediating the 
survival-promoting effects of either of these factors in the postnatal period. Whereas 
the contribution of NF-kB signalling to BDNF-promoted neurite growth occurs via 
the canonical pathway, the requirement of NF-kB signalling for CNTF-promoted 
growth occurs via a non-canonical NF-kB signalling pathway.
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Results
3.2 SN50 reduces neurite growth from nodose neurons
Translocation of NF-kB (p65/p50 dimers) from the cytoplasm to the nucleus is an 
essential step in its regulation of gene transcription. SN50 is a cell membrane 
permeable inhibitor of NF-kB nuclear translocation that blocks NF-KB-dependent 
transcription by blocking the nuclear localisation sequence of p50 [432]. To test and 
contrast the effect of SN50 on neurite growth promoted by neurotrophins and 
cytokines, dissociated cultures of PO nodose ganglion neurons were treated with either 
SN50 or an inactive control peptide (SM) 3 hours after plating. The culture medium 
was supplemented with either BDNF or CNTF 3 hours after plating, and neuronal 
survival and the size and complexity of neurite arbors was quantified 24 hours after 
plating. In BDNF supplemented cultures, SN50 but not the control peptide, 
significantly inhibited neurite growth. Total neurite length (Fig. 14B) and the total 
number of branch points (Fig. 14C) were reduced by about half by SN50, and 
branching with distance from the cell body was reduced by about half at each 30 pm 
interval (Fig. 14A). The typical appearances of SN50-treated and control peptide- 
treated neurons grown with BDNF are illustrated in Figure 18. SN50 did not 
significantly reduce the number of neurons surviving with BDNF (Fig. 14D).
In CNTF supplemented cultures, SN50 but not the control peptide virtually eliminated 
neurite growth as quantified by Sholl analysis, total neurite length and number of 
branch points (Figs. 15A, 15B and 15C). Despite the dramatic effect on neurite 
growth, the cell bodies of the SN50-treated neurons retained a normal appearance 
(Fig. 18) and continued to survive just as well as control peptide-treated neurons in 
the presence of CNTF, with around 80% of the neurons surviving at this time (Fig.
97
15D) as evidenced by staining with the vital dye calcein. In contrast, over half of the 
neurons grown without neurotrophic factors were dead by 24 hours (data not shown). 
BDNF and CNTF promoted the survival of similar numbers of nodose neurons (Figs. 
14D and 14H), and because there was no additional survival in the presence of both 
factors (data not shown) it appears that BDNF and CNTF promote the in vitro 
survival of the same major subset of nodose neurons at this stage of development.
These results demonstrate that blocking nuclear translocation of NF-kB in nodose 
neurons markedly affects neurite growth without affecting survival. The virtual 
elimination of neurite growth from neurons grown with CNTF suggests that NF-kB 
signalling is crucial for CNTF-promoted neurite growth, whereas the significant 
reduction in neurite growth from neurons grown with BDNF suggests that NF-kB 
signalling makes an important contribution to BDNF-promoted neurite growth.
33  k B decoy DNA reduces neurite growth from nodose neurons
To further investigate the importance of NF-kB in neurotrophic factor-promoted 
neurite growth, the consequences of inhibiting another key step in NF-kB signalling, 
the binding of activated NF-kB to DNA were studied. This was blocked by 
transfecting neurons with double stranded DNA oligonucleotides containing the kB 
consensus binding sequence found in the promoters and enhancers of NF-kB target 
genes. This kB decoy DNA has been successfully used in vitro and in vivo to inhibit 
NF-kB transcriptional activity by sequestering transcriptionally active NF-kB 
complexes [321,433,434]. PO nodose ganglion neurons were transfected with either 
the kB decoy DNA or a control oligonucleotide of scrambled sequence 3 hours after
98
plating. The culture medium was supplemented with either BDNF or CNTF 
immediately after transfection and neuronal survival and the size and complexity of 
neurite arbors was quantified 24 hours after plating.
In BDNF-supplemented cultures, the kB decoy DNA but not the control 
oligonucleotide caused a significant reduction in neurite growth. In these cultures, 
total neurite length, number of branch points and branching with distance of the cell 
body were reduced by just under 50% (Figs. 16A, 16B and 16C). kB decoy DNA did 
not affect the number of neurons surviving with BDNF (Fig. 16D). In CNTF 
supplemented cultures, the kB decoy DNA but not the control oligonucleotide caused 
a marked, three-fold reduction in neurite length (Fig. 17B) and branching (fig. 17C) 
and a marked reduction in neurite growth as quantified by Sholl analysis (Fig. 17A). 
As with SN50, kB decoy DNA had no detrimental effect on the survival of CNTF- 
supplemented neurons (Fig. 17D). The typical appearances of CNTF-treated and 
BDNF-treated neurons transfected with kB decoy DNA are illustrated in Figure 18.
These results show that blocking NF-kB-dependent transcription reduces neurite 
growth from newborn nodose ganglion neurons supported by CNTF or BDNF without 
significantly affecting survival. As with blocking nuclear translocation of NF-kB, 
blocking NF-KB-dependent transcription has a much greater effect on CNTF- 
promoted neurite growth than BDNF-promoted neurite growth.
3.4 Overexpression of p50/p65 increases neurite growth
To further characterize the role of NFkB signalling in neurite growth, PO nodose 
neurons were transfected with plasmids expressing NFkB subunits p50, p65, p50 plus
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p65 or control pcDNA and neurite growth was measured after 24 hours in culture with 
BDNF or CNTF. Figure 6 shows that cotransfection of nodose neurons supported by 
BDNF with p50/p65 significantly increased neurite growth (Fig. 19A), length (Fig. 
19B) and branching (Fig. 19C) without effecting neuronal survival (data not shown) 
compared to control transfected neurons. Figure 19 also shows that expression of 
either p50 or p65 alone had no effect on neurite growth. Similarly, for neurons 
supported by CNTF, cotransfection with p50/p65 significantly increased growth (Fig. 
19D), length (Fig. 19E) and branching (Fig. 19F) compared to control transfected 
neurons. Again, expression of either p50 or p65 alone had no effect on neurite growth 
in neurons supported by CNTF (not shown). These data support the above 
observations implicating NFkB in the positive regulation of neurite growth. These 
data also suggest that the NFkB p50/p65 heterodimer regulates the growth of nodose 
neurons supported by either BDNF or CNTF.
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Figure 14 | Effect of SN50 on BDNF-dependent neurite growth. P0 nodose neurons were treated with 
either SN50 (lOpM) or the inactive peptide SM (10|JM) together with BDNF (10 ng/ml) 3 hours after 
plating. The neurons were fluorescently labelled with Calcein-AM dye and images were digitally acquired 
for analysis of neurite growth and morphology 24 hours after plating. Sholl analysis (A), total neurite 
length (B) and number of branch points (C) in the neurite arbors of 50-90 neurons in each condition from a 
typical experiment are shown (means ± standard errors). Very similar data were obtained in three 
independent experiments. The percentage survival of neurons after 24 hours incubation in these conditions 
is shown in D. Statistical comparisons are with respect to SM-treated neurons (*  p<0.05, **p<0.01).
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Figure 15 | Effect of SN50 on CNTF-dependent neurite growth. P0 nodose neurons were treated with 
either SN50 (IOjjM) or the inactive peptide SM (10pM) together with CNTF (10 ng/ml) 3 hours after 
plating. The neurons were fluorescently labelled with Calcein-AM dye and images were digitally acquired 
for analysis of neurite growth and morphology 24 hours after plating. Sholl analysis (A), total neurite 
length (B) and number of branch points (C) in the neurite arbors of 50-90 neurons in each condition from a 
typical experiment are shown (means ± standard errors). Very similar data were obtained in three 
independent experiments. The percentage survival of neurons after 24 hours incubation in these conditions 
is shown in D. Statistical comparisons are with respect to SM-treated neurons (* p<0.05, **p<0.001).
102
In
te
rs
ec
tio
ns
B
6
5
~0~ Control 
Decoy4
3
2
1
0
1 30 120 210 300 390 480
Distance from soma (|Jm)
Vi
C♦Oa
o
J-iPQ
n  BDNF + Control DNA 
|  BDNF + Decoy
i
d
3oH
D
1400
1200
1000
800
600
400
200
0
I
O  BDNF + Control DNA 
■  BDNF + Decoy
1 100 -| T
T 80 -
_ *  £  60-
- jji 1 40-
“ ■
1
□  BDNF + Control DNA 
H  BDNF + Decoy
Figure 16 | Effect of KB decoy DNA BDNF-dependent neurite growth. P0 nodose neurons were 
transfected 3 hours after plating with a YFP expression plasmid together with either kB decoy DNA 
oligonucleotide or a scrambled control DNA oligonucleotide and were incubated with BDNF (10 ng/ml) 
until 24 hours after plating when images of labelled neurons were digitally acquired for analysis of neurite 
growth and morphology. Sholl analysis (A), total neurite length (B) and number of branch points (C) in the 
neurite arbors of 50-90 neurons in each condition are shown (means ± standard errors) from a typical 
experiment (very similar data were obtained in three independent experiments). The percentage survival of 
neurons after 24 hours incubation in these conditions as shown in D. Statistical comparisons are with respect 
to control-transfected neurons (* p<0.05).
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Figure 17 | Effect of kB decoy DNA CNTF-dependent neurite growth. P0 nodose neurons were 
transfected 3 hours after plating with a YFP expression plasmid together with either kB decoy DNA 
oligonucleotide or a scrambled control DNA oligonucleotide and were incubated with CNTF (50 ng/ml) 
until 24 hours after plating when images of labelled neurons were digitally acquired for analysis of neurite 
growth and morphology. Sholl analysis (A), total neurite length (B) and number of branch points (C) in the 
neurite arbors of 50-90 neurons in each condition are shown (means ± standard errors) from a typical 
experiment (very similar data were obtained in three independent experiments). The percentage survival of 
neurons after 24 hours incubation in these conditions as shown in D. Statistical comparisons are with respect 
to control-transfected neurons (* p<0.05, **p<0.001).
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Figure 18 | Effect of inhibiting NF-kB activity on neurite arbor size. Photomicrographs of typical PO 
nodose neurons incubated for 24 hours with either CNTF or BDNF together with either SN50 or SM control 
peptide and labelled with calcein-AM (4 panels on left) or transfected with a YFP plasmid and kB decoy 
DNA (2 panels on right). Scale bar = 30 mm.
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Figure 19 | Effect of Overexpressing NFkB subunits on neurite growth. P0 nodose neurons were 
transfected 3 hours after plating with a YFP expression plasmid together with p65, p50 or p65 plus p50 and 
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D. Statistical comparisons are with respect to control-transfected neurons (* p<0.05).
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3.5 Serine phosphorylation of IkB-<x contributes to BDNF-promoted neurite 
growth but is not required for CNTF-promoted growth
It has been previously shown that inhibiting the canonical NF-kB activation pathway 
in neonatal nodose ganglion neurons supported in culture with BDNF by transfecting 
these neurons with a plasmid expressing a super-repressor form of IxB-a results in 
reduced neurite growth [321]. This mutant form of IxB-a associates normally with 
NF-kB but has serine to alanine mutations at residues 32 and 36 that specifically 
prevent phosphorylation of IicB-a by the IKK complex and subsequent proteasome- 
mediated degradation, thereby preventing release and translocation of NF-kB to the 
nucleus [291,435,436]. Confirming previous findings, expression of the 32/36- 
SS/AA IkB-o, mutant in nodose grown under the same conditions with BDNF in the 
medium caused clear and significant reductions in neurite length, number of branch 
points and branching with distance from the cell body (Figs. 20A, 20B and 20C). 
Surprisingly, when nodose neurons were supported by CNTF, transfecting them with 
this 32/36-SS/AA hcB-a mutant did not affect neurite arbor size and complexity 
(Figs. 20E-G ). There were no significant differences in neurite length and branching 
between neurons expressing the 32/36-SS/AA IkB-o, mutant and control transfected 
neurons grown with CNTF (Figs. 20E-G). Expression of the 32/36-SS/AA IxB-a 
mutant did not significantly affect the number of neurons surviving in the presence of 
either CNTF or BDNF (Figs. 20D and 20H).
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3.6 Tyrosine phosphorylation of IkB-oi is crucial for CNTF-promoted neurite 
growth but is not required for BDNF-promoted growth
Because NF-kB activation and NF-KB-dependent transcription are required for 
CNTF-promoted neurite growth (Figs. 14-19) the potential role of an alternative 
mechanism of NF-kB activation for CNTF-promoted neurite growth was investigated. 
NF-kB activation by tyrosine phosphorylation of IkB-cx has recently been implicated 
in NGF-promoted survival and differentiation of PC12 cells [291,437,438]. Newborn 
nodose neurons were transfected with a plasmid expressing a Y42F IxB-a mutant that 
effectively and specifically blocks NF-kB activation by tyrosine phosphorylation of 
IkB-o, [424]. The Y42F IkB-o mutant had no significant effect on the size and 
complexity of neurite arbors growing from nodose neurons supported by BDNF (Figs. 
21 A, 21B and 21C). In marked contrast, the neurite arbors of neurons expressing this 
Y42F IkB-ol mutant were 4-fold shorter (Fig.21F) and had four-fold fewer branch 
points (Fig. 21G) and showed very clear reductions in branching with distance from 
the cell body (Fig. 2IE) compared with control-transfected neurons in the presence of 
CNTF. Like the 32/36-SS/FF hcB-a mutant, the Y42F IkB-o, mutant had no 
significant effect on the survival of newborn nodose neurons grown with either BDNF 
(Fig. 21D) or CNTF (Fig. 21H).
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Figure 20 | Effect of Serine Ik B -o  mutant on neurite growth. P0 nodose neurons were transfected 3 hours 
after plating with a YFP expression plasmid together with Ser IkB mutant and were incubated with BDNF 
(10 ng/ml) or CNTF (50ng/ml) until 24 hours after plating. Sholl analysis (A,D), total neurite length (B,E) 
and number of branch points (C,F) in the neurite arbors of 50-90 neurons in each condition are shown 
(means ± standard errors) from a typical experiment (very similar data were obtained in three independent 
experiments). The percentage survival of neurons after 24 hours incubation in these conditions as shown in 
D and G. Statistical comparisons are with respect to control-transfected neurons (* p<0.05).
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Figure 21 | Effect of Tyrosine Ik B -o  mutant on neurite growth. PO nodose neurons were transfected 3 
hours after plating with a YFP expression plasmid together with Tyr IkB mutant and were incubated with 
BDNF (10 ng/ml) or CNTF (50ng/ml) until 24 hours after plating. Sholl analysis (A£>), total neurite length 
(B,E) and number of branch points (C,F) in the neurite arbors of 50-90 neurons in each condition are shown 
(means ± standard errors) from a typical experiment (very similar data were obtained in three independent 
experiments). The percentage survival of neurons after 24 hours incubation in these conditions as shown in 
D and G. Statistical comparisons are with respect to control-transfected neurons (* p<0.05, **p<0.01).
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3.7 Proteasome-independent mechanism for CNTF promoted neurite growth
Phosphorylation of IkB-gc on serine residues leads to ubiquitination and proteasomal 
degradation. It has been reported that the proteasome inhibitor N-acetyl-Leu-Leu- 
norleucinal (ALLN) causes a highly significant decrease in neurite arbor size of 
newborn nodose neurons grown with BDNF [321]. Interestingly, addition of ALLN to 
CNTF-stimulated nodose neurons did not affect neurite growth and branching, 
implying a proteasome-independent mechanism for CNTF-promoted neurite growth 
(Figs. 22A-C). In addition, treatment of CNTF- supported neurons with another 
proteasome inhibitor, MG132 had no effect on neurite growth, length or branching 
(Figs. 22D-F). Representative images illustrating the inhibition of BDNF-dependent 
neurite growth elicited by MG 132 is shown Figs 22G and 22H. Whereas in the 
canonical NFkB activation pathway phosphorylation of IkB-ci on serine residues 32 
and 36 leads to proteasome-mediated degradation, phosphorylation of hcB-a on 
tyrosine 42 leads to dissociation of NFkB from hcB-a without degradation of IkB-o. 
[350]. In agreement with this, no detectable degradation of IkB-o, upon treatment of 
nodose neurons with CNTF was observed (Fig. 23A,B).
These results show that the contribution of NF-kB signalling to neurite growth and 
branching from neurons grown with BDNF and CNTF occurs by fundamentally 
different mechanisms within the NF-kB signalling network. Whereas the canonical 
NF-kB signalling pathway contributes to neurite growth from neurons supported with 
BDNF, NF-kB activation by an alternative mechanism involving tyrosine 
phosphorylation of IkB-o. is critically required for neurite growth from the same 
neurons when they are supported with CNTF.
I l l
3.8 BDNF and CNTF induce a differential pattern o f IkB-oc phosphorylation
To determine if BDNF and CNTF change the phosphorylation pattern of IxB-a, 
Western blots of proteins extracted from nodose neurons treated with these factors 
were probed with antibodies that specifically recognise phosphoserine IxB-a and 
phosphotyrosine IkB-cl PO nodose neurons were plated in neurotrophic factor free 
medium for 3 hours and treated with either CNTF or BDNF for 5,15 and 30 minutes 
before protein extraction and Western blotting. To avoid changes in the overall level 
of IkB-<x confounding the results because of potential differences in proteasomal 
degradation, the proteasome inhibitor ALLN was added to all cultures 3.5 hours after 
plating. Figure 24 shows that BDNF and CNTF each promoted transient increases in 
the levels of both phosphorylated forms of IicB-a. However, in three independent 
experiments, BDNF was consistently more effective than CNTF in increasing the 
level of phosphoserine IicB-a and CNTF was consistently more effective than BDNF 
increasing the level of phosphotyrosine IkB-cl The peak of these preferential 
increases in phospho-serine IxB-a with BDNF and phosphotyrosine IicB-a with CNTF 
was consistently between 60 and 80% above the basal levels of these phosphoproteins 
in unstimulated neurons, whereas the transient rises in the reciprocal phosphoprotein 
species reached no more than 30% above basal levels. These findings demonstrate 
that BDNF and CNTF promote preferential increases in phosphoserine IxB-a and 
phosphotyrosine IxB-a, respectively.
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Figure 22 | Effects of proteasome inhibition on BDNF and CNTF-dependent neurite 
growth. P0 nodose neurons were cultured for 24 hours in the presence o f  either BDNF 
(lOng/ml) or CNTF (50ng/ml) and proteasom e inhibitors ALLN (4pM ) or MG 132 (20nM) and 
neurite growth was analysed. (A-C) Effects o f  ALLN on CNTF-dependent growth. (D-F) 
Effects o f  MG 132 on CNTF-dependent neurite growth. Both inhibitors ALLN and MG 132 
strongly reduced BDNF-dependent neurite growth. Representative images o f  the effects o f  
MG132 on BDNF-supported growth are shown in G and H.
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Figure 23 |No degradation of I k B u  after treatment with CNTF. P0 nodose neurons were incubated, for 
the period of time indicated on the X-axis (B), with CNTF (50ng/ml) after which cells were lysed and total 
protein collected. Western blots and densitometry were then used to detect the levels total IxBa. (A) Western 
blot showing no effect o f CNTF on IjcBa. (B) Densitometry showing no effect of CNTF on IicBa.
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Figure 24 (Preferential tyrosine phosphorylation of IidBa after treatment with CNTF. P0 nodose 
neurons were incubated, for the period of time indicated on the X-axis, with either BDNF (lOng/ml) or 
CNTF (50ng/ml) after which cells were lysed and total protein collected. Western blots and densitometry 
were then used to detect the levels of serine and tyrosine-phosphorylated forms of IkBgl (A) Preferential 
increase in serine-phosphorylated IicBa upon treatment with BDNF. (B) Preferential increase in tyrosine- 
phosporylated IicBa upon treatment with CNTF.
115
3.9 Spleen tyrosine kinase (SYK) is required for CNTF-promoted neurite growth
In contrast to the extensive literature on NF-kB activation by the canonical pathway 
involving serine phosphorylation of IkB by the IKK complex, much less is known 
about NF-kB activation by tyrosine phosphorylation of IkB. However, SYK protein- 
tyrosine kinase has recently been shown to phosphorylate hcB-a on tyr42 following 
treatment of human myeloid KBM-5 cells with hydrogen peroxide [350]. To test the 
potential involvement of SYK in CNTF-promoted neurite growth, P0 nodose neurons 
were either treated with piceatannol, a potent selective SYK inhibitor [439], 3 hours 
after plating or transfected with a SYK dominant negative mutant construct. The 
culture medium was also supplemented with CNTF or BDNF at this time and the size 
and complexity of neurite arbors was quantified 24 hours after plating.
Figure 25 shows that the neurite arbors of CNTF-supplemented neurons treated with 
piceatannol were greatly reduced in size compared with untreated control cultures 
(Figs. 25E, 25F and 25G). In contrast, piceatannol had no significant effect on the size 
and complexity of the neurites of neurons grown with BDNF (Figs. 25 A, 25B and 
25C). Like the Y42F hcB-a mutant, piceatannol did not affect the number of neurons 
surviving with either CNTF or BDNF (Figs. 25D and 25H). These results show that 
piceatannol selectively inhibits CNTF-promoted neurite growth, suggesting that SYK- 
dependent tyrosine phosphorylation of IkB-o, is a key step in the neurite growth 
response of neurons to CNTF but not BDNF. To further investigate the effect of Syk 
inactivation on neurite outgrowth, DN-Syk (a truncated form of Syk that contains only 
tandem SH2 domains with no catalytic domain that interrupts endogenous active Syk 
kinase) was expressed in nodose neurons supported by CNTF, and neurite outgrowth, 
length and branching were measured. DN-Syk expression caused a marked decrease
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in neurite length (Fig. 26 A) and the number of branch points (Fig. 26B). These data 
implicate Syk as an intracellular mediator of neurite growth downstream of CNTF 
receptor activation. Indeed, exposure of newborn nodose neurons to CNTF causes a 
marked increase in Syk phosphorylation within 5 minutes (Fig 26C). Treatment of the 
same neurons with BDNF has no effect on the level of Syk phosphorylation (Fig 
26D). The timecourse of Syk-phosphorylation (Fig. 26C) and tyrosine 
phosphorylation of IkB-o, (Fig. 24), combined with the significant reduction in NFkB 
reporter activation following Syk inhibition (Fig. 27B ) strongly suggest that Syk 
signals upstream of NFkB in the regulation of CNTF-dependent neurite growth.
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Figure 25 |Effect of Syk inhibition on neurite growth. PO nodose neurons were incubated with BDNF (10 
ng/ml) or CNTF (50ng/ml) and lO^M piceatannol. Sholl analysis (A,D), total neurite length (B,E) and 
number of branch points (C,F) in the neurite arbors o f50-90 neurons in each condition are shown (means ± 
standard errors) from a typical experiment (very similar data were obtained in three independent 
experiments). The percentage survival of neurons after 24 hours incubation in these conditions as shown in 
D and G. Statistical comparisons are with respect to control. (* p<0.05, **p<0.01).
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Figure 26 |Effect of Syk-DN on CNTF-supported neurite growth. P0 nodose neurons were transfected 
with Syk-DN and incubated with CNTF (50ng/ml) ovemight.Total neurite length (A) and number of branch 
points (B) in the neurite arbors of 50-90 neurons in each condition are shown (means ± standard errors) from 
a typical experiment. (C) Western blot densitometry using anti-phospho Syk antibodies showing increased 
Syk activation in nodose neurons treated with CNTF. (D) No significant activation of Syk after treatment 
with BDNF. Statistical comparisons are with respect to control-transfected neurons (**p<0.01).
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3.10 NFkB reporter activation
Taken together, the above data suggest that NFkB signalling is crucial for CNTF- 
mediated neurite growth. To determine if NF-«B transcriptional activity is influenced 
by CNTF, newborn nodose neurons were transfected with a reporter construct in 
which GFP is under the control of an NF-«B promoter. Transfected neurons were 
positively identified by co-transfection with an RFP expression plasmid. Neurons 
were shot 3 hours after plating with gold particles coated with both these plasmids 
together with either the tyrosine I#iB-o plasmid or treated with Syk inhibitor and were 
incubated for a further 24 hours with CNTF. CNTF treatment promoted a two-fold 
increase in reporter signal compared with untreated controls and this rise was 
completely blocked in neurons transfected with the Y42F IkB-ci plasmid and in 
neurons treated with the potent selective SYK inhibitor (Fig. 27). Previous work has 
shown that the level of NFkB activation at P0 is not increased when neurons are 
treated with BDNF [321].
120
B200
cn
I  150'
<L>
•S 100
OhOh
o
X>
X
50
(r
No Factors CNTF
C0
00Oh
OI
S
120
1 0 0 i
80
60
40
20
0
*
No CNTF CNTF+ CNTF+ 
Factors IkB Y42F Syk
Inhibitor
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3.11 Discussion
I have studied the relative importance of NF-kB signalling in the neurite growth- 
promoting effects of BDNF and CNTF on developing sensory neurons and delineated 
the selective involvement of different NF-kB activation mechanisms in the response 
of neurons to these neurotrophic factors. General inhibition of NF-kB signalling in 
newborn nodose neurons by either blocking nuclear translocation of NF-kB with 
SN50 or inhibiting NF-kB dependent transcription with decoy kB DNA reduced 
neurite arbor size and complexity from BDNF-stimulated neurons by half, but almost 
eliminated neurite growth from CNTF-stimulated neurons. These results show that 
NF-kB signalling significantly contributes to BDNF-promoted neurite growth, but is 
crucial for CNTF-promoted neurite growth. While NF-kB signalling is known to play 
a participatory role in the neurite growth-promoting effects of the neurotrophins NGF 
and BDNF [321,431], the essential role of NF-kB signalling in CNTF-promoted 
growth is a striking, novel finding. Although CNTF is known to activate signalling 
pathways implicated in regulating neurite growth such as MEK/ERK and PI3-K/Akt 
[440,441], there have been no studies of the involvement of these or other signalling 
pathways in mediating the neurite growth promoting effects of CNTF and related 
neurotrophic cytokines in primary neurons. These results therefore provide an 
important insight into the intracellular signalling mechanisms that are crucial for the 
neurite growth-promoting actions of CNTF and possibly related cytokines.
Investigation and comparison of the involvement of NF-kB signalling in the 
neurite growth-promoting effects of BDNF and CNTF was facilitated in our 
experimental paradigm because these factors each support the survival of the majority 
of postnatal nodose neurons in culture and because inhibiting NF-kB signalling has no
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detectable effect on the number of neurons that survive with either factor. Previous 
work has established a neuroprotective role for NF-kB for a variety of CNS neurons 
[308, 339,442-446] and NF-kB signalling has been shown to contribute to the 
survival response of embryonic sympathetic and sensory to NGF [238, 318] and adult 
DRG neurons to TNF-a [447]. Although it has been reported that blocking NF-kB 
activation reduces the number of fetal nodose neurons that survive in culture with 
CNTF [319], our extensive investigation in which NF-kB activation has been blocked 
by a variety of complementary approaches and cell survival has been followed with 
vital dye staining contradicts this general conclusion. In CNTF supplemented cultures 
the cell bodies of neurons in which NF-kB signalling is blocked retain a normal 
appearance, even though these neurons are virtually devoid of processes. Importantly, 
staining with the vital dye calcein-AM showed no significant loss in the viability of 
these neurons in the presence of CNTF up to 72 hours in vitro. These findings 
therefore clearly demonstrate that NF-kB signalling is crucial for the growth of 
neurites from developing nodose neurons stimulated with CNTF, but is not required 
for the survival o f these neurons with CNTF.
One of the most striking findings of this study is that different NF-kB  
activation mechanisms are exclusively required for the neurite growth-promoting 
effects of BDNF and CNTF, respectively. Specifically blocking NF-kB activation by 
serine phosphorylation of hcB-a using a 32/36-SS/AA IkB-o, mutant selectively 
reduced BDNF-promoted neurite growth but had no effect on CNTF-promoted neurite 
growth. Specifically blocking NF-kB activation by tyrosine phosphorylation of IxB-a 
using a Y42F IkB-<x mutant selectively inhibited CNTF-promoted neurite growth 
whilst having no effect on BDNF-promoted neurite growth. Phosphorylation of IkB- 
a on serine residues 32 and 36 leads to ubiquitination and proteasome-mediated
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degradation of IkBoc and translocation of the liberated NF-kB to the nucleus [298]. 
The importance of this particular NF-kB activation mechanism for BDNF-promoted 
neurite growth is reinforced by the observation that the proteasome inhibitor ALLN 
reduces significantly the size of neurite arbors growing from nodose neurons cultured 
with BDNF [321]. ALLN does not, however, affect neurite arbor size when these 
neurons are cultured with CNTF, reinforcing the idea that serine phosphorylation and 
subsequent proteasome-mediated degradation of hcB-a is not required for CNTF- 
promoted neurite growth. Furthermore, the demonstration that inhibition of the SYK 
protein-tyrosine kinase or expression of dominant-negative SYK, whose substrates 
include IkB-a  [350], selectively blocks CNTF-promoted neurite growth, provides 
corroborating evidence for the importance of tyrosine phosphorylation of IkB-o, and 
implicates SYK in the neurite growth-promoting effects of CNTF but not BDNF. This 
is the first described role for Syk in primary neurons and it will be interesting in the 
future to investigate whether Syk activation regulates neurite growth in other 
populations of neurons.
BDNF and CNTF promote preferential transient increases in the levels of 
phosphoserine hcB-a and phosphotyrosine IkB-<x, respectively. These changes in the 
phosphorylation pattern of IkB-o, provide the most parsimonious explanation for the 
selective role of serine and tyrosine phosphorylation of hcB-a in the neurite growth- 
promoting effects of BDNF and CNTF, respectively. For each factor, the preferential 
transient rise in the corresponding phosphorylated IkB-a species may result in 
differential recruitment of NF-kB activity above a critical threshold that initiates 
transcriptional changes that promote neurite growth. This threshold need not be the 
same for each factor as a diversity of signalling pathways may cooperate with NF-kB
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to regulate neurite growth in each case. In addition to the preferential quantitative 
changes in the IicB-a phosphorylation pattern brought about by BDNF and CNTF, it is 
possible that these factors may also promote qualitative differences in NF-kB 
signalling downstream of IicB-a, such as different patterns of p65 phosphorylation 
[448], which might help explain differences in the relative importance of NF-kB in 
mediating the effects of these factors on neurite growth. Indeed, preliminary data 
(Nuria Gavalda- unpublished observation) suggest that the phosphorylation pattern of 
activated p65 differs between BDNF and CNTF -  treated nodose neurons.
While presenting considerable technical challenges for biochemical studies, 
research on primary neurons is a very powerful approach for elucidating growth factor 
physiology and signalling in the appropriate cellular and developmental context.
These studies of newborn nodose neurons have demonstrated an essential role for NF- 
kB signalling in CNTF -promoted neurite growth and revealed strikingly clear 
differences in the mechanism of NF-kB activation mediating the effects of this 
cytokine and BDNF. Future progress on unravelling how BDNF and CNTF influence 
NF-kB signalling in distinctive ways, and how this in turn has such marked effects on 
neurite growth in sensory and other neurons will be important for understanding the 
novel role for NF-kB in regulating neuronal morphology during development.
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Chapter 4
Abnormal sympathoadrenal development in PHD3-A mice
126
4.1 Introduction
In response to low oxygen tensions, organisms mount a wide-ranging adaptive 
response involving many cellular and systemic processes. Activation of hypoxia- 
inducible factor (HIF) plays a central role in this process, inducing transcriptional 
targets that enhance oxygen delivery, better adapt cells to hypoxia or modulate cell 
proliferation/ survival pathways . Hypoxia may, in different circumstances, either 
promote or protect cells from apoptosis, and HIF itself contributes to these processes 
both indirectly, through the defence of cellular energy supplies, or directly, via 
transcriptional changes in pro-apoptotic or pro-survival genes. However, to generate 
the anatomical and physiological integrity required for oxygen homeostasis in the 
intact organism, these adaptive responses to hypoxia must also be accurately 
interfaced with the developmental control of growth.
Though the nature of these connections remains poorly understood, it is of interest 
that the cellular oxygen sensor PHD3 (otherwise termed EGLN3 or HPH1), one of 
three Fe (Il)-dependent dioxygenases now known to negatively regulate HIF by prolyl 
hydroxylation of HIF-a subunits (HIF-la and HIF-2a), has been previously 
identified as a gene involved in developmental apoptosis of neurons [417,449,450]. 
Over 50 % of neurons produced during development die through apoptosis before 
adulthood [71]. This process is largely regulated by neurotrophic factors that are 
secreted in limited amounts by target tissues such that only those neurons making 
appropriate connections survive. During the investigation of these phenomena, PHD3 
mRNA was identified as a neuronal transcript that is induced by withdrawal of NGF 
[417]. Further studies have demonstrated that ectopic expression of PHD3 in primary 
sympathetic neurons from the developing superior cervical ganglion and in the
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adrenal medullary tumour cell line PC 12, resulted in apoptosis even in the presence of 
saturating quantities of NGF [417,449]. This action was not reproduced by a 
catalytically inactive PHD3 mutant [449], whereas hypoxia was able to suppress 
apoptosis in sympathetic neurons [451].Knock-down of PHD3 by siRNA in PC 12 
cells prevented apoptosis even in the absence of NGF [417,449]. Taken together, 
these observations in cultured cells indicate that oxygen sensitive catalytic activity of 
PHD3 has a role in the regulation of neuronal apoptosis, raising important questions 
about the extent of PHD3-dependent neuronal apoptosis in vivo and its role in the 
intact animal.
To better understand the physiological function(s) of the oxygen-sensitive prolyl 
hydroxylases that regulate HIF, I have investigated the neuronal pheonotype of mice 
in which three PHD (Prolyl Hydroxylase Domain) genes have been inactivated. 
Although PHD2-/- animals suffered embryonic lethality with placental and other 
developmental defects, PHD1-/- and PHDS-/- mice are viable as adults permitting 
more detailed analysis of the function of these molecules in vivo.
Therefore the developmental and physiological effects of inactivation of PHDS-/- on 
neuronal apoptosis were investigated. I show that PHD3-dependent modulation of 
NGF-dependent survival is a lineage-specific property affecting sympatho-adrenal 
neurones. Inter-crossing with animals heterozygous for HIF-la or HIF-2a 
inactivation implicated HIF-2a, but not HIF-la, in this process. Effects of PHD3 
appeared to extend beyond simple survival decisions. Neurones from PHDS-/-, but 
not PHD2+/- or PHD1-/-, mice manifest increased neurite growth as well as 
enhanced survival, and PHDS-/- mice manifest hyperplasia of sympatho-adrenal 
tissues including sympathetic ganglia, the carotid body and the adrenal medulla.
128
However, despite hyperplasia, the sympatho-adrenal system was dysfunctional in 
affected animals, with reduced innervation of target organs and dysregulated 
sympathetic responses including reduced iridial reflexes after exposure to dark. The 
findings demonstrate a key role for PHD3 in regulating the anatomical integrity of the 
sympatho-adrenal system, exemplifying how hypoxia and growth regulatory 
pathways may be interfaced for developmental control.
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4.2 Expression of PHD3 in sympathoadrenal tissues
PHD enzymes have distinct patterns of expression [412] and are differentially 
regulated in different cell types [413]. As a first step towards elucidating a role for 
PHD3 in neuronal development, the expression of PHD3 was analysed using an 
antibody directed towards PHD3 in wild type mice. PHD3 was highly expressed in 
tissues of the sympathoadrenal lineage including the SCG (Fig. 28A), Carotid Body 
(Fig. 28D) and the adrenal medulla (Fig. 28E). PHD3 expression was low in other 
NGF dependent neuronal populations such as the dorsal root (DRG, Fig. 28B) and 
trigeminal ganglion neurons TG (Fig. 28C) suggesting a specific role for PHD3 in 
sympathoadrenal tissues.
43  PHD3 inactivation increases survival of SCG neurons in vitro
PHD3 expression in PC 12 cells and primary neurons from the SCG leads to apoptotic 
cell death [417,418,449,450]. To analyse the neuronal phenotype of PHD3-/- mice 
in more detail, post-mitotic neurons from the SCG of newborn (P0) animals were 
cultured in the presence of a range of NGF concentrations. Viable neuronal counts 
were performed 3 hours after plating and again at 24 hours and % neuronal survival 
was calculated for each concentration of NGF. At non-saturating concentrations of 
NGF, the survival of neurons from PHD3-/- mice was consistently enhanced 
compared to that of neurons from wild-type mice (Fig. 29A). Interestingly, loss of 
PHD3 did not confer a survival advantage at very low NGF concentrations, 
suggesting that although PHD3 promotes apoptosis of these neurones, it is not 
absolutely required for this process. In contrast with PHD3-/- animals, there were no 
significant differences in survival between neurons from PHD1-/- or PHD2+/- and
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wild-type mice (Figure 29B and 29C; note we were unable to use PHD2-/- mice due 
to embryonic lethality between E l2.5 and E l4.5). These data provide strong evidence 
that inactivation of PHD3, but not PHD1 or PHD2, leads to increased survival of 
sympathetic neurons.
4.4 Specific survival effect of PHD3-/- in SCG neurons
NGF signalling through TrkA regulates the survival of many populations of neurons 
in the PNS and CNS. Expression of TrkA is required for retrograde transport of 
target-derived NGF [452-455] and deletion of TrkA or NGF in mice, causes extensive 
loss of sensory neurons of the TG and DRG [80, 81]. Since SCG, TG and DRG 
neurons express TrkA during development [179,216] I investigated whether PHD3- 
modulated apoptosis also takes place in other NGF responsive neuronal populations. 
Neurons from the SCG, DRG and TG of newborn (P0) PHD3-/ mice were cultured in 
the presence of a range of NGF concentrations. Viable neuronal counts were 
performed 3 hours after plating and again at 24 hours and the percentage neuronal 
survival was calculated at each concentration of NGF. In contrast with sympathetic 
neurones, PHD3-deficient sensory neurons from the DRG and TG showed no 
difference in survival at any NGF concentration tested (Figure 30B,C). These findings 
indicate that PHD3-dependent neuronal survival is not a general property of NGF- 
sensitive neurons but a specific property of sympathetic neurons.
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4.5 Induction of PHD3 mRNA following withdrawal of NGF
Knockdown of PHD3 in vitro prevents apoptosis in PC 12 cells even in the absence of 
NGF [418]. Interestingly, PHD3 mRNA is strongly induced after NGF withdrawal 
[417]. It was therefore considered whether a differential up regulation of PHD3 
might underlie the neuronal specificity of PHD3-dependent survival. Dissociated 
SCG, DRG and TG neurons from wild-type PO mouse pups were cultured overnight 
in 10 ng/ ml NGF. Neurons were then washed thoroughly with defined culture 
medium and grown either in the presence or absence of NGF for 10 hours (timepoint 
at which PHD3 mRNA induction is maximal in the SCG; [418]) before harvesting the 
cells for RNA. Using quantitative RT-PCR, we found that withdrawal of NGF in 
explanted neurons significantly increased PHD3 mRNA levels in the SCG (Fig. 31), 
but not in the DRG (Fig. 32A) or TG (Fig. 32B) suggesting that PHD3-dependent 
neuronal survival might be the result of cell-specific responsiveness of PHD3 mRNA 
to NGF withdrawal.
4.6 Reversal of survival effect in PHD3-/-;HIF2+/- mice
HIF activity is negatively regulated by modifications induced by the PHD enzymes on 
the HIF-a subunit (reviewed Fandrey et al. 2006). Recent investigation into the 
relative contribution of the three PHD enzymes to proline hydroxylation of HIF-1 and 
HIF-2a subunits has revealed a relative preference for PHD3 towards HIF-2a [413].
In order to investigate the downstream signalling mechanism which leads to increased 
survival of SCG neurons in PHD3-/- mice, PHD3-/- mice were crossed with HIF-1+/- 
and HIF-2+/- mice . Heterozygous HIF mice were used due to embryonic lethality in 
the corresponding homozygous knockout mouse. SCG from PHD3-/-, PHD3-/-;HIF-
132
1+/- and PHD3-/-;HIF-2+/- mice were cultured in the presence of a range of NGF 
concentrations. Viable neuronal counts were performed 3 hours after plating and 
again at 24 hours and percentage neuronal survival was calculated at each 
concentration of NGF. In accordance with published data which describes a 
preference of PHD3 for HIF-2a, inactivation of one allele of HIF-2 a significantly 
reduced survival of PHD3-/- SCG neurons (Fig. 33B). In contrast, inactivation of one 
allele of HIF-la had no effect on the survival of PHD3-/- SCG neurons at any 
concentration of NGF tested (Fig. 33A).
4.7 PHD3 inactivation increases NT-3 dependent survival of SCG neurons
NGF promotes neuronal survival by binding to and activating the receptor tyrosine 
kinase TrkA. Because neurotrophin-3 (NT-3) is also capable of promoting the 
survival of neonatal SCG neurons in culture by a TrkA-dependent mechanism, I 
investigated whether deletion of PHD3 affects the survival response of SCG neurons 
to this neurotrophin. Again, SCG from PHD3 mice were cultured in the presence of a 
range of NT-3 concentrations and percentage neuronal survival was measured at each 
concentration. As with NGF, PHD3-deficient SCG neurons showed increased 
survival in response to NT-3 compared with neurons from wild type littermates (Fig. 
34).
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Figure 28 |PHD3 expression. Immunohistochemistry showing strong staining of PHD3 in the SCG (A), 
adrenal medulla (D) and Carotid body (E) with relatively weak staining in sensory neurons of the DRG (B) 
and TG (C).
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Figure 29 (Increased survival of SCG neurons from PHD3-/- mice. PO SCG neurons were incubated for 
24 hours in the presence of a range of NGF concentrations. The percentage neuronal survival at each 
concentration was estimated and a dose-response curve constructed. (A) Dose response curve showing 
increased survival in SCG neurons from P H D 3 -/- mice. No difference in survival of SCG neurons cultured 
from PHD1-/- (B) or PHD2+/- (C) mice. Statistical comparisons are with respect to wild-type controls. Data 
from 3 independent repeats shown (* p<0.05, **p<0.01).
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Figure 30 |Specificity of P H D 3 - / -  effect. PHD3 inactivation increases survival of SCG neurons (A) but has 
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Figure 31 |PHD3 induction. Neonatal SCG neurons were incubated overnight with NGF (lOng/ml) after 
which NGF was withdrawn and total RNA isolated. (A) Induction of PHD3 mRNA expression 10 hours after 
NGF withdrawal from SCG neurons. Statistical comparisons are with respect to NGF control (** p<0.01).
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Figure 32 |Speciflcity of PHD3 induction. Neonatal DRG and TG neurons were incubated overnight with 
NGF (lOng/ml) after which NGF was withdrawn and total RNA isolated. No Induction of PHD3 mRNA 
expression 10 hours after NGF withdrawal from DRG (A) or TG (B) neurons.
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Figure 33 | HIF dependence of the PHD3 survival effect NGF-dose response curves from neonatal 
SCG neurons showing: (A) no difference in survival of neurons derived from P H D 3 -/- ;  H IF -1 + /-  
versus P H D 3 - /-  mice and (B) reduced survival of neurons derived from P H D 3 -/- ;  H IF -2 + /-  versus 
P H D 3 -/-  mice. Statistical comparisons are with respect to P H D 3 - /-  (*  p<0.05).
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Figure 34 | Increased NT-3-dependent survival of SCG neurons from PHD3-,/ -  mice. P0 SCG neurons 
were incubated for 24 hours in the presence of a range of NT-3 concentrations. The percentage neuronal 
survival at each concentration was estimated and a dose-response curve constructed. (A) Dose response 
curve showing increased survival in SCG neurons from P H D 3 -/- mice supported by NT-3. Data from 3 
independent repeats shown (* p<0.05).
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4.8 Enhanced NGF-promoted neurite growth from PHD3-deficient sympathetic 
neurons in vitro
In addition to supporting the survival of developing sympathetic neurons, NGF also 
promotes the growth of neurites from these neurons in culture. For this reason I 
investigated whether deletion of PHD3 affects neurite arbor size and complexity. Low 
density cultures of SCG neurons from PO PHD3-1- and wild type mice were grown 
with different concentrations of NGF and neurite arbor size and complexity were 
quantified using Sholl analysis 24 hours after plating. At subsaturating concentrations 
of NGF (Figs. 36 and 37), but not at saturating levels (Fig. 35), the neurite arbors of 
PHD3-deficient neurons were significantly longer than those of wild type neurons. 
Sholl analysis, which provides a spatial representation of neurite branching with 
distance from the cell body, revealed that the neurite arbors of PHD3-deficient 
neurons were larger and more branched than those of wild type mice in the presence 
of subsaturating levels of NGF. The typical appearance of the neurite arbors of 
PHD3-deficient and wild type SCG neurons grown at each concentration of NGF used 
are illustrated in Figures 35B-37B. These findings suggest that PHD3-deficient SCG 
neurons are more sensitive to the neurite growth-promoting, and survival-promoting 
effects of NGF.
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Figure 35 | PHD3 inactivation and neurite outgrowth at saturating NGF concentration. P0 SCG neurons 
from wild-type and PHD3-/- mice were incubated for 24 hours in NGF (lOng/ml) after which neurite growth 
was analysed. (A) Sholl analysis and (B) neurite length analysis revealed no significant differences in 
process outgrowth between wild-type and PHD3-/- SCG. (C) Photomicrographs showing the typical 
appearances of wild-type and PHD3-/- neurons cultured with NGF (10 ng/ml)
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Figure 36 | PHD3 inactivation and neurite outgrowth at a sub-saturating NGF concentration (1). P0
SCG neurons from wild-type and PHD3-/- mice were incubated for 24 hours in NGF (0.4ng/ml) and caspase 
inhibitors after which neurite growth was analysed. (A) Sholl analysis and (B) neurite length analysis 
revealed a significant increase in process outgrowth in PHD3-/- SCG. (C) Photomicrographs showing the 
typical appearances of wild-type and PHD3-/- neurons cultured with NGF (10 ng/ml). Statistical 
comparisons are with respect to wild-type controls and between 40-70 neurons were analysed per genotype. 
(* p<0.05, **p<0.01).
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Figure 37 | PHD3 inactivation and neurite outgrowth at a sub-saturating NGF concentration (2). P0 
SCG neurons from wild-type and PHD3-/- mice were incubated for 24 hours in NGF (0.08ng/ml) and 
caspase inhibitors after which neurite growth was analysed. (A) Sholl analysis and (B) neurite length 
analysis revealed a significant increase in process outgrowth in PHD3-/- SCG. (C) Photomicrographs 
showing the typical appearances of wild-type and PHD3-/- neurons cultured with NGF (10 ng/ml). Statistical 
comparisons are with respect to wild-type controls and between 40-70 neurons were analysed per genotype. 
(* p<0.05, **p<0.01).
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4.9 PHD3-deflcient mice have increased numbers of SCG neurons
To ascertain the developmental and physiological relevance of the in vitro 
observations, the total number of neurons in the SCG of wild type and PHD3-/- mice 
were compared. The neuronal complement of the SCG of newborn animals was 
estimated by counting the number of neurons in trypsin-dissociated cell suspensions 
obtained from carefully dissected ganglia. Neurons were recognized and distinguished 
from non-neuronal cells by their characteristic large, phase-bright, spherical cell 
bodies under phase contrast optics. SCG dissected from PHD3-/- newborn mice 
appeared larger than those of wild type littermates (Fig. 3 8  A) and contained 
significantly more neurons (Fig. 38B). Likewise, stereological measurements carried 
out on serially sectioned SCG in 3 to 6  month old mice revealed that the SCG was 
larger and contained significantly more neurons in PHD3-/- mice compared with age- 
matched wild type animals (Fig. 38C and D). As expected, the number of the neurons 
in the SCG of wild type adults was lower than that in newborns as a result of ongoing 
programmed cell death in the immediate postnatal period. However, the number of 
neurons in the SCG of PDH3-I- remained substantially unchanged between birth and 
adulthood, suggesting that programmed cell death during at least the postnatal period 
was largely curtailed in these mice. In contrast to the effect of PHD3 deletion on 
SCG neuron number, there were no significant differences between the numbers of 
neurons in the SCG of either PHD1-/- (Fig. 38E) or PHD2+/- (Fig. 38F) neonates 
compared with wild type littermates. Interestingly, in keeping with in vitro survival 
data (Fig. 29), there was a significant reduction in total viable neurons in neonatal 
PHD3-/-;HIF-2a+/- compared to PHD3-/- mice (Fig. 39A). This reduction was not 
observed in total counts from PHD3-/-;HIF-la+/~ SCG (Fig. 39B). Taken together 
with our in vitro survival data, these in vivo observations suggest that the selective
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increase in SCG neurons in PHD3-/- mice results from reduced cell loss during the 
phase of programmed cell death in the perinatal period as a consequence of the 
enhanced sensitivity of PHD3-deficient neurons to NGF.
4.10 PHD3-deficient mice have increased numbers of ceils in the adrenal medulla 
and carotid body
The discovery that PHD3-/- mice have significantly more sympathetic neurons than 
wild type mice prompted an examination cell number elsewhere in the 
sympathoadrenal system. Stereological analysis of adult mice (3 -6  months) revealed 
significantly more TH-positive cells in both the adrenal medulla and the carotid body 
(Figure 40). These data suggest that PHD3 specifically regulates the development of 
the sympatho-adrenal axis.
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Figure 38 | Effect of genetic inactivation of PHD3 on the anatomy of the SCG. (A) Bright field images of 
wild-type and PHD3-/- neonatal SCG; black bar represents 100 pm. (B) Neuronal complement of neonatal 
SCGs in wild-type and PHD3-/- mice; counts are of viable trypsin-dissociated neurons. (C,D) Stereological 
analysis of TH-positive neurons showing increased volume and cell numbers in the SCG from adult PHD3-/- 
mice. (E,F) No difference in total number of neurons in the SCG of PHD1-/- or PHD2+/- mice. Statistical 
comparisons are with respect to wild-type controls and values shown are averages from (n) separate mice as 
indicated in the parentheses. (* P < 0.05)
147
A40000
30000
3  25000
20000
15000
10000
□  PHD3-/- 
■  PHD3-/-; HIF2a+/~
B
40000
35000
CO 30000
20000
15000
10000
□  PHD3-/- 
■  PHD3-/-; HIF-1a+/-
Figure 39 |HIF2 mediates the effect of PHD3 inactivation on SCG anatomy. Comparison of neuronal 
complement of neonatal SCGs in mice of the indicated genotypes. HIF-2a heterozygosity (A), but not HIF- 
la  heterozygosity (B), is associated with reduced neuronal complement. Statistical comparisons are with 
respect to wild-type controls and values shown are averages from (n) separate mice as indicated in the 
parentheses. (* P < 0.05)
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Figure 40 |Effect of genetic inactivation of PHD3 on the anatomy of other sympatho-adrenal tissues. 
Adult stereological analysis displaying increased number of cells in the adrenal medulla (A) and carotid 
body (B). Statistical comparisons are with respect to wild-type controls and values shown are averages from 
(n) separate mice as indicated in the parentheses. (* P < 0.05)
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4.11 Sympathetic innervation of target tissues
Given that inactivation of PHD3 in vivo results in increased numbers of SCG neurons 
surviving to adulthood and that NGF is more effective in promoting neurite growth 
from cultured PHD3-deficient SCG neurons, I asked whether sympathetic innervation 
density is altered in PHD3-/- mice. The SCG innervates several anatomically discrete 
structures, including the iris, submandibular gland and pineal gland, whose 
innervation density can be relatively easily estimated by quantifying the area occupied 
by tyrosine hydroxylase (TH)-positive nerve fibres in tissue sections. Surprisingly, 
this analysis revealed significantly less TH-positive fibres in the iris (Fig 41), pineal 
gland (42) and submandibular gland (43) of PHD3-/- mice compared with wild type 
animals.
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Figure 41 | Decreased sympathetic innervation of the iris in PHD3-/- mice. (A) Com parison 
o f  sympathetic innervation density o f  the iris from adult wild type and PHD3-/- mice. (B) 
Representative images showing im munohistochemical detection o f  TH in the iris o f  w ild type 
and PHD3-/- mice. Statistical com parisons are with respect to w ild-type controls and values 
shown are averages from (n) separate m ice as indicated in the parentheses. (** P < 0.01)
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Figure 42 | Decreased sympathetic innervation of the pineal gland in PHD3-/- mice. (A)
Comparison o f  sympathetic innervation density o f  the pineal gland from adult wild type and 
PHD3-/- mice. (B) Representative images showing im m unohistochem ical detection o f  TH in the 
iris o f  w ild type and PHD3-/- mice. Statistical comparisons are w ith respect to w ild-type 
controls and values shown are averages from (n) separate mice as indicated in the parentheses.
(* P < 0.05)
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Figure 43 | Decreased sympathetic innervation of the submandibular gland in PHD3-/- 
mice. (A ) Com parison o f  sym pathetic innervation density o f  the iris from adult wild type and 
PHD3-/- mice. (B) Representative images showing immunohistochemical detection o f  TH in the 
iris o f  wild type and PHD3-/- mice. Statistical comparisons are with respect to wild-type 
controls and values shown are averages from (n) separate m ice as indicated in the parentheses. 
( * * P < 0 .0 1 )
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4.12 Physiological effects on the sympathetic nervous system
We next sought to assess the integrity of a physiological response that is dependent on 
the sympathetic nervous system. Because of the reduced sympathetic innervation of 
the iris in PHD3-/- mice (Figure 44), we tested light-to-dark pupillary responses. 
Postganglionic oculosympathetic fibers from the SCG travel with the long ciliary 
nerves to innervate the dilator pupillae muscle. Activation of the sympathetic nervous 
system leads to dilation of the pupil following relaxation of the dilator pupillae. While 
no differences in pupil diameter were seen under normal lighting conditions (150 lux; 
Figure 44A), pupil diameter was significantly decreased in the dark-adapted eye from 
PHD3-/- mice (0 lux; Figure 44B). This implies decreased tone in the sympathetically 
innervated dilator pupillae muscle fibres of PHD3-/- mice.
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Figure 44 | Physiological defect in an S C G  target of PHD3-A mice. M easurem ents o f  total 
pupil area in norm al light, 150 lux (A ) and in darkness, 0 lux (B). Representative im ages 
showing dark adapted eyes from  w ild-type and PHD3-/- m ice. Statistical com parisons are with 
respect to  w ild-type controls and values show n are averages from  (n) separate m ice as indicated 
in the parentheses. (** P <  0.01)
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4.13 Discussion
My findings show that the HIF prolyl hydroxylase PHD3 has an important role in 
regulating the development of the sympatho-adrenal system and that its ablation has 
substantial adverse physiological consequences that extend into adult life. 
Significantly more neurons were observed in the SCG of newborn PHD3-/- mice 
compared with wild type littermates, and this elevated number of SCG neurons is 
maintained to adulthood. The apparent failure of the neuronal complement of the 
SCG to decrease in PHD3-/- postnatally when naturally occurring programmed cell 
death ordinarily matches the number of sympathetic neurons to the requirements of 
their targets suggests that the elevated number of neurons in the SCG of PHD3- 
deficient mice is due to reduced cell death. It is well established that survival of SCG 
neurons during this period of development is critically dependent on the supply of 
NGF from their targets. The demonstration that the NGF survival dose response of 
PHD3-deficient SCG neurons in culture is shifted to lower NGF concentrations 
provides a plausible explanation for the enhanced survival of SCG neurons in PHD3- 
/- mice. The supply of target-derived NGF is able to support the survival of more of 
the innervating neurons in PHD3-/- mice because these neurons require less NGF to 
survive. Interestingly, the effect of PHD3 deletion on NGF responsiveness is 
restricted to neurons o f the sympathetic lineage in the peripheral nervous system as 
neural crest-derived, NGF-dependent sensory neurons from PHD3-/- mice responded 
normally to NGF in vitro.
As well as enhancing the sensitivity of SCG neurons to the survival-promoting 
effects of NGF, deletion of PHD3 also makes these neurons more responsive to the 
neurite growth-promoting effects of NGF in culture. Because target-derived NGF is
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not only required for sympathetic neuron survival during development in vivo but is 
also responsible for the terminal growth and branching of sympathetic axons in their 
targets, I expected to find increased sympathetic innervation density in PHD3-/- mice. 
Surprisingly, the opposite was observed in several SCG target tissues in these 
animals. One possible explanation for this apparent paradox is that the increased 
number of sympathetic neurons innervating target tissues results in elevated uptake 
and removal of NGF from these tissues by retrograde axonal transport, resulting in 
lower ambient levels of NGF in the targets. Whereas retrograde transport of NGF in 
signaling endosomes to the cell bodies of sympathetic neurons is required for 
survival, the extent of axonal growth and branching in target tissues is governed by 
the ambient level of NGF in these tissues. Mice overexpressing NGF also have 
increased survival of sympathetic neurons with increased process outgrowth but as in 
PHD3-/- mice described above, display significant decreases in target innervation 
[277]. The surprising decrease in sympathetic innervation was substantiated by the 
observation of reduced pupillary dilation in dark-adapted mice which is dependent on 
sympathetic tone. This result also demonstrates how slight effects on neuronal 
survival during development can have profound anatomical and physiological 
outcomes in the adult.
In conclusion, our findings reveal an important and unsuspected role for PHD3 in the 
developing sympatho-adrenal system. It is an intriguing possibility that this 
connection between hypoxia pathways and the developing sympatho-adrenal system 
might be a means by which changes in oxygen tension could influence key aspects of 
anatomical and physiological maturation of this system. Whether this provides a 
paradigm for environmental influences affecting development will be of interest in the 
future.
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Chapter 5
Neural activity regulates survival during a postnatal window in the 
development of sensory neurons
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5.1 Introduction
During the phase of naturally occurring cell death, developing neurons are reliant on 
target-derived neurotrophic factors. Neurons become dependent on neurotrophic 
factors around the time when their developing axons begin to innervate their target 
tissues [72]. The duration of neurotrophin independence and axonal growth rate are 
proportional to the distance between the developing neuron and its target, suggesting 
that there is an intrinsic clock that switches neurons from neurotrophin independence 
to dependence at the right time [72]. However, during the first few weeks of postnatal 
life, the expression of TrkA and TrkB on dorsal root and nodose ganglia, respectively, 
decreases. There is a gradual decline in TrkA expression in DRG neurons from over 
80% of cells expressing TrkA at El 5 to less than 50% by P21 [456]. More strikingly, 
only 10-20% of neonatal nodose neurons express TrkB and there is no detectable 
TrkB expression in adult nodose neurons [457]. Although there is some controversy 
surrounding the expression or lack of expression of TrkB in adult nodose neurons, 
there is no evidence to suggest that BDNF signalling through TrkB promotes survival 
in the adult.
It has been widely reported that neural activity is an important regulator of neuronal 
survival both in vivo [259,260, 361, 458]_and in vitro [253,255-257]. Neural activity 
has been shown to increase the survival of populations of CNS and PNS neurons, 
which raises the possibility that a secondary mechanism such as neural activity may 
serve as a synergistic or alternative survival cue (Mennerick and Zorumski 2000) 
during or after the period of neurotrophin-dependent survival. The calcium set-point 
hypothesis has been proposed to explain the relationship between neurotrophin- 
dependent survival and activity dependent survival [262,459]. Low intracellular free
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calcium concentration [Ca2+]i is associated with neurotrophic factor dependence, 
moderate [Ca2+]j is associated with neurotrophin independence and high [Ca2+]i is 
associated with toxicity. It has been suggested that trophic factor dependence is 
inversely related to [Ca2+]i which correlates with the observation that [Ca2+]j 
increases with age [264]. Most studies, however, have used peripheral neurons 
artificially aged in culture to examine the effects of neural activity on [Ca2+]i and 
neurotrophin independence.
In this section I will present the results of experiments that explore the switch from 
neurotrophin-dependence to independence, using neurons isolated from mice at 
various embryonic and postnatal stages. These results show that the timing of the 
switch differs between neuronal populations and suggest that this switch may be 
regulated by the onset of neuronal activity.
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5.2 Onset of postnatal neurotrophin- independence differs between neuronal 
populations
The survival of embryonic and neonatal neurons from the nodose, DRG and SCG is, 
like many other neural populations, dependent on neurotrophic factors. In contrast, 
adult neurons from the same populations survive in the absence of neurotrophic 
support in vitro. Since embryonic timing of neurotrophin dependence/independence 
varies between neuronal populations [72] I investigated the timing of postnatal 
neurotrophin-independence in several populations of neurons in vitro. Dissociated 
cultures were set up from nodose, DRG and SCG over a range of ages from 
embryonic day 16 (E16) to postnatal day 10 (P10) and percent survival in the absence 
of neurotrophic support was estimated. The typical percentage survival of peripheral 
neurons cultured with the appropriate neurotrophic factor lies within the range 65- 
85% (not shown). In neurons cultured in the absence of neurotrophic support, a 
comparable level of survival is not reached after the first 1 0  days of postnatal life in 
sympathetic neurons (Fig 44). Nodose neurons become neurotrophin independent 
between P0 and P5, whereas DRG neurons become independent between P5 and P10 
(Fig 44). These results suggest that the onset of neurotrophin-independence in vitro 
varies between populations of PNS neurons. Notably, SCG neurons remained 
dependent on neurotrophin support up to 10 days after birth. SCG neurons are known 
to depend on neurotrophic support for as long as 40 days after birth [118].
5.3 KCl-induced depolarisation increases survival of peripheral sensory neurons
Peripheral neurons are dependent on neurotrophic factors around the time when they 
start innervating their targets. Neural activity has also been shown to increase the 
survival of many populations of neurons in both the CNS and PNS [460]. In order to
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investigate whether activity might influence neuronal survival at different 
developmental stages, percent survival in cultures with depolarising concentrations of 
K+ (40 mM) was estimated for nodose, dorsal root and superior cervical ganglia. 
Neurons were cultured from ganglia obtained over a range of developmental ages 
from E16-P10 in the absence of neurotrophic support. The survival of nodose neurons 
cultured in the presence of depolarising concentrations of KC1 alone was comparable 
to the percentage survival of nodose neurons supported by neurotrophic factors (Fig. 
46). This effect was most dramatic in the immediate postnatal period, with 80% of P0 
neurons surviving in the presence of KC1 alone (Fig. 46B) compared to 30-40% 
survival in untreated cultures. The difference between both culture conditions 
disappeared by P10 (Fig. 46D) when these neurons become fully independent of 
neurotrophic factors. Similarly, an increase in neuronal survival was observed during 
a developmental window in sensory neurons of the DRG (Fig. 47). The age at which 
KCl-supported survival reached a level comparable to that of neurotrophin-supported 
cultures, was between P5-P10 (Fig. 47). In contrast to sensory neurons, depolarising 
concentrations of KC1 did not affect the survival of SCG neurons at any age tested 
(Fig. 48). These results suggest that embryonic sensory neurons are dependent on 
neurotrophins during early postnatal stages, but become entirely independent by P10. 
Furthermore, there is a developmental window during which depolarizing 
concentrations of K+ can increase the survival of sensory neurons cultured in the 
absence of neurotrophic factors and that the postnatal age at which this stimulation 
can modify survival differs between neuronal populations.
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Figure 45 | Neurotrophin-independent survival increases with age, N eurons from the nodose, 
dorsal root and superior cervical ganglia (a t ages indicated) w ere incubated w ithout 
neurotrophic support in defined m edium  for 24 hours after w hich the percentage neuronal 
survival was calculated. (A) N eurons from  both the nodose and dorsal root ganglia becom e 
neurotrophin-independent postnatally, w hereas SCG neurons rem ain dependent on N G F for 
survival.
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Figure 46 IDepolarisation causes neurotrophin-isdcpendence in nodose neurons from P0. Neurons 
from the nodose ganglion (at ages indicated) were incubated without neurotrophic support in defined 
medium for 24 hours in the presence or absence o f  KC1 (40mM) after which the percentage neuronal 
survival was calculated. Statistical comparison is with respect to the “no factors” condition and values 
shown are the average survival values obtained from three independent repeats (** P < 0.01 , *** P < 
0.005)
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Figure 47 |Dcpolarisation causes ncurotrophin-indcpcndcncc in DRG neurons from P5. Neurons 
from the DRG (at ages indicated) were incubated without neurotrophic support in defined medium for 24 
hours in the presence or absence o f KC1 (40mM) after which the percentage neuronal survival was 
calculated. Statistical comparison is with respect to the “no factors” condition and values shown are the 
average survival values obtained from three independent repeats (** P < 0.01 , *** P < 0.005)
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Figure 48 {Depolarisation has no effect on SCG neurons during early postnatal life. Neurons from the 
SCG (at ages indicated) were incubated without neurotrophic support in defined medium for 24 hours in 
the presence or absence o f KC1 (40mM) after which the percentage neuronal survival was calculated. 
Statistical comparison is with respect to the “no factors” condition and values shown are the average 
survival values obtained from three independent repeats.
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5.4 L-Type Ca channel blockers reverse effects of KC1 on sensory neuronal 
survival
Depolarisation of neurons by elevation of extracellular K+ has been shown to 
increase neuronal survival of central and peripheral neurons in vitro [460]. The 
reported survival promoting effects of elevated K+ in peripheral neurons seem to be 
largely mediated by calcium influx through L-Type, voltage-gated calcium channels 
[460, 461]. To confirm that the increased survival in sensory neurons (Figs 46 and 47) 
treated with 40 mM K+ is mediated by L-type calcium channels, we tested the effects 
of L-type calcium channel blockers verapamil and nifedepine. Neurons from postnatal 
nodose and dorsal root ganglia were cultured in defined media with and without 
elevated K+ and with elevated K+ plus either verapamil or nifedipine. Both verapamil 
and nifedipine reversed the increase in neuronal survival brought about by elevated 
extracellular K+ (Figs. 49 and 50). The developmental window during which L-type 
calcium channel blockers effected survival is the same as that during which elevated 
K+ influences neuronal survival for both nodose and DRG neurons (Figs. 49 and 50). 
These results suggest that increases in intracellular calcium concentration or neural 
activity, may be sufficient to promote neuronal survival in the absence of 
neurotrophic support during a window of postnatal development in sensory neurons.
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Figure 49 |L-type calcium channel inhibitors reverse the effects of KCI in nodose neurons. Neurons 
from the SCG (at ages indicated) were incubated without neurotrophic support in defined medium for 24 
hours in the presence or absence o f KCI (40mM) with verapamil (lOpM) or nifedipine (lOpM) after 
which the percentage neuronal survival was calculated. Statistical comparison is with respect to the 
“KCI” condition and values shown are the average survival values obtained from three independent 
repeats. (* p < 0.05, ** p < 0.01 ***p< 0.001)
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Figure 50 |L-type calcium channel inhibitors reverse the effects of KCI in DRG neurons. Neurons 
from the SCG (at ages indicated) were incubated without neurotrophic support in defined medium for 24 
hours in the presence or absence o f KCI (40mM) with verapamil (lOpM) or nifedipine (10|JM) after 
which the percentage neuronal survival was calculated. Statistical comparison is with respect to the 
“KCI” condition and values shown are the average survival values obtained from three independent 
repeats. (* p < 0.05, ***p< 0.001)
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5.5 Extracellular ATP promotes the survival of nodose neurons
ATP binds to P2X receptors, ATP-gated ion channels which generate inward currents 
caused by Na+ and Ca2+ influx, causing membrane depolarisation and facilitation of 
voltage-gated calcium entry. There are seven P2X receptor subunits (P2Xi-P2Xy) of 
which P2 X2 and P2 X3 seem to play the major role in mediating the primary sensory 
effects of ATP [462,463]. P2 X2 and P2 X3 are highly expressed in nodose neurons 
[464] and the addition of extracellular ATP leads to depolarisation of the majority of 
nodose neurons [463]. Nodose neurons from E16-P10 were cultured without 
neurotrophic factors in the presence or absence of extracellular ATP and neuronal 
survival was estimated. During the same developmental window during which 
elevated K+ effects survival, extracellular ATP caused a significant increase in the 
survival of nodose neurons (Fig 51). These results further implicate depolarisation in 
the regulation of survival of postnatal sensory neurons.
5.6 Hypoxia reverses effect of ATP on neuronal survival
ATP induces a sustained inward current in HEK cells expressing the homomeric P2 X2 
receptor under normoxic conditions, which is significantly reduced in hypoxia [465]. 
In order to investigate the effects of hypoxia on ATP-induced neuronal survival, 
neonatal nodose neurons were incubated overnight at 1% O2, in the presence or 
absence of ATP. In contrast to the marked effect on survival described above, 
extracellular ATP had no effect on neuronal survival under hypoxic conditions (Fig. 
52). This observation suggests that the survival-promoting effects of ATP may be 
mediated by binding to the highly expressed P2X2 receptor on nodose neurons.
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Figure 51 | ATP promotes survival o f neonatal nodose neurons. Neurons from the nodose ganglion (at 
ages indicated) were incubated in the absence o f  neurotrophic factors, with or without ATP (lOpM) and 
percentage neuronal survival was estimated every 24 hours up to 72 hours. ATP increases survival during 
a window o f postnatal development in nodose neurons. Statistical comparisons are with respect to the no 
factors (NF) condition and values shown are the average survival values obtained from three independent 
repeats. (* p < 0.05)
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Figure 52 | Hypoxia reverses effects of ATP. Neurons from the nodose ganglion (at ages indicated) were 
incubated at 1% 0 2 in the absence o f neurotrophic factors, with or without ATP (lOpM) and percentage 
neuronal survival was estimated every 24 hours up to 72 hours. ATP had no effect on neuronal survival 
when under hypoxic conditions. NF = No factors.
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5.7 Discussion
Embryonic sensory neurons cultured before target field innervation begins are 
independent of neurotrophic support [89, 466,467]. The survival of these early 
neurons is regulated by intracellular calcium [258]. Soon after this period of 
neurotrophin independence, sensory neurons become dependent on target-derived 
neurotrophic factors. According to the calcium set-point hypothesis [262], there are 
four postulated steady-state levels of [Ca2+]i that effect neuronal survival. (1) A very
'j I
low range of [Ca ]* results in cell death that cannot be reversed by addition of 
neurotrophic factors. (2) The [Ca2+]i of neurons at rest during the period of PCD 
which renders neurons dependent on neurotrophic factors for survival. (3) A range of 
[Ca2+]i slightly elevated above resting levels which promotes neuronal survival in the 
absence of neurotrophic factors. (4) Substantially elevated [Ca2+]j which causes cell 
death. Studies in vitro describe how neurons, aged in culture, regain their 
independence from neurotrophins which correlates with an increase in [Ca2+]i [262, 
459,468]. Further studies using DRG neurons of various developmental ages, not 
culture ages, confirm that older neurons become neurotrophin independent and that 
trophic factor dependence is inversely related to [Ca2+]i since [Ca2+]j increases as the 
neurons become independent of NGF [264]. Furthermore, mature, neurotrophin 
independent DRG neurons revert to neurotrophin-dependence if moved to low 
calcium media [468]. Here I have described how various populations of sensory 
neurons attain neurotrophin independence in vitro at different stages of postnatal 
development. Nodose neurons become independent of neurotrophic support between 
P0-P5, DRG neurons become independent between P5-P10 and sympathetic neurons 
did not reach independence at all within the tested range of developmental stages. 
During the postnatal period prior to the onset of neurotrophin independence, neuronal
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survival was increased by chronic K+ -induced depolarisation. It will be of interest to 
confirm that the relatively early onset of neurotrophin independence in nodose 
neurons correlates with an earlier rise in [Ca2+]i. Interestingly, the decreased 
dependence of nodose neurons on neurotrophic factors in vitro correlates with an 
early decrease in TrkB expression compared to a slightly later decrease in TrkA 
expression on DRG neurons [456, 457]. In contrast, SCG neurons remain dependent 
on neurotrophic support and continue to express TrkA into adulthood [469]. SCG 
neurons do not reach independence in vitro until mice are 1 2  weeks old and neuronal 
survival at this stage is unaffected by anti-NGF antibodies or TrkA inhibition [470]. It 
is plausible that both the cumulative effects of [Ca2+]j and the availability or level of 
expression of neurotrophic factors and their receptors determine neurotrophin 
independence. Nodose neurons survive in the absence of neurotrophic support 
between P5 and P10 in vitro but stereological analyses revealed a 50% reduction in 
cell number in nodose ganglia during a postnatal period when the neurons are 
independent of neurotrophic factors between P5 and PI4. Differential levels of 
activity may contribute to the 50% decrease in number of nodose neurons between 
days 1 and 14 of postnatal life, where less active neurons are eliminated [471].
As neurons are in the process of becoming neurotrophin independent (P0-P5 for 
nodose neurons, P5-P10 for DRG neurons), their survival is increased to maximal 
levels by chronic K+ mediated depolarisation. Influx of calcium through L-type 
voltage-gated calcium channels, resulted in neurotrophin independence at postnatal 
stages of development during which neurons are normally dependent on 
neurotrophins for survival. Embryonic neurons from all ganglia tested were found to 
be fully reliant on neurotrophins. SCG neurons aged in culture for 3 weeks have been
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shown to become independent of neurotrophic support and display a gradual increase 
in [Ca2+]j from 93nM in young neurons to 241nM in 3 week old neurons [459]. 
Interestingly, depolarisation of young neurons with K+ has been shown to promote an 
increase in [Ca2+]i to 240nM , leading to neurotrophin independence [459]. My
observations suggest that various populations of neurons may reach a threshold level
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of [Ca ji at different stages during postnatal development due to differential levels of 
neural activity. It would be of interest to compare [Ca2+]i of nodose, DRG and SCG 
neurons at different stages of postnatal development. The early onset of neurotrophin 
independence in nodose neurons would predict that optimal [Ca2+]i is reached sooner 
during postnatal development in this population compared to DRG or SCG neurons. 
Further work is also required to determine whether the subpopulation of nodose 
neurons that survive in the absence of neurotrophic factors or elevated K+ between 
P0-P5, do so because of comparatively higher [Ca2+] i . Extracellular ATP, a 
physiological agonist of P2X receptors on nodose neurons, promoted a significant 
increase in neuronal survival between P0-P5. Differential levels of activity between 
nodose neurons during this period of development may determine which neurons 
become independent and which die by PCD. Interestingly, the increase in survival 
promoted by ATP was reversed when neurons were grown under hypoxic conditions. 
It is possible that hypoxic conditions in utero could dampen the effects of neural 
activity on survival and increase dependence on neurotrophic factors.
It is well established that the survival of embryonic peripheral neurons is dependent 
on target derived neurotrophic factors. Deafferentation studies, studies in which 
ganglionic transmission has been blocked and many in vitro analyses have elucidated 
a role for activity in the regulation of survival during the development of numerous
175
populations of peripheral and central neurons [472]. My results suggest that the 
survival requirements of different populations of sensory neurons switch from 
neurotrophins to neural activity at different stages postnatally. My observation that the 
survival of nodose neurons can be increased by addition of ATP, suggests that the role 
of neural activity may be physiologically relevant during the early postnatal 
development of sensory neurons. Further work will be required to determine which of 
the P2 receptor subtypes mediates the observed effects of ATP on neuronal survival. 
Patch-clamp studies have revealed almost complete loss of ATP-induced inward 
current in P2 X2/P2 X3 double knockout mice [463]. It would therefore be of 
considerable interest to compare neuronal survival of WT and P2 X2/P2 X3 double 
knockout mice , in the absence and presence of ATP, during postnatal development.
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Appendix
Polv-omithine Solution
9.2g of boric acid (Sigma) was dissolved in 1L of dH20 and adjusted to pH 8.4 using 
5M NaOH. 500mg of poly-omithine (sigma) was then dissolved in the borate solution 
and filter sterilised. The poly-omithine solution was stored at 4°C for up to 2 weeks.
Trypsin
50mg Trypsin (Worthington) was dissolved in 5ml Ca2+/Mg2+ free PBS , filter 
sterilised and stored at -20°C.
PCR cycle conditions 
PHD1:
1. 95 C for 1 min
2. 95 C for 30 sec
3. 63 C for 30 sec
4. 72 C for 2 min
30 cycles of steps 2 to 4
5. 72 C for 10 mins 
6 .4C
PHD2:
1. 94 C for 2 min
2. 94 C for 30 sec
203
3. 52 C for 30 sec
4. 72 C for 1 min 15 sec 
32 cycles of steps 2 to 4
5. 72 C for 10 mins
6. 4 C
PHD3:
1. 95 C for 1 min
2. 95 C for 30 sec
3. 63 C for 30 sec
4. 72 C for 2 min
30 cycles of steps 2 to 4
5. 72 C for 10 mins
6. 4 C
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Brief Communications
Nuclear Factor-kB Activation via Tyrosine Phosphorylation 
of Inhibitor kB-cy Is Crucial for Ciliary Neurotrophic Factor- 
Promoted Neurite Growth from Developing Neurons
Denis Gallagher,1 Humberto Gutierrez,1 Nuria Gavalda,1 Gerard O’Keeffe,1 Ron Hay,2 and Alun M. Davies1
'School of Biosciences, Cardiff CF10 3US, United Kingdom, and 2School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom
The cytokine ciliary neurotrophic factor (CNTF) promotes the growth of neural processes from many kinds of neurons in the developing 
and regenerating adult nervous system, but the intracellular signaling mechanisms mediating this important function of CNTF are poorly 
understood. Here, we show that CNTF activates the nuclear factor-kB (NF-kB) transcriptional system in neonatal sensory neurons and 
that blocking NF-KB-dependent transcription inhibits CNTF-promoted neurite growth. Selectively blocking NF-kB activation by the 
noncanonical pathway that requires tyrosine phosphorylation of inhibitor «B-a (IkB-ck), but not by the canonical pathway that requires 
serine phosphorylation of IkB-cy, also effectively inhibits CNTF-promoted neurite growth. CNTF treatment activates spleen tyrosine 
kinase (SYK) whose substrates include IkB-cy. CNTF-induced SYK phosphorylation is rapidly followed by increased tyrosine phosphor­
ylation of iKB-a, and blocking SYK activation or tyrosine phosphorylation of IkB-q: prevents CNTF-induced NF-kB activation and 
CNTF-promoted neurite growth. These findings demonstrate that NF-kB signaling by an unusual activation mechanism is essential for 
the ability of CNTF to promote the growth of neural processes in the developing nervous system.
Key words: NF-kB; neurite; CNTF; SYK; development; sensory neuron
Introduction
Nuclear factor-k B ( N F - k B) is a ubiquitously expressed transcrip­
tion factor system that consists of homodimers or heterodimers 
of five structurally related proteins: p65, RelB, c-Rel, p50, and 
p52, of which the p50/p65 heterodimer is the most abundant and 
widely expressed (Hayden and Ghosh, 2004). N F - k B is held in an 
inactive form in the cytosol by interaction with a member of the 
I kB family of inhibitory proteins, I kB « , I k B/3, I kB e , IKB7 , Bcl-3, 
plOO and pl05, of which I k B cx is the predominantly expressed 
inhibitor. In the canonical N F - kB signaling pathway, N F - kB is 
activated by phosphorylation of I k B q  on serine residues 32 and 
36 by an I k B kinase complex. This leads to ubiquitination and 
proteasome-mediated degradation of I k B o  and translocation of 
the liberated N F - kB to the nucleus where it binds to consensus k B 
sequences in the promoter and enhancer regions of responsive 
genes (Hayden and Ghosh, 2004). N F - k B can also be activated by 
several alternative mechanisms including one in which I k Bcy is 
phosphorylated on tyrosine 42, which results in its dissociation 
from N F - k B without proteasome-mediated degradation (Koong 
et al., 1994; Imbert et al., 1996; Bui et al., 2001; Takada et al.,
2003).
Classically, N F - kB has been shown to regulate the expression 
of genes involved in innate and adaptive immune responses,
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stress responses, cell survival, and cell proliferation (Liang et al.,
2004). In the nervous system, N F - kB is activated by a variety of 
neurotrophic factors, cytokines, and neurotransmitters, and can 
promote neuronal survival or bring about neuronal death. 
N F - kB signaling also regulates synaptic function, plays a role 
learning and memory and participates in peripheral nerve myeli- 
nation (Kaltschmidt et al., 2005).
CNTF promotes the survival of a variety of neurons (Horton 
et al., 1998; Nishimune et al., 2000) and stimulates neurite growth 
and axon regeneration in several in vitro and in vivo experimental 
paradigms in the developing and mature nervous system (Hart- 
nick et al., 1996; Cui and Harvey, 2000; Siegel et al., 2000). Bind­
ing of CNTF to a receptor complex consisting of gpl30, leukemia 
inhibitory factor receptor /3, and CNTF receptor a  (Stahl and 
Yancopoulos, 1994) leads to the activation of several signal trans­
duction pathways including JAK (Janus kinase)/STAT (signal 
transducer and activator of transcription), MEK [extracellular 
signal-regulated kinase (ERK) kinase]/MAPK (mitogen- 
activated protein kinase), phosphoinositide 3-kinase (PI3-K)/ 
Akt, and N F - k B (Nishimune et al., 2000; Rane and Reddy, 2000). 
Because N F - kB signaling via the canonical activation pathway 
partially contributes to the neurite growth-promoting effects of 
the neurotrophins NGF and BDNF (Sole et al., 2004; Gutierrez et 
al., 2005), we investigated whether NF- kB signaling plays any role 
in the neurite growth-promoting effects of CNTF. Using neona­
tal mouse nodose ganglion sensory neurons, which are supported 
by CNTF (Horton et al., 1998), we show by a variety of comple­
mentary experimental approaches that N F - kB signaling is essen­
tial for CNTF-promoted neurite growth and that the N F - kB ac-
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tivation mechanism used by CNTF for promoting growth is 
distinct from that used by the neurotrophins.
Materials and Methods
Neuron culture and transfection. Dissociated cultures o f nodose ganglion 
neurons from newborn mice were grown in polyornithine/laminin- 
coated 35 mm dishes in defined medium and were transfected 3 h after 
plating with plasmid-coated or oligonucleotide-coated (kB decoy 
dsDNA, 5 '-GAGGGGACTTTCCCT-3scrambled control dsDNA, 5'- 
GATGCGTCTGTCGCA-3') gold microcarriers using the Bio-Rad (Her­
cules, CA) Gene-gun (Gutierrez et al., 2005). Immunocytochemistry was 
used to confirm that nodose neurons transfected with expression plas­
mids for Tyr IkB«, Ser IkBo:, and Syk dominant-negative mutants have 
increased expression o f the corresponding protein (data not shown). The 
survival o f transfected neurons was quantified by counting the numbers 
of yellow fluorescent protein (YFP)-labeled neurons 12 h after plating 
and at later time points and expressing the latter as a percentage o f the 
former. Survival in nontransfected cultures was estimated by counting 
the number of neurons in a grid 3 and 24 h after plating and expressing 
the latter as a percentage o f  the former.
Quantification of fluorescence. To estimate the relative level o f  NF-kB 
activation, neurons were transfected with a plasmid expressing green 
fluorescent protein (GFP) under the control o f an NF-kB promoter. 
Neurons were imaged with a Zeiss (Oberkochen, Germany) Axioplan 
confocal microscope and mean soma fluorescence intensity was obtained 
using LSM510 software.
Analysis of neuritic arbors. YFP-labeled neurons were visualized and 
digitally acquired using an Axioplan Zeiss confocal microscope. In non­
transfection experiments, neurons were fluo- 
rescently labeled with the vital dye calcein-AM 
(Invitrogen, Eugene, OR). Neuritic arbors were 
traced using LSM510 software from which total 
neurite length and number of branch points 
was calculated and Sholl analysis was per­
formed (Gutierrez et al., 2005).
Western blots. Neurons were plated at high 
density in polyornithine/laminin-coated 96- 
well plates (5000 neurons per well). Four hours 
after plating, 50 ng/ml CNTF was added for the 
indicated times. The cells were lysed in radio- 
immunoprecipitation assay buffer and insolu­
ble debris was removed by centrifugation. Sam­
ples were transferred to polyvinylidene 
difluoride membranes using the Bio-Rad 
TransBlot. Membranes were blocked with 5% 
dried milk in PBS with 0.1% Tween 20. Mem­
branes were then incubated with anti-phospho- 
Tyr IkB-ol antibody (1:200; Abeam, Cam­
bridge, UK), anti-phospho-Syk antibody 
(1:1000; Cell Signaling Technology, Beverly, 
MA), anti-lKB-a antibody (1:1000; Cell Signal­
ing Technology), or anti-/3-III tubulin antibody 
(1:10000; Promega, Hawthorne, Australia), 
which were detected with peroxidase-linked 
secondary antibody (GE Healthcare Bio- 
Sciences, Piscataway, NJ) and ECL-plus (GE 
Healthcare Bio-Sciences). Densitometry was 
performed using Adobe (San Jose, CA) 
Photoshop.
Results
Blocking NF-KB-dependent 
transcription inhibits CNTF-promoted 
neurite growth
To investigate the importance of N F - k B  in 
mediating the response of neurons to 
CNTF, we studied the consequences of 
specifically inhibiting a key step in N F - k B  
signaling, the binding of activated N F - k B  
to regulatory elements in target genes. This was blocked by trans­
fecting neurons with double stranded DNA oligonucleotides 
containing the k B  consensus binding sequence. This k B  decoy 
DNA has been successfully used in vitro and in vivo to inhibit 
N F - k B  transcriptional activity by sequestering transcriptionally 
active N F - k B  complexes (Morishita et al., 1997; Tomita et al., 
2000; Gutierrez et al., 2005). Postnatal day 0 (P0) nodose gan­
glion neurons were transfected with gold particles coated with 
either the k B  decoy DNA or a control oligonucleotide of scram­
bled sequence 3 h after plating. The cultures received CNTF after 
transfection and neuronal survival and neurite arbor size and 
complexity were quantified 24 h after plating.
The k B  decoy DNA, but not the control oligonucleotide 
caused a marked threefold reduction in neurite length and 
branching and a substantial reduction in neurite growth as quan­
tified by Sholl analysis (Fig. 1). Despite the dramatic effect on 
neurite growth, the cell bodies of neurons transfected with k B  
decoy DNA retained a normal appearance (Fig. 1E) and contin­
ued to survive just as well as control-transfected neurons in the 
presence of CNTF, with ~70% of the neurons surviving up to 
72 h after plating (Fig. 1C). Accordingly, N F k B  reporter activity 
was significantly reduced in neurons transfected with k B  decoy 
DNA and not in neurons transfected with control DNA (see Fig. 
4D). These results suggest that NF-KB-dependent transcription 
is required for CNTF-promoted neurite growth from newborn
9666 • J. Neurosci., September 5,2007 • 27(36):9664 -9669 Gallagher et al. •  NF-kB and Neurite Growth
a •* i
■S 3 -Io 0 i
C/3 -  \c- 1 I •*-» 1 ' fi
* Mi
TV-,
0
-1
0 150 300
Distance (nm)
B
C ontrol ^  i
S e r lK B -a  c/ 361
c S JO 5 1
4 -iCJ I<u 3 -I
1 i'
S3 2 1*
c  i J|■^ o o -j...
-1 Ji
O  CNTF
•   CNTF+
ALLN
0 150 300
Distance (fim)
C
< /3
6 - 
5co 4
-«—* 
oQ
C/5u, ?
V
1 -|-*->C»—<
0  -i
- 1
CNTF 
CNTF+ 
MG 132
K m,
150 300
Distance (jam)
Figure 2. CNTF does n o t p ro m o te  n eu rite  g ro w th  by canonical NF-kB signaling . A-C, Three 
hours a fter p lating , PO nod ose  n eu ro n s  w ere  tran sfec ted  w ith  a YFP expression p lasm id  to ­
g e th e r  w ith  e ith e r a  p lasm id  expressing  th e  32/36-SS/AA  Ik B -a  m u ta n t (Ser k B - a )  o r an 
em pty  control plasm id  (A) w ere  tre a te d  w ith  e ith e r  4  /xm ALLN or vehicle control (B) o r w ere  
tre a ted  w ith  20 nM MG132  or vehicle  control ( 0 -  After 24  h incubation  w ith  50 ng /m l CNTF, Sholl 
analysis w as perfo rm ed. M eans ±  SEs o f a typical e x p erim e n t a re  show n (50 - 9 0  n eurons per 
condition). Very sim ilar d a ta  w ere  o b ta in e d  in th re e  in d e p e n d en t experim ents . Statistical com ­
parisons a re  w ith  respect to  th e  e m p ty  p lasm id-tran sfec ted  n eurons or v eh icle-treated  neurons.
mouse nodose ganglion neurons, but is not needed for the sur­
vival of these neurons with CNTF. Similar decreases in the size 
and complexity of neurite arbors without any neuronal loss were 
observed in CNTF-supported nodose neurons treated with 
SN50, a cell-permeable inhibitor of NF-kB nuclear translocation 
(data not shown). Conversely, combined overexpression of p65/ 
p50 in CNTF-supported neurons resulted in a significant in­
crease in neurite length and branching (data not shown).
CNTF does not prom ote neurite growth via the canonical NF- 
kB signaling pathway
The canonical N F - kB signaling pathway can be selectively inhib­
ited by an I k B -cc protein possessing serine to alanine substitu­
tions at residues 32 and 36 that prevent its phosphorylation by the 
I kB kinase complex, but do not affect its association with N F - k B 
dimers (Roff et al., 1996). We showed previously that expression 
of this 32/36-SS/AA I k B -a mutant in nodose neurons grown with 
BDNF causes a 30% reduction in neurite arbor size (Gutierrez et 
al., 2005). In marked contrast to nodose neurons grown with 
BDNF, this 32/36-SS/AA I kB -cx had no effect whatsoever on the 
neurite arbors of nodose neurons grown with CNTF, as shown by 
Sholl analysis (Fig. 2A), suggesting that CNTF does not mediate 
its effects on neurite growth via the canonical N F - kB pathway.
Additional confirmation of the lack of involvement of canon­
ical NF-kB signaling in CNTF-promoted neurite growth was ob­
tained by inhibiting another key step in this pathway,
proteasome-mediated degradation of ubiquitinated phospho- 
serine IkB-cv (Hayden and Ghosh, 2004). We showed previously 
that the proteasome inhibitor N-acetyl-Leu-Leu-norleucinal 
(ALLN) reduces the size of the neurite arbors of nodose neurons 
grown with BDNF (Gutierrez et al., 2005). Neither ALLN (Fig. 
2B) nor another proteasome inhibitor MG132 (Fig. 2C) affected 
neurite arbor size in CNTF-supplemented cultures, suggesting 
that proteasome function is not required for CNTF-promoted 
growth. In contrast, we confirmed that both MG132 and ALLN 
significantly reduced BDNF-promoted neurite growth (data not 
shown). Western blot analysis of the level I KB-a protein in no­
dose neurons at intervals after CNTF treatment also failed to 
show any evidence of IkB-o degradation (see Fig. 4C).
Tyrosine phosphorylation of IkB-ck is required for 
CNTF-promoted growth
The noncanonical N F - kB activation mechanism that involves 
tyrosine phosphorylation of I kB o  can be effectively and specifi­
cally blocked with an I k B -o  protein that has a tyrosine to phenyl­
alanine substitution at residue 42 (Imbert et al., 1996). Nodose 
neurons transfected with a plasmid expressing this Y42F I kB -o  
mutant had markedly smaller and less branched neurite arbors 
than control-transfected neurons when grown with CNTF (Fig. 
3A -C ). The survival of newborn nodose neurons grown with 
CNTF was not effected by expression of the Y42F iKB-a mutant 
with 70-80% of neurons surviving after 24 h, confirming the 
above data that N F - kB signaling does not mediate the survival 
response of these neurons to CNTF. Although expression of the 
Y42F IKB-a mutant markedly inhibited CNTF-promoted neurite 
growth, its expression had no significant effect on the size and 
complexity of neurite arbors of nodose neurons grown with 
BDNF (data not shown). These results suggest that phosphoty- 
rosine iKB-a-dependent activation of N F - k B is essential for 
CNTF-promoted neurite-growth but not for BDNF-promoted 
growth
SYK is required for CNTF-promoted neurite growth
We investigated the potential involvement of the spleen tyrosine 
kinase (SYK) in CNTF-promoted neurite growth because this 
protein-tyrosine kinase has been shown previously to phosphor- 
ylate IkB-o on tyrosine 42 in myeloid cells (Takada et al., 2003). 
Because the enzymatic activity of SYK is regulated by tyrosine 
phosphorylation (Berton et al., 2005), we quantified the level of 
phospho-SYK in nodose neurons at intervals after CNTF treat­
ment to see whether CNTF is capable of activating SYK. Western 
blotting using an anti-phospho-SYK antibody failed to detect 
phospho-SYK in untreated neurons, but within 5 min of CNTF 
treatment, a very strong signal was evident which decreased 
markedly by 30 min (Fig. 4A). In contrast, BDNF treatment did 
not induce SYK phosphorylation (data not shown). Western blot 
analysis using a specific anti-phosphotyrosine IkBo antibody re­
vealed that the rapid rise and peak in phospho-SYK 5 min after 
CNTF treatment was followed by a rise in phosphotyrosine I kB- a  
that was first evident after 15 min treatment with CNTF and was 
further elevated after 30 min (Fig. 4B).
To determine whether the sequential tyrosine phosphoryla­
tion of SYK and IkBo in response to CNTF is necessary for 
CNTF-promoted N F - kB activation, we transfected nodose neu­
rons with a reporter construct in which GFP is under the control 
of an N F - k B promoter and studied the effects of inhibiting SYK 
activation and blocking tyrosine phosphorylation of I kBo  on 
reporter signal intensity (Fig. 4D). Whereas CNTF treatment 
promoted a twofold increase in reporter signal compared with
Gallagher et al. •  NF-k B and Neurite Growth J. Neurosci., September 5,2007 • 27(36):9664 —9669 • 9667
ontrol 
Tvr IkBcx
°  0.6-
X 0.5
c
" 7 16-
O 5 o.oo 4
1 32C 7 f3 1
JL
0 150 300
Distance (jtm)
a  0 
□  CNTF+Control DNA 
|  CNTF+Tyr I k B oc
Control
dnSvk
O0.6
3  0.4
«= 0.1-
G
c«7
8 5 
° * > i  jCO 4 -
c ->
f*
13 2
I *
JL
0 150 300
Distance (>im)
CO 0  
□  CNTF+Control DNA 
■  CNTF+dnSyk
**
i
CNTF
CNTF
+Pic
w o 4
S 0.2-
0 150 300
Distance (kim) □  CNTF 
■  CNTF+Pic
Figure 3. Tyrosine p hosphorylation  o f  k B a  and  activa tion  o f  SYK kinase a re  requ ired  for 
CNTF-promoted neu rite  g ro w th . A-K, Three hou rs a fte r  p lating , PO n odose  neurons w ere  tra n s ­
fected  w ith  a YFP expression p lasm id  to g e th e r  w ith  e ith e r  a p lasm id  expressing  th e  Y42FI K B -a  
m u ta n t {Tyr I K B -a) or an  em p ty  control p lasm id  [A-C], o r w ere  transfec ted  w ith  a YFP expres­
sion plasm id to g e th e r  w ith  e ith e r  a p lasm id  expressing  a  d o m in a n t-n e g a tiv e  SYK pro tein  (dn - 
Syk) or an em p ty  control p lasm id  ( £ - 6 ) ,  o r tre a te d  w ith  e ith e r  10 /xm p iceatanno l (Pic) or 
vehicle control {l-K). A fter 24  h incubation  w ith  50 n g /m l CNTF, Sholl analysis (A, E,l), n eu rite  
arbor leng th  (B, F, 6 ), and  branch  p o in t n u m b e r (C  G, K) w ere  a scertained . M eans ±  SEs o f a 
typical experim ent are  show n (50 - 9 0  neu ron s p er condition ). Very sim ilar d a ta  w ere  ob ta in ed  
in th ree  in depend en t e xp erim en ts . S tatistical com parisons a re  w ith  respect to  e ith e r  control- 
transfected  neurons or v eh ic le -trea ted  n eu ron s. **p < 0 .001.
untreated controls, this rise was completely blocked in neurons 
treated with the potent selective SYK inhibitor piceatannol (Ol­
iver et al., 1994) and in neurons transfected with the Y42F IkB-cx 
plasmid.
To test the role of SYK in mediating the neurite growth- 
promoting effects of CNTF, we studied the neurite arbors of 
CNTF-supported nodose neurons that were either treated with 
piceatannol or transfected with a plasmid expressing dominant- 
negative SYK. Both approaches caused a substantial reduction in
CNTF-promoted neurite growth (Fig. 3E -K ) and NF-kB activa­
tion, but not BDNF-promoted neurite growth (data not shown), 
and had no effect on survival with either factor (data not shown). 
These findings indicate that CNTF-dependent activation of SYK 
and the subsequent activation of NF-kB by tyrosine phosphory­
lation of I KB-a are essential steps in the neurite growth response 
of neurons to CNTF, but not BDNF.
Discussion
Using a variety of complementary experimental approaches, we 
have demonstrated that NF-kB signaling by an uncommon non- 
canonical activation mechanism is essential for the ability of 
CNTF to promote neurite growth. Inhibiting NF-KB-dependent 
transcription, blocking tyrosine phosphorylation of IkBo and 
inhibiting SYK activation each caused very substantial reductions 
in the size and complexity of the neurite arbors of CNTF- 
stimulated neurons. Although NF-kB signaling makes a small 
contribution to the neurite growth-promoting effects of the neu- 
rotrophins NGF and BDNF (Sole et al., 2004; Gutierrez et al.,
2005), the essential role of NF-kB signaling in CNTF-promoted 
growth is a striking, novel finding. Although CNTF is known to 
activate signaling pathways implicated in regulating neurite 
growth such as MEK/ERK and PI3-K/Akt (Alonzi et al., 2001), 
there have been no direct studies of the involvement of these or 
other signaling pathways in mediating the neurite growth pro­
moting effects of CNTF and related neurotrophic cytokines in 
primary neurons. Our results therefore provide an important 
insight into the intracellular signaling mechanisms that are cru­
cial for the neurite growth-promoting actions of cytokines like 
CNTF.
A striking finding of our study is that CNTF uses a distinctive 
noncanonical NF-kB activation mechanism involving tyrosine 
phosphorylation of IkBo to promote neurite growth. Previous 
work has shown that the contribution of NF-kB signaling to 
neurotrophin-promoted neurite growth occurs via the canonical 
pathway that involves serine phosphorylation of IkBo and pro­
teasome mediated degradation of iKBa (Sole et al., 2004; Gutier­
rez et al., 2005). Our demonstration that neither the 32/36-SS/AA 
I KB-a mutant nor proteasome inhibition affect CNTF-promoted 
neurite growth indicate that the canonical NF-kB activation 
mechanism plays no part in the neurite growth-promoting ac­
tions of CNTF. Rather, we show that CNTF promotes tyrosine 
phosphorylation of I KB-a and selectively blocking this with a 
Y42F IKB-a mutant completely inhibits CNTF-enhanced NF-kB 
transcriptional activity and blocks CNTF-promoted neurite 
growth. Because the Y42F IKB-a mutant does not affect BDNF- 
promoted neurite growth, our findings imply that different 
NF-kB activation mechanisms are exclusively required for the 
neurite growth-promoting effects of CNTF and neurotrophins.
Our work has implicated the SYK protein-tyrosine kinase in 
CNTF-promoted NF-kB activation and neurite growth. We have 
shown that CNTF promotes rapid sequential tyrosine phosphor­
ylation of SYK and IKB-a. Pharmacological blockade of SYK and 
expression of a dominant-negative SYK protein inhibit CNTF- 
promoted neurite growth. SYK is a widely expressed protein- 
tyrosine kinase (Yanagi et al., 2001) that has been extensively 
studied from the standpoint of its role in immunoreceptor sig­
naling in leukocytes (Berton et al., 2005). Although overexpres­
sion of SYK has been reported to promote the differentiation of 
embryonal carcinoma P19 cells into neuron-like cells (Tsujimura 
et al., 2 0 0 1 ), we provide the first clear evidence in primary neu­
rons that SYK plays a crucial role in regulating the growth of 
neural processes. In future work it will be interesting to ascertain
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the link between the CNTF receptor com­
plex and SYK and to establish whether 
other signaling pathways activated by 
CNTF cooperate with NF-kB in mediating 
the effects of this cytokine on neurite 
growth.
Investigation of the key role of NF-kB 
signaling in CNTF-promoted neurite 
growth has been facilitated in newborn 
nodose neurons because CNTF supports 
the survival of the majority of these neu­
rons in culture and NF-kB inhibition has 
no detectable effect on their survival. Pre­
vious work has established a neuroprotec - 
tive role for NF-kB for a variety of CNS 
neurons (Kaltschmidt et al., 2005) and 
NF-kB signaling has been shown to con­
tribute to the survival response of embry­
onic sympathetic and sensory to NGF 
(Maggirwar et al., 1998; Hamanoue et al.,
1999) and adult DRG neurons to tumor 
necrosis factor-a (Fernyhough et al.,
2005). Although it has been reported that 
NF-kB plays a role in mediating the sur­
vival response of cultured fetal nodose 
neurons to CNTF (Middleton et al., 2000), 
our more extensive investigation in which 
NF-kB activation has been blocked by va­
riety of complementary approaches con­
tradicts this general conclusion. Whereas 
inhibiting NF-kB signaling leaves the cell 
bodies of newborn nodose neurons with­
out processes, these cell bodies retained a 
normal appearance and were stained with 
the vital dye calcein-AM with no significant 
loss in number up to 48 h in vitro. Likewise, 
inhibiting NF-kB activation in fetal nodose 
neurons by the same diverse approaches vir­
tually eliminated neurite growth while leav­
ing cell bodies intact and viable (data not 
shown). Our findings therefore clearly dem­
onstrate that NF-kB signaling is crucial for 
the growth of neurites from developing no­
dose neurons stimulated with CNTF, but is 
not required for the survival response of 
these neurons to CNTF.
Studying primary neurons is a very 
powerful approach for elucidating growth 
factor physiology and signaling in the ap­
propriate cellular and developmental con­
text. Our studies of newborn nodose neu­
rons have demonstrated a striking, 
essential role for NF-kB signaling in 
CNTF-promoted neurite growth and re­
vealed that the NF-kB activation mecha­
nism mediating this response of neurons 
to CNTF is distinct from the NF-kB acti­
vation mechanism mediating the much 
smaller contribution of NF-kB signaling 
to neurotrophin-promoted neurite growth. Although the very 
limited availability of primary neurons presents considerable 
technical challenges for biochemical studies of signaling net­
works, future progress on unraveling how cytokines and neuro-
trophins influence NF-kB signaling in distinctive ways and how this 
in turn has such marked effects on neurite growth will be important 
in understanding the emerging role of NF-kB signaling in regulating 
neuronal morphology in development.
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Cell culture studies have implicated the oxygen-sensitive hypoxia-inducible factor (HIF) prolyl hydroxylase 
PHD3 in the regulation of neuronal apoptosis. To better understand this function in vivo, we have created 
PHD3~'~ mice and analyzed the neuronal phenotype. Reduced apoptosis in superior cervical ganglion (SCG) 
neurons cultured from PHD3~'~ mice is associated with an increase in the number of cells in the SCG, as well 
as in the adrenal medulla and carotid body. Genetic analysis by intercrossing PHD3~'~ mice with H IF-la+/~ 
and HIF-2a+/~ mice demonstrated an interaction with HIF-2a but not HIF-la, supporting the nonredundant 
involvement of a PHD3-HIF-2a pathway in the regulation of sympathoadrenal development. Despite the 
increased number of cells, the sympathoadrenal system appeared hypofunctional in PHD3~'~ mice, with 
reduced target tissue innervation, adrenal medullary secretory capacity, sympathoadrenal responses, and 
systemic blood pressure. These observations suggest that the role of PHD3 in sympathoadrenal development 
extends beyond simple control of cell survival and organ mass, with functional PHD3 being required for proper 
anatomical and physiological integrity of the system. Perturbation of this interface between developmental and 
adaptive signaling by hypoxic, metabolic, or other stresses could have important effects on key sympathoad­
renal functions, such as blood pressure regulation.
In response to low oxygen tensions, organisms mount a wide- 
ranging adaptive response involving many cellular and systemic 
processes. Activation of hypoxia-inducible factor (HIF) plays a 
central role in this process, inducing transcriptional targets that 
enhance oxygen delivery, better adapt cells to hypoxia, or mod­
ulate cell proliferation or survival pathways (reviewed in ref­
erences 16 and 37). Hypoxia may, under different circum­
stances, either promote or protect cells from apoptosis, and 
HIF itself contributes to these processes both indirectly, 
through the defense of cellular energy supplies, and directly, 
via transcriptional changes in proapoptotic or prosurvival 
genes. However, to generate the anatomical and physiological 
integrity required for oxygen homeostasis in the intact organ­
ism, these adaptive responses to hypoxia must also be accu­
rately interfaced with the developmental control of growth.
Though the nature of these adaptive-developmental connec-
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tions remains poorly understood, it is of interest that the cel­
lular oxygen sensor PHD3 (otherwise termed EGLN3 or 
HPH1), one of three Fe(II)-dependent dioxygenases now 
known to negatively regulate HIF by prolyl hydroxylation of 
HIF-a subunits (HIF-la and HIF-2a) (6 , 13), had been pre­
viously identified as a gene involved in developmental apopto­
sis of neurons (23-25, 40). Over 50% of neurons produced 
during development die through apoptosis before adulthood 
(reviewed in references 10 and 31). This process is largely 
regulated by neurotrophic factors that are secreted in limited 
amounts by target tissues such that only those neurons making 
appropriate connections survive. During the investigation of 
these phenomena, PHD3 mRNA was identified as a neuronal 
transcript that is induced by withdrawal of the neurotrophin 
nerve growth factor (NGF) (24). Further studies have demon­
strated that overexpression of PHD3 in primary sympathetic 
neurons cultured from the developing superior cervical gan­
glion and in the adrenal medullary tumor cell line PC12 results 
in apoptosis even in the presence of saturating quantities of 
NGF (23, 24). This effect was not reproduced by a catalytically 
inactive PHD3 mutant (23), whereas hypoxia was able to sup­
press apoptosis in sympathetic neurons (44). Furthermore, 
knock-down of PHD3 by small interfering RNA in PC12 cells 
prevented apoptosis even in the absence of NGF (23). Taken
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together, these observations in cultured cells indicate that the 
oxygen-sensitive catalytic activity of PHD3 has a role in the 
regulation of neuronal apoptosis, raising important questions 
about the extent of PHD3-dependent neuronal apoptosis in 
vivo and its role in the intact animal.
To address this, we have inactivated PHD3 (by homologous 
recombination in the mouse) and have analyzed the develop­
mental and physiological effects on neuronal apoptosis. We 
show that PHD3-dependent modulation of NGF-dependent 
survival is a lineage-specific property affecting the sympathetic 
nervous system and that sympathetic neurons from PH D3~f~, 
but not PHD2+/~ or P H D 1 ~ , mice manifest increased NGF- 
promoted neurite growth as well as enhanced survival. In­
creased numbers of sympathetic neurons survive to adulthood, 
and PHD3~'~ mice have increased numbers of neurons in the 
superior cervical ganglia (SCG) and increased numbers of 
chromaffin and glomus cells in the adrenal medulla and carotid 
body. However, despite this increase in cell number, the sym­
pathoadrenal system was dysfunctional in PHD3~'~ mice, with 
reduced innervation of target organs and dysregulated re­
sponses, including reduced catecholamine secretion and re­
duced systemic blood pressure. The findings demonstrate a key 
role for PHD3 in regulating the anatomical and physiological 
integrity of the sympathoadrenal system.
MATERIALS AND METHODS
Targeting vector and PHD3 inactivation. For construction of the PHD3 tar­
geting vector, the following fragments were cloned in a pPNTLox2 vector (from 
5' to 3’): a 3.4-kb BamHl fragment located 3.1 kb upstream of exon 1 (5' flank) 
and a neomycin resistance cassette in the opposite orientation, a 3.9-kb EcoRl 
fragment located 1.4 kb downstream of exon 1 (3' flank), and a thymidine kinase 
selection cassette (Fig. 1A). Embryonic stem (ES) cells (129 SvEv background) 
were electroporated with the linearized targeting vector for PHD3 as described 
elsewhere (39). Resistant clones were screened for homologous recombination 
by Southern blotting (Fig. IB) and PCR (not shown). Correctly recombined ES 
cells were then aggregated with morula-stage embryos. To obtain PHD3~'~ germ 
line offspring in a 50% Swiss/50% 129 SvEv background, chimeric male mice 
were intercrossed with wild-type Swiss female mice. PHD3 mRNA transcripts 
were quantified by RNase protection assay in embryos (Fig. 1C), using a ribo- 
probe protecting bp 217 to 383, 5' to 3', of PHD3 mRNA, and real-time reverse 
transcription-PCR (RT-PCR) in mouse embryonic fibroblasts (Fig. ID), using 
the following forward and reverse primers: 5'-TCCCACTCTTCCACCTTC-3' 
and 5'-CTGTAGCCGTATTCATTGTC-3' for glyceraldehyde-3-phosphate de­
hydrogenase (GAPDH); 5 '-CTATGGGAAGAGCAAAGC-3' and 5 -AGAGC 
AGATGATGTGGAA-3’ for PHD3, which amplify bp 1779 to 2008, a sequence 
distal to the deleted region, in response to normoxia or hypoxia (1% oxygen for 
16 h). PHD3 protein levels were also measured by Western blotting in mouse 
embryonic fibroblasts with a monoclonal mouse anti-PIID3 antibody, P3-188e 
(1), to confirm their absence in P H D 3 tissues.
Animals. Wild-type, PHD3'~, PHDr'~, PHD2+'~, PHD3\ HIF-la'  , 
and PHD3~'~; HIF-2a’ and HIF-2a mice on a mixed Swiss/129SvEv ge­
netic background were used in the experiments. Mice from the same litter were 
used for all comparisons, except for HIF-2a+/~ versus PHD3~'~\ HIF-2a+/~ 
(see Fig. 5D, below) where appropriate crosses were unlikely, by Mendelian 
inheritance, to produce the required genotypes within littcrmatcs. For adult 
mice, males of between 3 and 6 months of age were used.
Neuronal culture. SCG, dorsal root ganglia (DRG), and trigeminal ganglia 
(TG) were dissected from postnatal day 0 (P0) mouse pups, trypsinized in 0.05% 
trypsin in Hanks’ balanced salt solution (Gibco) for 20 min at 37°C, and disso­
ciated by trituration. Dissociated cultures of SCG, DRG, and TG neurons were 
then plated at low density (150 to 300 cells/dish) on a poly-omithine/laminin 
substrate in 35-mm tissue culture dishes in defined, serum-free medium, as 
described previously (11). A range of concentrations (0 to 250 ng/ml) of NGF or 
neurotrophin 3 (NT-3; both were from R&D Systems, Minneapolis, MN) was 
added to support the survival of cultured neurons.
Neuronal survival was measured by counting the number of neurons in a 12- 
by 12-mm grid in the center of the dish both 3 and 24 h after plating (as described
in reference 11). The number of neurons surviving after 24 h was expressed as a 
percentage of the initial number of neurons.
Total viable neuronal counts were measured by counting the number of phase- 
bright neurons using a Neubauer hemocytometer immediately following disso­
ciation of neurons.
Neuritic morphology was measured by culturing neonatal SCG neurons for 
24 h with 10, 0.4, or 0.08 ng/ml NGF, as described above. Caspase inhibitors (100 
p.M; Calbiochem) were added to cultures containing limiting levels of NGF (0.4 
and 0.08 ng/ml) in order to avoid biased sampling of differentially surviving 
neurons. Neurons were then fluorescently labeled with the vital dye calcein-AM 
(Invitrogen), and images were acquired using an Axioplan Zeiss laser scanning 
confocal microscope. Neuritic arbors were traced using LSM510 software in 
order to calculate the total neurite length and the extent of arborization by Sholl 
analysis. For the latter, concentric, digitally generated rings, 30 p.m apart, were 
centered on the cell soma, and the number of neurites intersecting each ring was 
counted (38).
Quantitative RT-PCR. Dissociated SCG, DRG, and TG neurons from wild- 
type P0 mouse pups were cultured overnight in 10 ng/ml NGF as described 
above. Neurons were then washed with defined culture medium and grown in 
either the presence or absence of NGF for 10 h (the time point at which PHD3 
mRNA induction is maximal in the SCG [24]) before harvesting the cells for 
RNA. Total RNA was isolated with the RNeasy Mini extraction kit (Qiagen, 
Hilden, Germany) and then reverse transcribed for 1 h at 37°C with StrataScript 
reverse transcriptase (Stratagene). Reverse transcription reactions were ampli­
fied using the Brilliant QPCR core reagent kit (Stratagene) according to the 
manufacturer’s protocol. The PCR was performed with the Mx3000P apparatus 
(Stratagene) for 45 cycles of 95°C for 30 s, 52°C (for PHD3) or 51°C (for 
GAPDH) for 1 min, and 72°C for 30 s. A melting curve was obtained to confirm 
that the Sybr green (Molecular Probes) signal corresponded to a unique and 
specific amplicon. Standard curves were generated for every real-time PCR run 
by using serial fourfold dilutions of a reverse-transcribed RNA extract from adult 
heart. Primers for PHD3 and GAPDH were as described above.
Histological and stereological analyses. To estimate the total tyrosine hydrox­
ylase (TH)-positive cell number, the SCG, adrenal medulla, and carotid body 
from adult mice were fixed in formalin overnight and then transferred into 
phosphate-buffered saline (PBS) containing 30% sucrose. Twenty-p-m sections 
were blocked for 1 h at room temperature with 10% fetal calf serum and 1 mg/ml 
bovine serum albumin containing 0.1% Triton X-100 in PBS and then incubated 
for 16 h at 4°C with a rabbit anti-TH polyclonal antibody (Pel-Freez; diluted 
1:1,000 in blocking solution). The sections were washed four times in PBS-Triton 
before being incubated with goat anti-rabbit secondary antibody (Envision+; 
Dako). Stereological estimation of the number of TH-positive cells was per­
formed on sections spaced 80 p.m (SCG and adrenal medulla) or 40 p.m (carotid 
body) throughout the organ. The number of cells was estimated by systematic 
random sampling using a 106,954-pjn3 optical dissector (43), excluding cells in 
the superficial planes of sections. The volume of each organ was estimated 
according to Cavalieri’s principle (8). The adrenal medulla cell volume was 
calculated using a rotator vertical probe. Seven randomly selected TH-positive 
cells were measured in different sections per individual adrenal gland. Stereo­
logical measurements were performed using the CAST grid system (Olympus) 
with a coefficient of error of <0.09.
To detect apoptosis in the SCG from P0 mice, tissues were fixed in formalin 
overnight and then transferred to 70% ethanol and paraffin embedded. The 
terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling 
(TUNEL) method was performed on 7-p.m sections of the SCG using the 
ApopTag peroxidase in situ apoptosis detection kit (Chemicon International) 
according to the manufacturer’s directions.
To assess the density of sympathetic innervation, the eyes and submandibular 
and pineal glands from adult mice (or P5 mice for the pineal glands) were fixed 
and cryoprotected as above. Fifteen-pm serial sections were blocked for 1 h at 
room temperature with 10% normal goat serum containing 0.1% Triton X-100 in 
10 mM PBS and then incubated for 18 h at 4°C with a rabbit anti-TH polyclonal 
antibody (diluted 1:200 in PBS with 1% normal goat serum; Chemicon). The 
sections were washed three times in PBS before being incubated with goat 
anti-rabbit secondary antibody (Alexa-Fluor, diluted 1:500 in PBS with 1 % nor­
mal goat serum; Invitrogen). The outlines of the iris and submandibular and 
pineal glands were traced using Adobe Photoshop 7. The total and TH-positive 
areas were measured using automated pixel counts, and the ratio of TH-positive 
area to total area was used to calculated the TH-positive density.
Pupillometry. Adult wild-type and PHD3~'~ mice were dark adapted for 1 h. 
Subsequently, animals were removed from their home cage, immobilized by 
scruffing, and pupil reactions were monitored (at 0 lx followed by 150 lx of bright 
white light) using a commercial charge-coupled-device camcorder (DCR-
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FIG. 1. PHD3 targeting strategy. (A) Targeting strategy for PHD3 inactivation. Top: wild-type PHD3 allele diagram, indicating the position of exon 1 (dark 
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HC17E; Sony, Tokyo, Japan) attached to a dissecting microscope (Olympus, 
Tokyo, Japan) under infrared light-emitting diode illumination ( \ max of 850 nm). 
Pupil areas were estimated by manually fitting an ellipse to digitalized video still 
images using Windows Movie Maker (Microsoft, Redmond, WA) and Adobe 
Photoshop (San Jose, CA) software.
In vivo hemodynamics. Adult mice were anesthetized with 2% isoflurane in 
100% oxygen via a nose cone. Mice were placed supine with body temperature 
regulated at 37°C and allowed to breathe spontaneously. The right carotid artery 
was cannulated with a 1.4 French microtipped cannula (SPR-839; Millar Instru­
ments, Houston, TX) advanced retrograde into the left ventricular (LV) cavity 
under ultrasound guidance. The right jugular vein was cannulated with polyeth­
ylene tubing for intravenous drug administration. Isoflurane was reduced to
1.5%, followed by a period of equilibration until hemodynamic indices were 
stable for >15 min. Pressure measurements were recorded using a Powerlab 4SP 
data recorder (ADInstruments, Chalgrove, United Kingdom) at baseline in both 
the LV and aorta and in the LV during infusion of p,-adrenoreceptor stimulation 
with dobutamine hydrochloride (16 ng/g of body wt/min).
A subset of these mice were used to test baroreceptor reflex function by 
intravenous bolus administration of the oq-adrenoreceptor agonist phenyleph­
rine hydrochloride (at 50 |i.g/kg) to induce brief periods of elevated blood 
pressure (30). Baroreceptor reflex gain was calculated as the maximal change in 
heart rate over the maximal change in blood pressure. Drug solutions for bolus 
injection were made up in 0.9%> saline and a volume of 5 jjlL Mice were killed by 
cervical dislocation or removal of the heart, and the cardiac chambers blotted 
and weighed.
Radiotelemetry. PAC10 radiotelemeters (Data Sciences International, MN) 
were implanted in the left carotid artery of adult mice under isoflurane 
anesthesia as previously described (7, 29). Mice were allowed to recover for 
10 days following the operation, and then continuous measurements of blood 
pressure and activity state were recorded, at 500 Hz, for three consecutive 
days using standard acquisition software (Data Sciences International, MN). 
Blood pressure was analyzed on a beat-per-beat basis according to the activity 
state of the mouse at the time of recording (Spike 2, version 6.1; Cambridge 
Electronic Design, Cambridge, United Kingdom). Two activity states were 
defined: rest, no movement of the animal as detected by the telemeter within 
30 s of measurement; activity, movement of the mouse within its cage at the 
time of recording.
Amperometric recording of single-cell catecholamine secretion in isolated 
slices. Adult mouse suprarenal gland dissection, slicing, and culture, as well as 
the measurement of catecholamine secretion, were performed following previ­
ously described procedures (14). Slices were transferred to a recording chamber 
and continuously perfused with a solution containing 117 mM NaCl, 4.5 mM 
KC1. 23 mM NaHCO,, 1 mM MgCl2. 2.5 mM CaCl2, 5 mM glucose, and 5 mM 
sucrose. When 40 mM or 20 mM potassium solutions were used, equimolar 
quantities of sodium were used to replace potassium. The solution was bubbled 
with a gas mixture of 5% C 02 to adjust the pH to 7.2. All the experiments were 
performed in a chamber at 36°C. Secretion rate (femtocoulombs/min) was cal­
culated as the amount of charge transferred to the recording electrode during a 
given time period (32).
Plasma catecholamines. Blood from adult mice (anesthetized with Nembutal; 
600 jcg/kg of body weight) was collected into heparinized tubes on ice that were 
then centrifuged at 6,000 x g for 5 min at 4°C to separate plasma. Plasma 
catecholamine levels were quantified by immunoassay according to the manu­
facturer’s instructions (IBL-Hamburg).
Statistical analyses. Data arc expressed as means ± standard errors of the 
means (SEM), with the number of experiments indicated. Statistical analyses 
were performed using Student’s t test. P values of <0.05 were considered statis­
tically significant.
RESULTS
Generation of PHD3-deficient mice. Mice deficient in PHD3 
were generated by standard homologous recombination pro­
cedures in ES cells. The PHD3 targeting strategy involved 
removing a genomic region encompassing the promoter and 
first exon, including the translational initiation site (Fig. 1A 
and B), and cells from PHD3~'~  homozygous animals ex­
pressed no PHD3 transcript (Fig. 1C and D, left panel) or 
protein (Fig. ID, right panel). A small reduction in the ex­
pected number of PHD3~!~ live births was noted among the
offspring of heterozygous matings (PHD3+/+, 77 [29%], 
PHD3+/~, 145 [54%], PHD3~'~, 47 [17%]), but otherwise 
PHD3~ ~ mice appeared healthy and reached adult life with­
out obvious abnormality.
Enhanced survival of sympathetic neurons from PHD3-/_  
mice in vitro. Because experimental manipulation of PHD3 
expression in cultured sympathetic neurons and PC12 cells has 
been reported to affect cell survival (23-25, 40), we directly 
compared the survival of sympathetic neurons obtained from 
the SCG of wild-type and P//D5-7- mice. Heterozygous mice 
were mated to obtain offspring of all three genotypes, and 
dissociated low-density cultures of SCG neurons were estab­
lished from newborn littermates. To minimize variability aris­
ing from technical considerations, in this and all subsequent 
experiments, comparisons of ganglia explanted from mice of 
different genotypes were performed in a pair-wise fashion at 
the same experimental session. The neurons were cultured 
with a range of NGF concentrations, and neuronal survival was 
estimated 24 h after plating. At nonsaturating concentrations 
of NGF, the survival of neurons from PHD3~'~ mice was 
consistently enhanced compared to that of neurons from wild- 
type mice (Fig. 2A, left panel). Interestingly, loss of PHD3 did 
not confer a survival advantage at very low NGF concentra­
tions, suggesting that, although PHD3 reduces the capacity of 
neurons to survive in the presence of NGF, it is not required 
for the death of NGF-deprived neurons.
To test whether other prolyl hydroxylases that regulate HIF 
also affect the NGF survival response, similar cultures of SCG 
neurons were established from PHD1~'~ and PHD2+/~ mice 
(2 ) and compared with those from their littermate controls 
(PHD2~f~ mice could not be used because they die in utero 
between embryonic day 12.5 [E12.5] and E14.5 [2, 41]). In 
contrast with neurons from PHD3~ ~ mice, no differences in 
NGF dose responses were observed (Fig. 2A, middle and right 
panels).
NGF promotes neuronal survival by binding to and activat­
ing the receptor tyrosine kinase TrkA (10). Because NT-3 is 
also capable of promoting the survival of neonatal SCG neu­
rons in culture by a TrkA-dependent mechanism (12), we in­
vestigated whether inactivation of PHD3 affects the survival 
response of SCG neurons to this neurotrophin. As with NGF, 
SCG neurons from PHD3~'~ mice survived more effectively 
with NT-3 than neurons from wild-type littermates (Fig. 2B).
In addition to sympathetic neurons, large numbers of 
sensory neurons in the developing peripheral nervous sys­
tem are also dependent on NGF for survival. To ascertain 
whether the absence of PHD3 also affects the NGF survival 
response of these neurons, we established low-density dis­
sociated cultures from two populations of sensory neurons 
that are mostly comprised of NGF-dependent neurons: 
those of the DRG and TG. In contrast to SCG neurons, the 
NGF dose responses of DRG and TG neurons from wild- 
type and PHD3 '~ mice were completely overlapping (Fig. 
2C). Since NGF withdrawal has been reported to induce 
PHD3 mRNA expression in sympathetic neurons (24), we 
considered whether this property might underlie the speci­
ficity of PHD3-dependent survival effects. To investigate 
this, we cultured SCG, DRG, and TG neurons with NGF 
and deprived them of this neurotrophin by extensive wash­
ing 12 h after plating. Measurement of PHD3 mRNA by
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RT-PCR 10 h after deprivation revealed a greater-than- 
twofold increase in PHD3 mRNA relative to GAPDH 
mRNA in sympathetic neurons but no significant change in 
sensory neurons (Fig. 2D). Thus, both PHD3-dependent 
neuronal survival and responsiveness of PHD3 mRNA to 
NGF withdrawal appear to be specific to sympathetic neu­
rons rather than a general property of NGF-sensitive neu­
rons.
HIF-2-dependent survival in sympathetic neurons from 
PHD3~J~ mice in vitro. Because of the known function of PHD3 
as a HIF hydroxylase regulating the abundance of HIF-la and 
HIF-2a, we investigated whether the influence of PHD3 on the 
NGF dose response of SCG neurons depends on either 
HIF-la or HIF-2a. Since homozygous inactivation of HIF-la 
or HIF-2a results in embryonic lethality (20, 33, 34, 42), we 
analyzed the effects of heterozygous inactivation by generating 
appropriate crosses with PHD3~'~ animals to allow for litter- 
mate comparisons. Although we observed some variation in 
the overall survival of explanted neurons from PHD3~ ~ mice 
at different experimental sessions, clear differences were ob­
served in pair-wise comparisons o tP H D 3~ /~ animals with and 
without heterozygous inactivation of different HIF-a isoforms. 
Heterozygous HIF-la inactivation did not significantly affect 
the NGF dose response of cultured PHD3-deficient SCG neu­
rons {PHD3~ ~ versus PH D3~/~; H lF -la +'~ littermate neo­
nates) (Fig. 3A). In contrast, inactivating one allele of HIF-2a 
caused a significant shift in the NGF dose response of PHD3- 
deficient SCG neurons to higher NGF concentrations 
(.PHD3~I~ versus PHD3~'~\ H IF-2a+/~ littermate neonates) 
(Fig. 3B), suggesting that appropriate expression of HIF-2a, 
but not HIF-la, is required for the influence of PHD3 on the 
NGF survival dose response in culture.
Enhanced NGF-promoted neurite growth of sympathetic 
neurons from PHD3~'~ mice in vitro. In addition to support­
ing the survival of developing sympathetic neurons, NGF also 
promotes the growth of neurites from these neurons in culture 
(15). For this reason, we investigated neurite arbor size and 
complexity in sympathetic neurons from PHD3~'~  mice. Low- 
density cultures of SCG neurons from P0 PHD3~'~ and wild-
type mice were grown with different concentrations of NGF, 
and neurite arbor size and complexity were quantified 24 h 
after plating. At subsaturating concentrations of NGF (Fig. 4B 
and C), but not at saturating levels (Fig. 4A), the neurite 
arbors of PHD3-deficient neurons were significantly longer 
than those of wild-type neurons. Sholl analysis, which provides 
a graphic representation of neurite branching with distance 
from the cell body, revealed that the neurite arbors of PHD3- 
deficient neurons were larger and more branched than those of 
wild-type mice in the presence of subsaturating levels of NGF 
(Fig. 4B and C). The typical appearance of the neurite arbors 
of PHD3-deficient and wild-type SCG neurons grown with 
subsaturating NGF are illustrated in Fig. 4D. Because the 
neurites in short-term SCG cultures, such as those used in our 
study, are exclusively axons rather than dendrites, we conclude 
that PHD3 also modulates axonal growth and branching in 
culture.
PHD3-deficient mice have increased numbers of SCG neu­
rons. To ascertain the developmental and physiological rel­
evance of our in vitro observations, we compared the num­
ber of neurons in the SCG of wild-type and PH D 3~f^ mice. 
The neuronal complement of the SCG of newborn animals 
was estimated by counting the number of neurons in trypsin- 
dissociated cell suspensions obtained from carefully dis­
sected ganglia. In order to minimize variability assignable to 
genetic background, absolute age of neurons, and dissocia­
tion technique, these comparisons were made between gan­
glia explanted at the same experimental session from mice 
within the same litter. Neurons were recognized and distin­
guished from nonneuronal cells by their characteristic large, 
phase-bright, spherical cell bodies under phase-contrast op­
tics. SCG dissected from newborn mice appeared
larger than those of wild-type littermates (Fig. 5A) and 
contained significantly more neurons (Fig. 5B). Likewise, 
stereological measurements carried out on serially sectioned 
SCG in 3- to 6 -month-old mice revealed that the SCG was 
larger and contained significantly more neurons in PHD3~'~ 
mice compared with age-matched wild-type animals (Fig. 
5C). As expected, the number of neurons in the SCG of
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FIG. 4. Neurite length and arborization of sympathetic neurons 
cultured from PHD3~‘~ mice. Increased neurite length and arboriza­
tion in PO PHD3~~  mice at 0.4 (B) and 0.08 ng/ml NGF (C), but not 
at 10 ng/ml NGF (A). Neurite length is presented as the mean ± SEM 
on 40 to 70 neurons per genotype (similar results were obtained in 
three independent experiments). (D ) Representative images of neu­
rons cultured in 0.4 ng/ml NGF and fluorescently labeled with the vital 
dye calcein-AM. Bar, 50 p.m.
wild-type adults was lower than that in newborns as a result 
of ongoing programmed cell death in the immediate post­
natal period. However, the number of neurons in the SCG 
of PHD3~'~ mice remained substantially unchanged be­
tween birth and adulthood, suggesting that programmed cell 
death during at least the postnatal period was largely cur­
tailed in these mice. In keeping with this, we observed a 
modest reduction in the number of apoptotic or TUNEL- 
positive cells in the SCG from PO PHD3~'~ mice (—30% 
decrease, n =  7, P <  0.05, from 6.7 x 10- 5  to 4.9 X 10- 5  
TUNEL-positive cells/pm2 SCG area).
In contrast to the effect of PHD3 deletion on SCG neuron 
number, there were no significant differences between the 
numbers of neurons in the SCG of either PHDl~'~ or 
PHD2+/~ neonates compared with wild-type littermates (data 
not shown).
To investigate the in vivo significance of HIF-a gene dosage 
on the survival of cultured neurons from PHD3~'~ mice, we 
compared the number of neurons in the SCG of PHD3~'~ 
versus PHD3~'~\ H IF -la+/~ littermate neonates and 
PHD3~ ~ versus PHD3~'~; HIF-2a*/_ littermate neonates. 
Consistent with the studies of survival in culture, these studies 
revealed that heterozygous inactivation of HIF-2a, but not 
HIF-la, reduced the SCG neuronal population in PHD3~'~ 
animals (Fig. 5D). Interestingly, this effect was not observed in 
the PHD3-positive background (comparison of wild-type ver­
sus HIF-2a+/~ mice) (Fig. 5D). Further experiments designed 
to test the effect of PHD3 inactivation in the context of HIF-2a 
heterozygosity (comparison of PHD3~'~\ HIF-2a+/~ versus 
HIF-2a+/~ mice) revealed no significant differences in SCG 
cell numbers (Fig. 5D), suggesting that PHD3-dependent ef­
fects on cell number were affected by integrity of the HIF-2a 
pathway and vice versa. Taken together with our in vitro sur­
vival data, these in vivo observations suggest that the selective 
increase in SCG neurons in PHD3~'~ mice results from re­
duced cell loss during the phase of programmed cell death in 
the perinatal period as a consequence of the enhanced sensi­
tivity of PHD3-deficient neurons to NGF and that this effect is 
at least partially dependent on HIF-2a.
PHD3-deficient mice have increased numbers of cells in the 
adrenal medulla and carotid body. NGF-dependent cells of 
the sympathoadrenal axis extend to the neural crest-derived 
chromaffin and glomus cells of the adrenal medulla and carotid 
body. Our findings that PHD3~ ~ mice have significantly more 
sympathetic neurons than wild-type mice prompted us to ex­
amine cell number elsewhere in the sympathoadrenal system. 
Stereological analysis of adult mice (3 to 6  months old) re­
vealed significantly more TH-positive cells in both the adrenal 
medulla and the carotid body (Fig. 6 ). Interestingly, though 
total numbers of cells were increased in both organs in 
PHD3~'~ mice, overall organ volume was increased for the 
carotid body, but decreased for the adrenal medulla, in 
PFID3~ ~ mice (Fig. 6 ). The latter phenomenon may be ex­
plained by a reduction in chromaffin cell volume (from 1,743 
|xm3 in wild-type to 1,195 |xm3 in PHD3~'~ mice; P  <  0.05; n = 
7), consistent with the significant increase in TH-positive cell 
density in the adrenal medulla (Fig. 6A).
Sympathetic innervation of target tissues. Given that inac­
tivation of PHD3 in vivo results in increased numbers of SCG 
neurons surviving to adulthood and that NGF is more effective 
in promoting neurite growth from cultured PHD3-deficient 
SCG neurons, we asked whether sympathetic innervation den­
sity is increased in PHD3~'~ mice. The SCG innervates several 
anatomically discrete structures, including the iris, submandib-
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ular gland, and pineal gland, whose innervation density can be 
relatively easily estimated by quantifying the area occupied by 
TH-positive nerve fibers in tissue sections. Surprisingly, this 
analysis revealed significantly fewer TH-positive fibers in the 
iris, submandibular gland, and pineal gland of PHD3~‘~ mice 
compared with wild-type animals (Fig. 7A, B, and C).
Physiological effects on the sympathetic nervous system. We 
next sought to assess the integrity of physiological responses 
that are dependent on the sympathetic nervous system. Be­
cause of the reduced sympathetic innervation of the iris in 
PHD3~ ~ mice (Fig. 7A), we tested light-to-dark pupillary 
responses. While no differences in pupil diameter were seen 
under normal lighting conditions (150 lx) (Fig. 7D), pupil di­
ameter was significantly decreased in the dark-adapted eye 
from PHD3~'~ mice (0 be) (Fig. 7D). This implies decreased 
tone in the sympathetically innervated dilator pupillae muscle 
fibers of PHD3~ ~ mice.
Since one of the most important roles of sympathoadrenal
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function is in the control of blood pressure, we went on to 
perform a series of measurements of systemic blood pressure 
regulation. First, a series of resting measurements were per­
formed under anesthesia. These revealed a modest but signif­
icant reduction in blood pressure in / ’T/Di-7- mice versus 
wild-type littermates (Table 1) but no significant differences in 
heart rate (Table 1). Consistent with reduced arterial pressure, 
we found that left ventricular weights were significantly re­
duced in PHD3~ ~ mice versus wild-type mice (Table 1).
To pursue the differences in blood pressure further, measure­
ments of aortic blood pressure were repeated in conscious mice 
using radiotelemetry. These confirmed that, at rest, PHD3~/~ 
mice were hypotensive compared to wild-type mice, with reduced 
systolic blood pressures (Fig. 8). Furthermore, the difference in 
systolic blood pressure was enhanced when the mice became 
active, with as much as 20 mm Hg difference in systolic pressure 
between PHD3~ ~ mice and littermate controls (Fig. 8).
If reduced blood pressure were due to sympathoadrenal dys­
function rather than a primary cardiac or vascular defect, we 
argued that responses to exogenous adrenoreceptor agonists 
should be preserved or even exaggerated. Under anesthesia, we 
measured responses to infusions of the a,-agonist phenylephrine 
and the (3,-agonist dobutamine. Results are shown in Table 1. In 
response to the exogenous a,-adrenoreceptor agonist phenyleph­
rine, the maximal rise in blood pressure was exaggerated in 
PHD3~ ~ mice versus wild-type littermates. Interestingly, reflex 
bradycardia was blunted in PHD3~ ~ animals, suggesting that
baroreceptor reflex sensitivity, a measure of endogenous auto­
nomic function, was reduced. In response to the exogenous 
adrenoreceptor agonist dobutamine, PHD3~ ~ mice also showed 
an exaggerated increase in heart rate and contractility, consistent 
with reduced intrinsic sympathetic function rather than a primary 
cardiac or vascular cause of hypotension.
Finally, we tested adrenal medullary function both by measur­
ing individual chromaffin cell catecholamine secretion rates by 
amperometry in explanted adrenal slices and by measuring total 
circulating catecholamine levels in intact animals. Amperometri- 
cally measured basal secretion of catecholamines was reduced by 
approximately 50% in chromaffin cells from PHD3~'~ mice (Fig. 
9A). Secretion in response to potassium-induced depolarization 
was similarly reduced (20 mM potassium) or reduced to a smaller 
extent (40 mM potassium) in PHD3~'~ mice (Fig. 9A), consistent 
with reduced secretory capacity. Plasma catecholamine levels 
were also lower in PHD3~'~ mice (Fig. 9B), suggesting that the 
observed increase in chromaffin cell number was not sufficient to 
compensate for the decrease in chromaffin cell functionality un­
der physiological conditions.
DISCUSSION
Our findings show that the HIF prolyl hydroxylase PHD3 
has an important role in regulating the development of the 
sympathoadrenal system and that its ablation has substantial 
physiological consequences that extend into adult life.
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FIG. 7. Sympathetic innervation o f SCG target tissues from PHD3~‘~ mice: immunohistochemistry demonstrating TH-positive neurons in SCG 
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We observed significantly more neurons in the SCG of new­
born PHD3~‘~ mice compared with wild-type littermates, and 
this elevated number of SCG neurons was maintained to adult­
hood. The apparent failure of the neuronal complement of the 
SCG to decrease in PHD3~'~ mice postnatally, when naturally
occurring programmed cell death ordinarily matches the num­
ber of sympathetic neurons to the requirements of their tar­
gets, suggests that the elevated number of neurons in the SCG 
of PHD3-deficient mice is due to reduced cell death, in keep­
ing with the observed shift in the NGF survival dose response
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TABLE 1. Cardiovascular function in anesthetized mice"
Parameter (no. of animals in exptl groups)
Result for group
P value
Wild type PHD3~'-
Postmortem ventricular wt (10 WT, 7 PH D 3~ /_)
LV/body wt (mg/g) 3.19 ±  0.10 2.72 ±  0.06 0.001
RV/body wt (mg/g) 0.98 ±  0.04 0.99 ±  0.03 0.85
Arterial pressure (10 WT, 8 PH D 3~/_ )
Systolic (mmHg) 105 ±  3 94 ±  5 0.009
Diastolic (mmHg) 75 ±  2 69 ±  2 0.06
MAP (mm Hg) 89 ±  2 79 ± 1 0.005
LV hemodynamics: baseline (10 WT, 7 PHD3
dP/dtmiX (mm Hg/s) 7,858 ±  474 7,363 ±  623 0.53
Heart rate (bpm) 437 ±  11 446 ±  17 0.66
LV hemodynamics: dobutamine (9 WT, 7 PHD 3~’~)
dP/dtmax (%  o f baseline) 126 ±  4 152 ±  13 0.04
Heart rate (% o f baseline) 117 ±  2 129 ±  3 0.006
LV hemodynamics: phenylephrine (5 WT, 4 PH D 3~'~ )
MAP (% of baseline) 135 ±  5 159 ±  22 0.07
Heart rate (% of baseline) -3 1  ±  5 -2 1  ±  15 0.28
Baroreceptor gain (bpm/mm Hg) - 6 .6  ±  1.3 -2 .5  ±  0.9 0.04
“ All values are means ± SEM. WT. wild type: MAP, mean arterial pressure; bpm, beats per minute.
of PHD3-deficient SCG neurons in culture to lower NGF con­
centrations. Interestingly, the effect of PHD3 inactivation on 
NGF responsiveness in the peripheral nervous system appears 
to be restricted to neurons of the sympathetic lineage, as neu­
ral crest-derived, NGF-dependent sensory neurons from 
PHD3~'~ mice responded normally to NGF. It is unclear 
whether dysregulated apoptosis might occur in regions within 
the central nervous system in P H D 3~ ~  mice. However, these 
mice are viable as adults, without obvious neurological abnor­
malities. In addition, brains from PHD3~'~ mice were not 
obviously abnormal and were not significantly different in 
weight (0.43 ± 0.01 g versus 0.43 ± 0.00 g in PHD3~‘~ and 
wild-type males; 0.42 ± 0.01 g versus 0.44 ± 0.01 g in PHD3~'~ 
and wild-type females). Nevertheless, these observations do 
not preclude dysregulation of apoptosis that is compensated 
for or might be revealed in pathological situations.
As well as enhancing the sensitivity of SCG neurons to the 
survival-promoting effects of NGF, deletion of PHD3 also 
makes these neurons more responsive to the neurite growth- 
promoting effects of NGF in culture. Because target-derived 
NGF is not only required for sympathetic neuron survival 
during development in vivo but is also responsible for the 
terminal growth and branching of sympathetic axons in their 
targets, we expected to find increased sympathetic innervation 
density in P H D 3 ~ mice. Surprisingly, we observed the oppo­
site in several SCG target tissues in these animals. One possi­
ble explanation for this apparent paradox is that the increased 
number of sympathetic neurons innervating target tissues re­
sults in elevated uptake and removal of NGF from these tissues 
by retrograde axonal transport, resulting in lower ambient lev­
els of NGF in the targets. Whereas retrograde transport of 
NGF in signaling endosomes to the cell bodies of sympathetic 
neurons is required for survival, the extent of axonal growth 
and branching in target tissues is governed by the ambient level 
of NGF in these tissues (15).
In addition to possessing elevated numbers of sympathetic 
neurons, P/TDi-7- mice have increased numbers of chromaffin 
and glomus cells in the adrenal medulla and carotid body. 
Together with sympathetic neurons, these cells are derived 
from the sympathoadrenal neural crest lineage (22). Whether 
the increase in chromaffin or glomus cell number in PHD3~'~ 
mice results from enhanced survival or from enhanced prolif­
eration and/or differentiation of their precursors is not known.
Despite the increased number of cells in parts of the sym­
pathoadrenal system of PHD3~'~ mice, we observed impaired 
homeostatic and physiological responses regulated by this sys­
tem, including reduced blood pressure, impaired light-to-dark 
pupillary dilation, and reduced catecholamine secretion from 
adrenal chromaffin cells, with lower plasma catecholamine lev­
els in PHD3~/~ mice. Sympathetic function is a key determi­
nant of systemic blood pressure regulation (reviewed in refer­
ence 17), and elevated sympathetic activity is present in many 
forms of human hypertension. Apart from the findings re­
ported here, we have not so far observed other basal abnor­
malities in PHD3_/~ mice. Thus, though PHD3 could have 
other, as-yet-unknown effects on blood pressure regulation, the 
evidence for sympathetic hypofunction, reduced catechol­
amine secretion, reduced responses to activity, and preserved 
responses to exogenous adreno-agonists all support a causal 
link between sympathoadrenal dysregulation and blood pres­
sure dysregulation in PHD3~ ~ animals.
Though previous cellular studies have implicated oxygen- 
dependent catalytic activity of PHD3 in the regulation of neu­
ronal survival, these studies have given conflicting data on the 
role played by the known substrates HIF-la and HIF-2a (23, 
44). In the current work we found that heterozygous inactiva­
tion of HIF-2a, but not HIF-la, had major effects on sympa­
thetic neuronal survival and the neuronal complement of the 
SCG.
Interestingly, neonatal sympathetic failure has been ob­
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FIG. 8. Aortic blood pressures in conscious, adult PHD 3~!~ mice, as measured by radiotelemetry. (A) Pooled frequency histogram of systolic 
blood pressure over the 3-day recording period (using 1 mm Hg bins) from four (wild-type) or five (P //D 3_/_) resting (solid lines) and active 
(dotted lines) mice. (B) Average blood pressure recordings over a 3-day recording period. Decreased systolic and diastolic blood pressures were 
observed in PHD3~ ~ mice. These differences were enhanced when the mice were active.
served in HIF-2a~'~ mice, and HIF-2a mRNA has been re­
ported to be strongly expressed in sympathoadrenal tissues of 
the mouse (42). Though difficulties in obtaining background- 
free immunohistochemical signals precluded assessment in the 
mouse, we have also found that PHD3 is strongly expressed in 
the rat sympathoadrenal system, suggesting that the two pro­
teins are coexpressed in this lineage (B. Wijeyekoon and C. W. 
Pugh, unpublished data). Interestingly, studies of small inter­
fering RNA-mediated suppression of PHDs in tissue culture 
have indicated that PHD3 appears to exert greater regulatory 
effects on HIF-2a than HIF-la (1). Taken together, the sim­
plest synthesis of these findings is that PHD3 inactivation pro­
motes sympathoadrenal neuronal survival, at least in part, 
through upregulation of HIF-2a. Nevertheless, consistent with 
a recent report of pharmacological PHD inhibition in sympa­
thetic neurons (26), HIF-2a protein levels in the SCG of these 
normoxic animals were below the detection threshold for im- 
munohistochemistry, so this could not be confirmed. It should 
also be noted that this explanation does not preclude the ex­
istence of other PHD3 substrates that may contribute to the 
observed effect. Indeed, the lack of effect of HIF-2a heterozy­
gosity on a PHD3-positive background suggests that the rela­
tionship between HIF-2a and neuronal survival is not simple
and depends on PHD3 status, perhaps implying the existence 
of other substrates in addition to HIF-2a. Thus, the impor­
tance of PHD3, as opposed to PHD1 or PHD2, in neuronal 
apoptosis might reflect the existence of a discrete, non-HIF, 
PHD3 substrate in this process, or the relative abundance of 
PHD3 in these cells coupled to the preferred targeting of 
HIF-2a by PHD3, or both.
Whether and how adult sympathetic hypofunction in 
PHD3~'~ mice relates to dysregulation of HIF-2a is also un­
clear. Together with the finding of sympathetic failure in as­
sociation with complete inactivation of HIF-2a in some but not 
all studies (33, 42), our findings suggest that although an intact 
PHD3/HIF-2a system is necessary for proper sympathoadrenal 
development, there is no simple relationship of hyper- or hy- 
pofunctionality to predicted effects of these genotypes on 
HIF-2a levels.
While we have demonstrated physiological deficits in adult 
PHD3~'~ mice, it is not clear whether deficits arise purely as a 
consequence of PHD3 deficiency during development or 
whether there is an ongoing PHD3 requirement for sympa­
thetic function in the adult. A great deal of interest has been 
generated by the possibility that environmental effects on de­
velopment might influence medically important aspects of
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FIG . 9. C a techo lam ine  secre tion  in PHD3~'~ m ice. (A ) R e p resen ta tiv e  am p ero m etric  record ings o f basal ca techo lam ine  re lease , as well 
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the secretion  ra te  (in  fC /m in) u n d e r  basal conditions, as w ell as w ith 20 m M  and  40 m M  potassium  (20 and 40 K). (B ) C ircu la ting  
catecholam ines (ad re n a lin e  and  n o rad re n a lin e )  from  anesth e tized , ad u lt m ice. B oth  ad ren a l slice and  circulating  ca techo lam ines are  red u ced  
in PHD3~!~ m ice.
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adult physiology, such as blood pressure regulation (reviewed 
in references 3 to 5 and 28). However, there are as yet few 
mechanistic clues as to how such processes might operate. The 
dependence of PHD activity on oxygen and cofactors, such as 
the Krebs cycle intermediate 2-oxoglutarate, Fe(II), and ascor- 
bate (35), and inhibition of PHDs by metabolic intermediates, 
such as succinate, fumarate, pyruvate, and oxaloacetate (9, 18, 
19, 21, 27, 36), raises the interesting possibility that environ­
mental influences on PHD3 activity could perturb sympathetic 
development in a manner that might have important effects on 
cardiovascular control.
In conclusion, our findings reveal an important role for 
PHD3 in the developing sympathoadrenal system. It is an 
intriguing possibility that this connection between hypoxia 
pathways and the developing sympathoadrenal system might 
be a means by which changes in oxygen tension could influence 
key aspects of anatomical and physiological maturation of this 
system. Whether this provides a paradigm for environmental 
influences affecting development will be of interest in the fu­
ture.
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